<!DOCTYPE html>
<html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled" lang="en" dir="ltr">
<head>
<meta charset="UTF-8">
<title>Prostate cancer - Wikipedia</title>
<script>document.documentElement.className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled";(function(){var cookie=document.cookie.match(/(?:^|; )enwikimwclientprefs=([^;]+)/);if(cookie){var featureName=cookie[1];document.documentElement.className=document.documentElement.className.replace(featureName+'-enabled',featureName+'-disabled');}}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"d67d9cfd-5bc3-4a71-b213-eeb8c8764d3d","wgCSPNonce":false,
"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Prostate_cancer","wgTitle":"Prostate cancer","wgCurRevisionId":1162216808,"wgRevisionId":1162216808,"wgArticleId":88078,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Wikipedia articles needing clarification from September 2022","Articles citing retracted publications","All articles with dead external links","Articles with dead external links from October 2022","Articles with permanently dead external links","CS1 maint: unfit URL","Articles with short description","Short description matches Wikidata","Short description is different from Wikidata","Wikipedia articles in need of updating from February 2023","All Wikipedia articles in need of updating","Articles needing additional references from August 2020","All articles needing additional references","All articles lacking reliable references",
"Articles lacking reliable references from November 2017","All articles with unsourced statements","Articles with unsourced statements from December 2022","Pages using Sister project links with default search","Articles with Curlie links","Articles with BNF identifiers","Articles with BNFdata identifiers","Articles with GND identifiers","Articles with J9U identifiers","Articles with LCCN identifiers","Articles with NDL identifiers","Articles with NKC identifiers","Prostate cancer","Male genital neoplasia","Neoplastic and hyperplastic prostate disorders","Types of cancer"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Prostate_cancer","wgRelevantArticleId":88078,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},
"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":100000,"wgNoticeProject":"wikipedia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":10,"wgULSCurrentAutonym":"English","wgEditSubmitButtonLabelPublish":true,"wgCentralAuthMobileDomain":false,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q181257","GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false};RLSTATE={"skins.vector.user.styles":"ready","ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","skins.vector.user":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","codex-search-styles":"ready","skins.vector.styles":
"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.wikimediaBadges":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","ext.scribunto.logs","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","mmv.head","mmv.bootstrap.autostart","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.cx.eventlogging.campaigns","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","ext.echo.centralauth","ext.uls.compactlinks","ext.uls.interface","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.growthExperiments.SuggestedEditSession"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=codex-search-styles%7Cext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cskins.vector.icons%2Cstyles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022">
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022"></script>
<meta name="ResourceLoaderDynamicStyles" content="">
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022">
<meta name="generator" content="MediaWiki 1.41.0-wmf.13">
<meta name="referrer" content="origin">
<meta name="referrer" content="origin-when-crossorigin">
<meta name="referrer" content="origin-when-cross-origin">
<meta name="robots" content="max-image-preview:standard">
<meta name="format-detection" content="telephone=no">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/1200px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png">
<meta property="og:image:width" content="1200">
<meta property="og:image:height" content="1069">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/800px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png">
<meta property="og:image:width" content="800">
<meta property="og:image:height" content="713">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/640px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png">
<meta property="og:image:width" content="640">
<meta property="og:image:height" content="570">
<meta name="viewport" content="width=1000">
<meta property="og:title" content="Prostate cancer - Wikipedia">
<meta property="og:type" content="website">
<link rel="preconnect" href="//upload.wikimedia.org">
<link rel="alternate" media="only screen and (max-width: 720px)" href="//en.m.wikipedia.org/wiki/Prostate_cancer">
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Prostate_cancer&amp;action=edit">
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png">
<link rel="icon" href="/static/favicon/wikipedia.ico">
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)">
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd">
<link rel="canonical" href="https://en.wikipedia.org/wiki/Prostate_cancer">
<link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en">
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom">
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<link rel="dns-prefetch" href="//login.wikimedia.org">
</head>
<body class="skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Prostate_cancer rootpage-Prostate_cancer skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a>
<div class="vector-header-container">
	<header class="vector-header mw-header">
		<div class="vector-header-start">
			<nav class="vector-main-menu-landmark" aria-label="Site" role="navigation">
				
<div id="vector-main-menu-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right"  >
	<input type="checkbox"
		id="vector-main-menu-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-main-menu-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Main menu"
		
	/>
	<label
		id="vector-main-menu-dropdown-label"
		for="vector-main-menu-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span>


		<span class="vector-menu-heading-label">Main menu</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


				<div id="vector-main-menu-unpinned-container" class="vector-unpinned-container">
		
<div id="vector-main-menu" class="vector-main-menu vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="main-menu-pinned"
	data-pinnable-element-id="vector-main-menu"
	data-pinned-container-id="vector-main-menu-pinned-container"
	data-unpinned-container-id="vector-main-menu-unpinned-container"
>
	<div class="vector-pinnable-header-label">Main menu</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button>
</div>

	
<div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation"  >
	<div class="vector-menu-heading">
		Navigation
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li><li id="n-sitesupport" class="mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation"><span>Donate</span></a></li></ul>
		
	</div>
</div>

	
	
<div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction"  >
	<div class="vector-menu-heading">
		Contribute
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li></ul>
		
	</div>
</div>

	
<div class="vector-main-menu-action vector-main-menu-action-lang-alert">
	<div class="vector-main-menu-action-item">
		<div class="vector-main-menu-action-heading vector-menu-heading">Languages</div>
		<div class="vector-main-menu-action-content vector-menu-content">
			<div class="mw-message-box-notice vector-language-sidebar-alert mw-message-box">Language links are at the top of the page across from the title.</div>
		</div>
	</div>
</div>

</div>

				</div>

	</div>
</div>
		</nav>
			
<a href="/wiki/Main_Page" class="mw-logo">
	<img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt=""
		aria-hidden="true" height="50" width="50">
	<span class="mw-logo-container">
		<img class="mw-logo-wordmark" alt="Wikipedia"
			src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;">
		<img class="mw-logo-tagline"
			alt="The Free Encyclopedia"
			src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;">
	</span>
</a>

		</div>
		<div class="vector-header-end">
			
<div id="p-search" role="search" class="vector-search-box-vue  vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box">
	<a href="/wiki/Special:Search"
	
		id=""
		class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle"
		title="Search Wikipedia [f]"accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span>

<span>Search</span>
	</a>
	
	<div class="vector-typeahead-search-container">
		<div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width">
			<form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button">
				<div id="simpleSearch" class="cdx-search-input__input-wrapper"  data-search-loc="header-moved">
					<div class="cdx-text-input cdx-text-input--has-start-icon">
						<input
							class="cdx-text-input__input"
							 type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput"
							
						>
						<span class="cdx-text-input__icon cdx-text-input__start-icon"></span>
					</div>
					<input type="hidden" name="title" value="Special:Search">
				</div>
				<button class="cdx-button cdx-search-input__end-button">Search</button>
			</form>
		</div>
	</div>
</div>

			<nav class="vector-user-links" aria-label="Personal tools" role="navigation" >
	
<div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet mw-portlet-vector-user-menu-overflow"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Prostate+cancer" title="You are encouraged to create an account and log in; however, it is not mandatory"><span>Create account</span></a></li><li id="pt-login-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Prostate+cancer" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span>Log in</span></a></li></ul>
		
	</div>
</div>

	
<div id="vector-user-links-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out"  title="Log in and more options" >
	<input type="checkbox"
		id="vector-user-links-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-user-links-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Personal tools"
		
	/>
	<label
		id="vector-user-links-dropdown-label"
		for="vector-user-links-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span>


		<span class="vector-menu-heading-label">Personal tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


		
<div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item"  title="User menu" >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Prostate+cancer" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Prostate+cancer" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li></ul>
		
	</div>
</div>

<div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor"  >
	<div class="vector-menu-heading">
		Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a>
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li></ul>
		
	</div>
</div>

	
	</div>
</div>
</nav>

		</div>
	</header>
</div>
<div class="mw-page-container">
	<div class="mw-page-container-inner">
		<div class="vector-main-menu-container ">
			<div id="mw-navigation">
				<nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site" role="navigation">
					<div id="vector-main-menu-pinned-container" class="vector-pinned-container">
				
					</div>
		</nav>
			</div>
		</div>
		<div class="vector-sitenotice-container">
			<div id="siteNotice"><!-- CentralNotice --></div>
		</div>
		<input type="checkbox" id="vector-toc-collapsed-checkbox" class="vector-menu-checkbox">
		<nav id="mw-panel-toc" role="navigation" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark vector-sticky-pinned-container">
			<div id="vector-toc-pinned-container" class="vector-pinned-container">
					<div id="vector-toc" class="vector-toc vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned"
	data-feature-name="toc-pinned"
	data-pinnable-element-id="vector-toc"
	
	
>
	<h2 class="vector-pinnable-header-label">Contents</h2>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button>
</div>


	<ul class="vector-toc-contents" id="mw-panel-toc-list">
		<li id="toc-mw-content-text"
			class="vector-toc-list-item vector-toc-level-1">
			<a href="#" class="vector-toc-link">
				<div class="vector-toc-text">(Top)</div>
			</a>
		</li>
		<li id="toc-Signs_and_symptoms"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Signs_and_symptoms">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">1</span>Signs and symptoms</div>
		</a>
		
		<ul id="toc-Signs_and_symptoms-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Cause"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Cause">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">2</span>Cause</div>
		</a>
		
		<ul id="toc-Cause-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Risk_factors"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Risk_factors">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">3</span>Risk factors</div>
		</a>
		
			<button aria-controls="toc-Risk_factors-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Risk factors subsection</span>
			</button>
		
		<ul id="toc-Risk_factors-sublist" class="vector-toc-list">
			<li id="toc-Age"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Age">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.1</span>Age</div>
			</a>
			
			<ul id="toc-Age-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Genetics"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Genetics">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.2</span>Genetics</div>
			</a>
			
			<ul id="toc-Genetics-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Body_and_lifestyle"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Body_and_lifestyle">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.3</span>Body and lifestyle</div>
			</a>
			
			<ul id="toc-Body_and_lifestyle-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Inflammation"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Inflammation">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.4</span>Inflammation</div>
			</a>
			
			<ul id="toc-Inflammation-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Pathophysiology"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Pathophysiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">4</span>Pathophysiology</div>
		</a>
		
		<ul id="toc-Pathophysiology-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Screening"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Screening">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">5</span>Screening</div>
		</a>
		
		<ul id="toc-Screening-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Diagnosis"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Diagnosis">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">6</span>Diagnosis</div>
		</a>
		
			<button aria-controls="toc-Diagnosis-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Diagnosis subsection</span>
			</button>
		
		<ul id="toc-Diagnosis-sublist" class="vector-toc-list">
			<li id="toc-Staging"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Staging">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.1</span>Staging</div>
			</a>
			
			<ul id="toc-Staging-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Prevention"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Prevention">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">7</span>Prevention</div>
		</a>
		
		<ul id="toc-Prevention-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Management"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Management">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">8</span>Management</div>
		</a>
		
			<button aria-controls="toc-Management-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Management subsection</span>
			</button>
		
		<ul id="toc-Management-sublist" class="vector-toc-list">
			<li id="toc-Localized_disease"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Localized_disease">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">8.1</span>Localized disease</div>
			</a>
			
			<ul id="toc-Localized_disease-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Metastatic_disease"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Metastatic_disease">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">8.2</span>Metastatic disease</div>
			</a>
			
			<ul id="toc-Metastatic_disease-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Supportive_care"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Supportive_care">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">8.3</span>Supportive care</div>
			</a>
			
			<ul id="toc-Supportive_care-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Prognosis"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Prognosis">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">9</span>Prognosis</div>
		</a>
		
		<ul id="toc-Prognosis-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Epidemiology"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Epidemiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">10</span>Epidemiology</div>
		</a>
		
			<button aria-controls="toc-Epidemiology-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Epidemiology subsection</span>
			</button>
		
		<ul id="toc-Epidemiology-sublist" class="vector-toc-list">
			<li id="toc-United_States"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#United_States">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.1</span>United States</div>
			</a>
			
			<ul id="toc-United_States-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Canada"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Canada">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.2</span>Canada</div>
			</a>
			
			<ul id="toc-Canada-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Europe"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Europe">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.3</span>Europe</div>
			</a>
			
			<ul id="toc-Europe-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-History"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#History">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">11</span>History</div>
		</a>
		
		<ul id="toc-History-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Society_and_culture"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Society_and_culture">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">12</span>Society and culture</div>
		</a>
		
		<ul id="toc-Society_and_culture-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Research"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Research">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">13</span>Research</div>
		</a>
		
			<button aria-controls="toc-Research-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Research subsection</span>
			</button>
		
		<ul id="toc-Research-sublist" class="vector-toc-list">
			<li id="toc-Castration-resistant_prostate_cancer"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Castration-resistant_prostate_cancer">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">13.1</span>Castration-resistant prostate cancer</div>
			</a>
			
			<ul id="toc-Castration-resistant_prostate_cancer-sublist" class="vector-toc-list">
				<li id="toc-Evolution"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Evolution">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">13.1.1</span>Evolution</div>
			</a>
			
			<ul id="toc-Evolution-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
		</li>
		<li id="toc-Pre-clinical"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Pre-clinical">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">13.2</span>Pre-clinical</div>
			</a>
			
			<ul id="toc-Pre-clinical-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Cancer_models"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Cancer_models">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">13.3</span>Cancer models</div>
			</a>
			
			<ul id="toc-Cancer_models-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Diagnosis_2"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Diagnosis_2">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">13.4</span>Diagnosis</div>
			</a>
			
			<ul id="toc-Diagnosis_2-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-See_also"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#See_also">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">14</span>See also</div>
		</a>
		
		<ul id="toc-See_also-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-References"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#References">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">15</span>References</div>
		</a>
		
			<button aria-controls="toc-References-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle References subsection</span>
			</button>
		
		<ul id="toc-References-sublist" class="vector-toc-list">
			<li id="toc-Works_cited"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Works_cited">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">15.1</span>Works cited</div>
			</a>
			
			<ul id="toc-Works_cited-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-External_links"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#External_links">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">16</span>External links</div>
		</a>
		
		<ul id="toc-External_links-sublist" class="vector-toc-list">
		</ul>
	</li>
</ul>
</div>

			</div>
		</nav>
		<div class="mw-content-container">
			<main id="content" class="mw-body" role="main">
				<header class="mw-body-header vector-page-titlebar">
					<label
						id="vector-toc-collapsed-button"
						class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet vector-button-flush-left cdx-button--icon-only"
						for="vector-toc-collapsed-checkbox"
						role="button"
						aria-controls="vector-toc"
						tabindex="0"
						title="Table of Contents">
						<span class="vector-icon mw-ui-icon-wikimedia-listBullet"></span>
						<span>Toggle the table of contents</span>
					</label>
				
					<nav role="navigation" aria-label="Contents" class="vector-toc-landmark">
						
<div id="vector-page-titlebar-toc" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-titlebar-toc vector-button-flush-left"  >
	<input type="checkbox"
		id="vector-page-titlebar-toc-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-titlebar-toc"
		class="vector-menu-checkbox "
		
		aria-label="Toggle the table of contents"
		
	/>
	<label
		id="vector-page-titlebar-toc-label"
		for="vector-page-titlebar-toc-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span>


		<span class="vector-menu-heading-label">Toggle the table of contents</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


							<div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container">
			</div>
		
	</div>
</div>
					</nav>
					<h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">Prostate cancer</span></h1>
				
							
<div id="p-lang-btn" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-lang"  >
	<input type="checkbox"
		id="p-lang-btn-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-lang-btn"
		class="vector-menu-checkbox mw-interlanguage-selector"
		aria-label="Go to an article in another language. Available in 73 languages"
		
		
	/>
	<label
		id="p-lang-btn-label"
		for="p-lang-btn-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-73"
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span>


		<span class="vector-menu-heading-label">73 languages</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

		<div class="vector-menu-content">
			
			<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-af mw-list-item"><a href="https://af.wikipedia.org/wiki/Prostaatkanker" title="Prostaatkanker – Afrikaans" lang="af" hreflang="af" class="interlanguage-link-target"><span>Afrikaans</span></a></li><li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D8%A7%D9%84%D8%A8%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA%D8%A7" title="سرطان البروستاتا – Arabic" lang="ar" hreflang="ar" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-ast mw-list-item"><a href="https://ast.wikipedia.org/wiki/C%C3%A1ncanu_de_pr%C3%B3stata" title="Cáncanu de próstata – Asturian" lang="ast" hreflang="ast" class="interlanguage-link-target"><span>Asturianu</span></a></li><li class="interlanguage-link interwiki-az mw-list-item"><a href="https://az.wikipedia.org/wiki/Prostat_x%C9%99r%C3%A7%C9%99ngi" title="Prostat xərçəngi – Azerbaijani" lang="az" hreflang="az" class="interlanguage-link-target"><span>Azərbaycanca</span></a></li><li class="interlanguage-link interwiki-bn mw-list-item"><a href="https://bn.wikipedia.org/wiki/%E0%A6%AA%E0%A7%8D%E0%A6%B0%E0%A7%8B%E0%A6%B8%E0%A7%8D%E0%A6%9F%E0%A7%87%E0%A6%9F_%E0%A6%95%E0%A7%8D%E0%A6%AF%E0%A6%BE%E0%A6%A8%E0%A7%8D%E0%A6%B8%E0%A6%BE%E0%A6%B0" title="প্রোস্টেট ক্যান্সার – Bangla" lang="bn" hreflang="bn" class="interlanguage-link-target"><span>বাংলা</span></a></li><li class="interlanguage-link interwiki-be mw-list-item"><a href="https://be.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BF%D1%80%D0%B0%D0%B4%D1%81%D1%82%D0%B0%D0%BB%D1%91%D0%B2%D0%B0%D0%B9_%D0%B7%D0%B0%D0%BB%D0%BE%D0%B7%D1%8B" title="Рак прадсталёвай залозы – Belarusian" lang="be" hreflang="be" class="interlanguage-link-target"><span>Беларуская</span></a></li><li class="interlanguage-link interwiki-be-x-old mw-list-item"><a href="https://be-tarask.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BF%D0%B0%D0%B4%D0%BA%D0%B0%D1%80%D1%8D%D0%BD%D1%8C%D0%BD%D1%96%D1%86%D1%8B" title="Рак падкарэньніцы – Belarusian (Taraškievica orthography)" lang="be-tarask" hreflang="be-tarask" class="interlanguage-link-target"><span>Беларуская (тарашкевіца)</span></a></li><li class="interlanguage-link interwiki-bg mw-list-item"><a href="https://bg.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BD%D0%B0_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B0%D1%82%D0%B0" title="Рак на простатата – Bulgarian" lang="bg" hreflang="bg" class="interlanguage-link-target"><span>Български</span></a></li><li class="interlanguage-link interwiki-bs mw-list-item"><a href="https://bs.wikipedia.org/wiki/Rak_prostate" title="Rak prostate – Bosnian" lang="bs" hreflang="bs" class="interlanguage-link-target"><span>Bosanski</span></a></li><li class="interlanguage-link interwiki-ca badge-Q17437798 badge-goodarticle mw-list-item" title="good article badge"><a href="https://ca.wikipedia.org/wiki/C%C3%A0ncer_de_pr%C3%B2stata" title="Càncer de pròstata – Catalan" lang="ca" hreflang="ca" class="interlanguage-link-target"><span>Català</span></a></li><li class="interlanguage-link interwiki-cs mw-list-item"><a href="https://cs.wikipedia.org/wiki/Karcinom_prostaty" title="Karcinom prostaty – Czech" lang="cs" hreflang="cs" class="interlanguage-link-target"><span>Čeština</span></a></li><li class="interlanguage-link interwiki-cy mw-list-item"><a href="https://cy.wikipedia.org/wiki/Canser_y_brostad" title="Canser y brostad – Welsh" lang="cy" hreflang="cy" class="interlanguage-link-target"><span>Cymraeg</span></a></li><li class="interlanguage-link interwiki-da mw-list-item"><a href="https://da.wikipedia.org/wiki/Prostatakr%C3%A6ft" title="Prostatakræft – Danish" lang="da" hreflang="da" class="interlanguage-link-target"><span>Dansk</span></a></li><li class="interlanguage-link interwiki-de badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://de.wikipedia.org/wiki/Prostatakrebs" title="Prostatakrebs – German" lang="de" hreflang="de" class="interlanguage-link-target"><span>Deutsch</span></a></li><li class="interlanguage-link interwiki-dv mw-list-item"><a href="https://dv.wikipedia.org/wiki/%DE%95%DE%B0%DE%83%DE%AE%DE%90%DE%B0%DE%93%DE%AD%DE%93%DE%B0_%DE%86%DE%AC%DE%82%DE%B0%DE%90%DE%A6%DE%83%DE%AA" title="ޕްރޮސްޓޭޓް ކެންސަރު – Divehi" lang="dv" hreflang="dv" class="interlanguage-link-target"><span>ދިވެހިބަސް</span></a></li><li class="interlanguage-link interwiki-et mw-list-item"><a href="https://et.wikipedia.org/wiki/Eesn%C3%A4%C3%A4rme_kartsinoom" title="Eesnäärme kartsinoom – Estonian" lang="et" hreflang="et" class="interlanguage-link-target"><span>Eesti</span></a></li><li class="interlanguage-link interwiki-el mw-list-item"><a href="https://el.wikipedia.org/wiki/%CE%9A%CE%B1%CF%81%CE%BA%CE%AF%CE%BD%CE%BF%CF%82_%CF%84%CE%BF%CF%85_%CF%80%CF%81%CE%BF%CF%83%CF%84%CE%AC%CF%84%CE%B7" title="Καρκίνος του προστάτη – Greek" lang="el" hreflang="el" class="interlanguage-link-target"><span>Ελληνικά</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/C%C3%A1ncer_de_pr%C3%B3stata" title="Cáncer de próstata – Spanish" lang="es" hreflang="es" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-eo mw-list-item"><a href="https://eo.wikipedia.org/wiki/Prostata_kancero" title="Prostata kancero – Esperanto" lang="eo" hreflang="eo" class="interlanguage-link-target"><span>Esperanto</span></a></li><li class="interlanguage-link interwiki-eu mw-list-item"><a href="https://eu.wikipedia.org/wiki/Prostatako_minbizi" title="Prostatako minbizi – Basque" lang="eu" hreflang="eu" class="interlanguage-link-target"><span>Euskara</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D9%BE%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA" title="سرطان پروستات – Persian" lang="fa" hreflang="fa" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Cancer_de_la_prostate" title="Cancer de la prostate – French" lang="fr" hreflang="fr" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-ga mw-list-item"><a href="https://ga.wikipedia.org/wiki/Ailse_phr%C3%B3stataigh" title="Ailse phróstataigh – Irish" lang="ga" hreflang="ga" class="interlanguage-link-target"><span>Gaeilge</span></a></li><li class="interlanguage-link interwiki-gl mw-list-item"><a href="https://gl.wikipedia.org/wiki/Cancro_de_pr%C3%B3stata" title="Cancro de próstata – Galician" lang="gl" hreflang="gl" class="interlanguage-link-target"><span>Galego</span></a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/%EC%A0%84%EB%A6%BD%EC%84%A0%EC%95%94" title="전립선암 – Korean" lang="ko" hreflang="ko" class="interlanguage-link-target"><span>한국어</span></a></li><li class="interlanguage-link interwiki-ha mw-list-item"><a href="https://ha.wikipedia.org/wiki/Ciwon_daji_na_prostate" title="Ciwon daji na prostate – Hausa" lang="ha" hreflang="ha" class="interlanguage-link-target"><span>Hausa</span></a></li><li class="interlanguage-link interwiki-hy mw-list-item"><a href="https://hy.wikipedia.org/wiki/%D5%87%D5%A1%D5%A3%D5%A1%D5%B6%D5%A1%D5%AF%D5%A1%D5%A3%D5%A5%D5%B2%D5%B1%D5%AB_%D6%84%D5%A1%D5%B2%D6%81%D5%AF%D5%A5%D5%B2" title="Շագանակագեղձի քաղցկեղ – Armenian" lang="hy" hreflang="hy" class="interlanguage-link-target"><span>Հայերեն</span></a></li><li class="interlanguage-link interwiki-hi mw-list-item"><a href="https://hi.wikipedia.org/wiki/%E0%A4%AA%E0%A5%8D%E0%A4%B0%E0%A5%8B%E0%A4%B8%E0%A5%8D%E0%A4%9F%E0%A5%87%E0%A4%9F_%E0%A4%95%E0%A5%88%E0%A4%82%E0%A4%B8%E0%A4%B0" title="प्रोस्टेट कैंसर – Hindi" lang="hi" hreflang="hi" class="interlanguage-link-target"><span>हिन्दी</span></a></li><li class="interlanguage-link interwiki-hr mw-list-item"><a href="https://hr.wikipedia.org/wiki/Rak_prostate" title="Rak prostate – Croatian" lang="hr" hreflang="hr" class="interlanguage-link-target"><span>Hrvatski</span></a></li><li class="interlanguage-link interwiki-id mw-list-item"><a href="https://id.wikipedia.org/wiki/Kanker_prostat" title="Kanker prostat – Indonesian" lang="id" hreflang="id" class="interlanguage-link-target"><span>Bahasa Indonesia</span></a></li><li class="interlanguage-link interwiki-it badge-Q17437798 badge-goodarticle mw-list-item" title="good article badge"><a href="https://it.wikipedia.org/wiki/Carcinoma_della_prostata" title="Carcinoma della prostata – Italian" lang="it" hreflang="it" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%A1%D7%A8%D7%98%D7%9F_%D7%94%D7%A2%D7%A8%D7%9E%D7%95%D7%A0%D7%99%D7%AA" title="סרטן הערמונית – Hebrew" lang="he" hreflang="he" class="interlanguage-link-target"><span>עברית</span></a></li><li class="interlanguage-link interwiki-jv mw-list-item"><a href="https://jv.wikipedia.org/wiki/Kanker_prostat" title="Kanker prostat – Javanese" lang="jv" hreflang="jv" class="interlanguage-link-target"><span>Jawa</span></a></li><li class="interlanguage-link interwiki-la mw-list-item"><a href="https://la.wikipedia.org/wiki/Cancer_prostatae" title="Cancer prostatae – Latin" lang="la" hreflang="la" class="interlanguage-link-target"><span>Latina</span></a></li><li class="interlanguage-link interwiki-lv mw-list-item"><a href="https://lv.wikipedia.org/wiki/Prostatas_v%C4%93zis" title="Prostatas vēzis – Latvian" lang="lv" hreflang="lv" class="interlanguage-link-target"><span>Latviešu</span></a></li><li class="interlanguage-link interwiki-lt mw-list-item"><a href="https://lt.wikipedia.org/wiki/Prostatos_v%C4%97%C5%BEys" title="Prostatos vėžys – Lithuanian" lang="lt" hreflang="lt" class="interlanguage-link-target"><span>Lietuvių</span></a></li><li class="interlanguage-link interwiki-ln mw-list-item"><a href="https://ln.wikipedia.org/wiki/Kov%C3%ADmba_ya_prost%C3%A1ti" title="Kovímba ya prostáti – Lingala" lang="ln" hreflang="ln" class="interlanguage-link-target"><span>Lingála</span></a></li><li class="interlanguage-link interwiki-hu mw-list-item"><a href="https://hu.wikipedia.org/wiki/Prosztatar%C3%A1k" title="Prosztatarák – Hungarian" lang="hu" hreflang="hu" class="interlanguage-link-target"><span>Magyar</span></a></li><li class="interlanguage-link interwiki-mk mw-list-item"><a href="https://mk.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BD%D0%B0_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B0" title="Рак на простата – Macedonian" lang="mk" hreflang="mk" class="interlanguage-link-target"><span>Македонски</span></a></li><li class="interlanguage-link interwiki-mr mw-list-item"><a href="https://mr.wikipedia.org/wiki/%E0%A4%AA%E0%A5%8C%E0%A4%B0%E0%A5%81%E0%A4%B7_%E0%A4%97%E0%A5%8D%E0%A4%B0%E0%A4%82%E0%A4%A5%E0%A5%80%E0%A4%9A%E0%A4%BE_%E0%A4%95%E0%A4%B0%E0%A5%8D%E0%A4%95%E0%A4%B0%E0%A5%8B%E0%A4%97" title="पौरुष ग्रंथीचा कर्करोग – Marathi" lang="mr" hreflang="mr" class="interlanguage-link-target"><span>मराठी</span></a></li><li class="interlanguage-link interwiki-arz mw-list-item"><a href="https://arz.wikipedia.org/wiki/%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D8%A8%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA%D8%A7" title="سرطان بروستاتا – Egyptian Arabic" lang="arz" hreflang="arz" class="interlanguage-link-target"><span>مصرى</span></a></li><li class="interlanguage-link interwiki-ms mw-list-item"><a href="https://ms.wikipedia.org/wiki/Barah_prostat" title="Barah prostat – Malay" lang="ms" hreflang="ms" class="interlanguage-link-target"><span>Bahasa Melayu</span></a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Prostaatkanker" title="Prostaatkanker – Dutch" lang="nl" hreflang="nl" class="interlanguage-link-target"><span>Nederlands</span></a></li><li class="interlanguage-link interwiki-new mw-list-item"><a href="https://new.wikipedia.org/wiki/%E0%A4%AA%E0%A5%8D%E0%A4%B0%E0%A5%8B%E0%A4%B8%E0%A5%8D%E0%A4%9F%E0%A5%8D%E0%A4%B0%E0%A5%87%E0%A4%9F_%E0%A4%95%E0%A5%8D%E0%A4%AF%E0%A4%BE%E0%A4%A8%E0%A5%8D%E0%A4%B8%E0%A4%B0" title="प्रोस्ट्रेट क्यान्सर – Newari" lang="new" hreflang="new" class="interlanguage-link-target"><span>नेपाल भाषा</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E5%89%8D%E7%AB%8B%E8%85%BA%E7%99%8C" title="前立腺癌 – Japanese" lang="ja" hreflang="ja" class="interlanguage-link-target"><span>日本語</span></a></li><li class="interlanguage-link interwiki-no mw-list-item"><a href="https://no.wikipedia.org/wiki/Prostatakreft" title="Prostatakreft – Norwegian Bokmål" lang="nb" hreflang="nb" class="interlanguage-link-target"><span>Norsk bokmål</span></a></li><li class="interlanguage-link interwiki-or mw-list-item"><a href="https://or.wikipedia.org/wiki/%E0%AC%AA%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AD%8D%E0%AC%9F%E0%AD%87%E0%AC%9F_%E0%AC%95%E0%AC%B0%E0%AD%8D%E0%AC%95%E0%AC%9F" title="ପ୍ରୋସ୍ଟେଟ କର୍କଟ – Odia" lang="or" hreflang="or" class="interlanguage-link-target"><span>ଓଡ଼ିଆ</span></a></li><li class="interlanguage-link interwiki-pa mw-list-item"><a href="https://pa.wikipedia.org/wiki/%E0%A8%AA%E0%A9%8D%E0%A8%B0%E0%A9%8B%E0%A8%B8%E0%A8%9F%E0%A9%87%E0%A8%9F_%E0%A8%95%E0%A9%88%E0%A8%82%E0%A8%B8%E0%A8%B0" title="ਪ੍ਰੋਸਟੇਟ ਕੈਂਸਰ – Punjabi" lang="pa" hreflang="pa" class="interlanguage-link-target"><span>ਪੰਜਾਬੀ</span></a></li><li class="interlanguage-link interwiki-ps mw-list-item"><a href="https://ps.wikipedia.org/wiki/%D8%AF_%D9%BE%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA_%D8%B3%D8%B1%D8%B7%D8%A7%D9%86" title="د پروستات سرطان – Pashto" lang="ps" hreflang="ps" class="interlanguage-link-target"><span>پښتو</span></a></li><li class="interlanguage-link interwiki-pl badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://pl.wikipedia.org/wiki/Rak_gruczo%C5%82u_krokowego" title="Rak gruczołu krokowego – Polish" lang="pl" hreflang="pl" class="interlanguage-link-target"><span>Polski</span></a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/C%C3%A2ncer_de_pr%C3%B3stata" title="Câncer de próstata – Portuguese" lang="pt" hreflang="pt" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Cancer_de_prostat%C4%83" title="Cancer de prostată – Romanian" lang="ro" hreflang="ro" class="interlanguage-link-target"><span>Română</span></a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BF%D1%80%D0%B5%D0%B4%D1%81%D1%82%D0%B0%D1%82%D0%B5%D0%BB%D1%8C%D0%BD%D0%BE%D0%B9_%D0%B6%D0%B5%D0%BB%D0%B5%D0%B7%D1%8B" title="Рак предстательной железы – Russian" lang="ru" hreflang="ru" class="interlanguage-link-target"><span>Русский</span></a></li><li class="interlanguage-link interwiki-simple mw-list-item"><a href="https://simple.wikipedia.org/wiki/Prostate_cancer" title="Prostate cancer – Simple English" lang="en-simple" hreflang="en-simple" class="interlanguage-link-target"><span>Simple English</span></a></li><li class="interlanguage-link interwiki-sk mw-list-item"><a href="https://sk.wikipedia.org/wiki/Rakovina_prostaty" title="Rakovina prostaty – Slovak" lang="sk" hreflang="sk" class="interlanguage-link-target"><span>Slovenčina</span></a></li><li class="interlanguage-link interwiki-sl mw-list-item"><a href="https://sl.wikipedia.org/wiki/Rak_prostate" title="Rak prostate – Slovenian" lang="sl" hreflang="sl" class="interlanguage-link-target"><span>Slovenščina</span></a></li><li class="interlanguage-link interwiki-ckb mw-list-item"><a href="https://ckb.wikipedia.org/wiki/%D8%B4%DB%8E%D8%B1%D9%BE%DB%95%D9%86%D8%AC%DB%95%DB%8C_%D9%BE%D8%B1%DB%86%D8%B3%D8%AA%D8%A7%D8%AA" title="شێرپەنجەی پرۆستات – Central Kurdish" lang="ckb" hreflang="ckb" class="interlanguage-link-target"><span>کوردی</span></a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/Zlo%C4%87udni_rak_kestenja%C4%8De" title="Zloćudni rak kestenjače – Serbian" lang="sr" hreflang="sr" class="interlanguage-link-target"><span>Српски / srpski</span></a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Rak_prostate" title="Rak prostate – Serbo-Croatian" lang="sh" hreflang="sh" class="interlanguage-link-target"><span>Srpskohrvatski / српскохрватски</span></a></li><li class="interlanguage-link interwiki-su mw-list-item"><a href="https://su.wikipedia.org/wiki/Kangker_prostat" title="Kangker prostat – Sundanese" lang="su" hreflang="su" class="interlanguage-link-target"><span>Sunda</span></a></li><li class="interlanguage-link interwiki-fi badge-Q17437796 badge-featuredarticle mw-list-item" title="featured article badge"><a href="https://fi.wikipedia.org/wiki/Eturauhasen_sy%C3%B6p%C3%A4" title="Eturauhasen syöpä – Finnish" lang="fi" hreflang="fi" class="interlanguage-link-target"><span>Suomi</span></a></li><li class="interlanguage-link interwiki-sv mw-list-item"><a href="https://sv.wikipedia.org/wiki/Prostatacancer" title="Prostatacancer – Swedish" lang="sv" hreflang="sv" class="interlanguage-link-target"><span>Svenska</span></a></li><li class="interlanguage-link interwiki-tl mw-list-item"><a href="https://tl.wikipedia.org/wiki/Kanser_sa_prostata" title="Kanser sa prostata – Tagalog" lang="tl" hreflang="tl" class="interlanguage-link-target"><span>Tagalog</span></a></li><li class="interlanguage-link interwiki-ta mw-list-item"><a href="https://ta.wikipedia.org/wiki/%E0%AE%AE%E0%AF%81%E0%AE%A9%E0%AF%8D%E0%AE%A9%E0%AE%BF%E0%AE%B1%E0%AF%8D%E0%AE%95%E0%AF%81%E0%AE%9E%E0%AF%8D%E0%AE%9A%E0%AF%81%E0%AE%B0%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AE%BF_%E0%AE%AA%E0%AF%81%E0%AE%B1%E0%AF%8D%E0%AE%B1%E0%AF%81%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D" title="முன்னிற்குஞ்சுரப்பி புற்றுநோய் – Tamil" lang="ta" hreflang="ta" class="interlanguage-link-target"><span>தமிழ்</span></a></li><li class="interlanguage-link interwiki-tt mw-list-item"><a href="https://tt.wikipedia.org/wiki/%D0%9F%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B0_%D0%B1%D0%B8%D0%B7%D0%B5_%D1%8F%D0%BC%D0%B0%D0%BD_%D1%88%D0%B5%D1%88%D0%B5" title="Простата бизе яман шеше – Tatar" lang="tt" hreflang="tt" class="interlanguage-link-target"><span>Татарча / tatarça</span></a></li><li class="interlanguage-link interwiki-te mw-list-item"><a href="https://te.wikipedia.org/wiki/%E0%B0%AA%E0%B1%8C%E0%B0%B0%E0%B1%81%E0%B0%B7_%E0%B0%97%E0%B1%8D%E0%B0%B0%E0%B0%82%E0%B0%A7%E0%B0%BF_%E0%B0%95%E0%B1%8D%E0%B0%AF%E0%B0%BE%E0%B0%A8%E0%B1%8D%E0%B0%B8%E0%B0%B0%E0%B1%8D" title="పౌరుష గ్రంధి క్యాన్సర్ – Telugu" lang="te" hreflang="te" class="interlanguage-link-target"><span>తెలుగు</span></a></li><li class="interlanguage-link interwiki-th mw-list-item"><a href="https://th.wikipedia.org/wiki/%E0%B8%A1%E0%B8%B0%E0%B9%80%E0%B8%A3%E0%B9%87%E0%B8%87%E0%B8%95%E0%B9%88%E0%B8%AD%E0%B8%A1%E0%B8%A5%E0%B8%B9%E0%B8%81%E0%B8%AB%E0%B8%A1%E0%B8%B2%E0%B8%81" title="มะเร็งต่อมลูกหมาก – Thai" lang="th" hreflang="th" class="interlanguage-link-target"><span>ไทย</span></a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/Prostat_kanseri" title="Prostat kanseri – Turkish" lang="tr" hreflang="tr" class="interlanguage-link-target"><span>Türkçe</span></a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%B8" title="Рак простати – Ukrainian" lang="uk" hreflang="uk" class="interlanguage-link-target"><span>Українська</span></a></li><li class="interlanguage-link interwiki-vi mw-list-item"><a href="https://vi.wikipedia.org/wiki/Ung_th%C6%B0_tuy%E1%BA%BFn_ti%E1%BB%81n_li%E1%BB%87t" title="Ung thư tuyến tiền liệt – Vietnamese" lang="vi" hreflang="vi" class="interlanguage-link-target"><span>Tiếng Việt</span></a></li><li class="interlanguage-link interwiki-wuu mw-list-item"><a href="https://wuu.wikipedia.org/wiki/%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" title="前列腺癌 – Wu Chinese" lang="wuu" hreflang="wuu" class="interlanguage-link-target"><span>吴语</span></a></li><li class="interlanguage-link interwiki-zh-yue mw-list-item"><a href="https://zh-yue.wikipedia.org/wiki/%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" title="前列腺癌 – Cantonese" lang="yue" hreflang="yue" class="interlanguage-link-target"><span>粵語</span></a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" title="前列腺癌 – Chinese" lang="zh" hreflang="zh" class="interlanguage-link-target"><span>中文</span></a></li></ul>
			<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q181257#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
		</div>

	</div>
</div>
				</header>
				<div class="vector-page-toolbar">
					<div class="vector-page-toolbar-container">
						<div id="left-navigation">
							<nav aria-label="Namespaces">
								
<div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Prostate_cancer" title="View the content page [c]" accesskey="c" class=""><span>Article</span></a>
</li>
<li id="ca-talk" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Talk:Prostate_cancer" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t" class=""><span>Talk</span></a>
</li>

		</ul>
		
	</div>
</div>

								

<div id="p-variants" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-variants emptyPortlet"  >
	<input type="checkbox"
		id="p-variants-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-variants"
		class="vector-menu-checkbox"
		aria-label="Change language variant"
		
		
	/>
	<label
		id="p-variants-label"
		for="p-variants-checkbox"
		class="vector-menu-heading "
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">English</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"></ul>
		
	</div>

	</div>
</div>
							</nav>
						</div>
						<div id="right-navigation" class="vector-collapsible">
							<nav aria-label="Views">
								
<div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Prostate_cancer" class=""><span>Read</span></a>
</li>
<li id="ca-edit" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=Prostate_cancer&amp;action=edit" title="Edit this page [e]" accesskey="e" class=""><span>Edit</span></a>
</li>
<li id="ca-history" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=Prostate_cancer&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class=""><span>View history</span></a>
</li>

		</ul>
		
	</div>
</div>

							</nav>
				
							<nav class="vector-page-tools-landmark" aria-label="More options">
								
<div id="vector-page-tools-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-tools-dropdown"  >
	<input type="checkbox"
		id="vector-page-tools-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-tools-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Tools"
		
	/>
	<label
		id="vector-page-tools-dropdown-label"
		for="vector-page-tools-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet"
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">Tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


									<div id="vector-page-tools-unpinned-container" class="vector-unpinned-container">
						
<div id="vector-page-tools" class="vector-page-tools vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="page-tools-pinned"
	data-pinnable-element-id="vector-page-tools"
	data-pinned-container-id="vector-page-tools-pinned-container"
	data-unpinned-container-id="vector-page-tools-unpinned-container"
>
	<div class="vector-pinnable-header-label">Tools</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button>
</div>

	
<div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items"  title="More options" >
	<div class="vector-menu-heading">
		Actions
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Prostate_cancer"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Prostate_cancer&amp;action=edit"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Prostate_cancer&amp;action=history"><span>View history</span></a></li></ul>
		
	</div>
</div>

<div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb"  >
	<div class="vector-menu-heading">
		General
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Prostate_cancer" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Prostate_cancer" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Prostate_cancer&amp;oldid=1162216808" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Prostate_cancer&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Prostate_cancer&amp;id=1162216808&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-wikibase" class="mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q181257" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li></ul>
		
	</div>
</div>

<div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export"  >
	<div class="vector-menu-heading">
		Print/export
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Prostate_cancer&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Prostate_cancer&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li></ul>
		
	</div>
</div>

<div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects"  >
	<div class="vector-menu-heading">
		In other projects
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Prostate_cancer" hreflang="en"><span>Wikimedia Commons</span></a></li></ul>
		
	</div>
</div>

</div>

									</div>
				
	</div>
</div>
							</nav>
						</div>
					</div>
				</div>
				<div class="vector-column-end">
					<nav class="vector-page-tools-landmark vector-sticky-pinned-container" aria-label="More options">
						<div id="vector-page-tools-pinned-container" class="vector-pinned-container">
			
						</div>
	</nav>
				</div>
				<div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container>
					<div class="vector-body-before-content">
							<div class="mw-indicators">
		</div>

						<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
					</div>
					<div id="contentSub"><div id="mw-content-subtitle"></div></div>
					
					
					<div id="mw-content-text" class="mw-body-content mw-content-ltr" lang="en" dir="ltr"><div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Male reproductive organ cancer</div>
<div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Medical condition</div><style data-mw-deduplicate="TemplateStyles:r1066479718">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}</style><table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background:#ccc">Prostate cancer</th></tr><tr><th scope="row" class="infobox-label">Other names</th><td class="infobox-data">Carcinoma of the prostate</td></tr><tr><td colspan="2" class="infobox-full-data"><a href="/wiki/File:Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg" class="image"><img alt="Diagram showing the position of the prostate and rectum CRUK 358.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/300px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png" decoding="async" width="300" height="267" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/450px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg/600px-Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg.png 2x" data-file-width="375" data-file-height="334" /></a></td></tr><tr><td colspan="2" class="infobox-full-data">Position of the prostate</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_specialty" title="Medical specialty">Specialty</a></th><td class="infobox-data"><a href="/wiki/Oncology" title="Oncology">Oncology</a>, <a href="/wiki/Urology" title="Urology">urology</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Signs_and_symptoms" title="Signs and symptoms">Symptoms</a></th><td class="infobox-data">None, difficulty <a href="/wiki/Urination" title="Urination">urinating</a>, blood in the urine, <a href="/wiki/Pelvic_pain" title="Pelvic pain">pain in the pelvis</a>, back, or when urinating<sup id="cite_ref-NCI2014TxPro_1-0" class="reference"><a href="#cite_note-NCI2014TxPro-1">&#91;1&#93;</a></sup><sup id="cite_ref-NCI2013TxPt_2-0" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Usual onset</th><td class="infobox-data">Age &gt; 50<sup id="cite_ref-WCR2014_3-0" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Risk_factor" title="Risk factor">Risk factors</a></th><td class="infobox-data">Older age, family history, race<sup id="cite_ref-WCR2014_3-1" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_diagnosis" title="Medical diagnosis">Diagnostic method</a></th><td class="infobox-data"><a href="/wiki/Tissue_biopsy" class="mw-redirect" title="Tissue biopsy">Tissue biopsy</a>, <a href="/wiki/Medical_imaging" title="Medical imaging">medical imaging</a><sup id="cite_ref-NCI2013TxPt_2-1" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Differential_diagnosis" title="Differential diagnosis">Differential diagnosis</a></th><td class="infobox-data"><a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">Benign prostatic hyperplasia</a><sup id="cite_ref-NCI2014TxPro_1-1" class="reference"><a href="#cite_note-NCI2014TxPro-1">&#91;1&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Treatment</th><td class="infobox-data"><a href="/wiki/Active_surveillance_of_prostate_cancer" title="Active surveillance of prostate cancer">Active surveillance</a>, surgery, <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a>, <a href="/wiki/Hormonal_therapy_(oncology)" title="Hormonal therapy (oncology)">hormone therapy</a>, <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a><sup id="cite_ref-NCI2013TxPt_2-2" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Prognosis" title="Prognosis">Prognosis</a></th><td class="infobox-data"><a href="/wiki/Five-year_survival_rate" title="Five-year survival rate">five-year survival rate</a> 97.1% (US)<sup id="cite_ref-SEER2014_4-0" class="reference"><a href="#cite_note-SEER2014-4">&#91;4&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Frequency</th><td class="infobox-data">1.2 million new cases (2018)<sup id="cite_ref-Bray2018_5-0" class="reference"><a href="#cite_note-Bray2018-5">&#91;5&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Deaths</th><td class="infobox-data">359,000 (2018)<sup id="cite_ref-Bray2018_5-1" class="reference"><a href="#cite_note-Bray2018-5">&#91;5&#93;</a></sup></td></tr></tbody></table>
<p><a href="/wiki/Cancer" title="Cancer">Cancer</a> of the <a href="/wiki/Prostate" title="Prostate">prostate</a><sup id="cite_ref-6" class="reference"><a href="#cite_note-6">&#91;6&#93;</a></sup><sup id="cite_ref-7" class="reference"><a href="#cite_note-7">&#91;7&#93;</a></sup> is the second most common <a href="/wiki/Cancerous_tumor" class="mw-redirect" title="Cancerous tumor">cancerous tumor</a> worldwide and is the fifth leading cause of cancer-related mortality among men.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">&#91;8&#93;</a></sup> The prostate is a <a href="/wiki/Gland" title="Gland">gland</a> in the <a href="/wiki/Male_reproductive_system" title="Male reproductive system">male reproductive system</a> that surrounds the <a href="/wiki/Urethra" title="Urethra">urethra</a> just below the <a href="/wiki/Bladder" title="Bladder">bladder</a>. Most prostate cancers are slow growing. Cancerous cells may <a href="/wiki/Metastasis" title="Metastasis">spread</a> to other areas of the body, particularly the <a href="/wiki/Bone" title="Bone">bones</a> and <a href="/wiki/Lymph_node" title="Lymph node">lymph nodes</a>. It may initially cause no symptoms. In later stages, symptoms include pain or difficulty <a href="/wiki/Urination" title="Urination">urinating</a>, <a href="/wiki/Hematuria" title="Hematuria">blood in the urine</a>, or <a href="/wiki/Pelvic_pain" title="Pelvic pain">pain in the pelvis</a> or back. <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">Benign prostatic hyperplasia</a> may produce similar symptoms. Other late symptoms include fatigue, due to <a href="/wiki/Anemia" title="Anemia">low levels of red blood cells</a>.
</p><p>Factors that increase the risk of prostate cancer include older age, family history, and <a href="/wiki/Race_(human_classification)" class="mw-redirect" title="Race (human classification)">race</a>.<sup id="cite_ref-WCR2014_3-2" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup><sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup> About 99% of cases occur after age 50.<sup id="cite_ref-WCR2014_3-3" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup> A <a href="/wiki/First-degree_relative" title="First-degree relative">first-degree relative</a> with the disease increases the risk two- to three-fold.<sup id="cite_ref-WCR2014_3-4" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup> Other factors include a <a href="/wiki/Diet_(nutrition)" title="Diet (nutrition)">diet</a> high in <a href="/wiki/Processed_meat" title="Processed meat">processed meat</a> and <a href="/wiki/Red_meat" title="Red meat">red meat</a>.<sup id="cite_ref-WCR2014_3-5" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup> An increased risk is associated with the <a href="/wiki/BRCA_mutation" title="BRCA mutation"><i>BRCA </i>mutations</a>.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10">&#91;10&#93;</a></sup> Diagnosis is by <a href="/wiki/Biopsy" title="Biopsy">biopsy</a>.<sup id="cite_ref-NCI2013TxPt_2-3" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup> <a href="/wiki/Medical_imaging" title="Medical imaging">Medical imaging</a> may be done to assess whether <a href="/wiki/Metastasis" title="Metastasis">metastasis</a> is present.<sup id="cite_ref-NCI2013TxPt_2-4" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup>
</p><p><a href="/wiki/Prostate_cancer_screening" title="Prostate cancer screening">Prostate cancer screening</a>, including <a href="/wiki/Prostate-specific_antigen" title="Prostate-specific antigen">prostate-specific antigen</a> (PSA) testing, increases cancer detection but whether it improves outcomes is controversial.<sup id="cite_ref-WCR2014_3-6" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup><sup id="cite_ref-NCI2018TxPro_11-0" class="reference"><a href="#cite_note-NCI2018TxPro-11">&#91;11&#93;</a></sup><sup id="cite_ref-Catalona2018_12-0" class="reference"><a href="#cite_note-Catalona2018-12">&#91;12&#93;</a></sup><sup id="cite_ref-NHS2015Screen_13-0" class="reference"><a href="#cite_note-NHS2015Screen-13">&#91;13&#93;</a></sup> Informed decision making is recommended for those 55 to 69 years old.<sup id="cite_ref-USPSTF2018_14-0" class="reference"><a href="#cite_note-USPSTF2018-14">&#91;14&#93;</a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup> Testing, if carried out, is more appropriate for those with a longer life expectancy.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup> Although <a href="/wiki/5%CE%B1-reductase_inhibitors" class="mw-redirect" title="5α-reductase inhibitors">5α-reductase inhibitors</a> appear to decrease low-grade cancer risk, they do not affect high-grade cancer risk, and are not recommended for prevention.<sup id="cite_ref-WCR2014_3-7" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup> <a href="/wiki/Vitamin" title="Vitamin">Vitamin</a> or <a href="/wiki/Dietary_element" class="mw-redirect" title="Dietary element">mineral</a> supplementation does not appear to affect risk.<sup id="cite_ref-WCR2014_3-8" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup><sup id="cite_ref-Strat2011_17-0" class="reference"><a href="#cite_note-Strat2011-17">&#91;17&#93;</a></sup>
</p><p>Many cases are managed with <a href="/wiki/Active_surveillance_of_prostate_cancer" title="Active surveillance of prostate cancer">active surveillance</a> or <a href="/wiki/Watchful_waiting" title="Watchful waiting">watchful waiting</a>.<sup id="cite_ref-NCI2013TxPt_2-5" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup> Other treatments may include a combination of <a href="/wiki/Radical_prostatectomy" class="mw-redirect" title="Radical prostatectomy">surgery</a>, <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a>, <a href="/wiki/Hormonal_therapy_(oncology)" title="Hormonal therapy (oncology)">hormone therapy</a>, or <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>.<sup id="cite_ref-NCI2013TxPt_2-6" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup> Tumors limited to the prostate may be curable.<sup id="cite_ref-NCI2014TxPro_1-2" class="reference"><a href="#cite_note-NCI2014TxPro-1">&#91;1&#93;</a></sup> <a href="/wiki/Pain_medication" class="mw-redirect" title="Pain medication">Pain medications</a>, <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonates</a>, and <a href="/wiki/Targeted_therapy" title="Targeted therapy">targeted therapy</a>,<sup id="cite_ref-Luszczak_2020_7_18-0" class="reference"><a href="#cite_note-Luszczak_2020_7-18">&#91;18&#93;</a></sup> among others, may be useful.<sup id="cite_ref-NCI2013TxPt_2-7" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup> Outcomes depend on age, health status and how aggressive and extensive the cancer is.<sup id="cite_ref-NCI2013TxPt_2-8" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup> Most men with prostate cancer do not die from it.<sup id="cite_ref-NCI2013TxPt_2-9" class="reference"><a href="#cite_note-NCI2013TxPt-2">&#91;2&#93;</a></sup> The <a href="/wiki/United_States" title="United States">United States</a> <a href="/wiki/Five-year_survival_rate" title="Five-year survival rate">five-year survival rate</a> is 97.1%.<sup id="cite_ref-SEER2014_4-1" class="reference"><a href="#cite_note-SEER2014-4">&#91;4&#93;</a></sup>
</p><p>Globally, it is the second-most common cancer. It is the fifth-leading cause of cancer-related death in men.<sup id="cite_ref-WCR2014Epi_19-0" class="reference"><a href="#cite_note-WCR2014Epi-19">&#91;19&#93;</a></sup> In 2018, it was diagnosed in 1.2 million and caused 359,000 deaths.<sup id="cite_ref-Bray2018_5-2" class="reference"><a href="#cite_note-Bray2018-5">&#91;5&#93;</a></sup> It was the most common cancer in males in 84 countries,<sup id="cite_ref-WCR2014_3-9" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup> occurring more commonly in the <a href="/wiki/Developed_world" class="mw-redirect" title="Developed world">developed world</a>.<sup id="cite_ref-Baade2009_20-0" class="reference"><a href="#cite_note-Baade2009-20">&#91;20&#93;</a></sup> Rates have been increasing in the <a href="/wiki/Developing_world" class="mw-redirect" title="Developing world">developing world</a>.<sup id="cite_ref-Baade2009_20-1" class="reference"><a href="#cite_note-Baade2009-20">&#91;20&#93;</a></sup> Detection increased significantly in the 1980s and 1990s in many areas due to increased PSA testing.<sup id="cite_ref-WCR2014_3-10" class="reference"><a href="#cite_note-WCR2014-3">&#91;3&#93;</a></sup> One study reported prostate cancer in 30% to 70% of Russian and Japanese men over age 60 who had died of unrelated causes.<sup id="cite_ref-NCI2014TxPro_1-3" class="reference"><a href="#cite_note-NCI2014TxPro-1">&#91;1&#93;</a></sup>
</p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc" /></div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg/220px-Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg.png" decoding="async" width="220" height="199" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg/330px-Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/59/Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg/440px-Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg.png 2x" data-file-width="375" data-file-height="339" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Diagram_showing_prostate_cancer_pressing_on_the_urethra_CRUK_182.svg" class="internal" title="Enlarge"></a></div>A diagram of prostate cancer pressing on the urethra, which can cause symptoms</div></div></div>
<p>Early prostate cancer usually has no symptoms.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup> Many men are tested for prostate cancer after complaining of <a href="/wiki/Lower_urinary_tract_symptoms" title="Lower urinary tract symptoms">lower urinary tract symptoms</a> – problems with normal urination including trouble starting to urinate, weak or intermittent stream, trouble fully emptying the bladder, and frequent urination. These symptoms are common in men, with over 50% of men over age 50 experiencing some form of urination problem.<sup id="cite_ref-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;_22-0" class="reference"><a href="#cite_note-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;-22">&#91;22&#93;</a></sup> <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">Erectile dysfunction</a> – also very common in men as they age – is associated with an increased risk of prostate cancer.<sup id="cite_ref-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;_22-1" class="reference"><a href="#cite_note-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;-22">&#91;22&#93;</a></sup> There are no symptoms that distinguish early prostate cancer from other causes of prostate enlargement, such as <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">benign prostatic hyperplasia</a>.<sup id="cite_ref-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;_22-2" class="reference"><a href="#cite_note-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;-22">&#91;22&#93;</a></sup>
</p><p>As a tumor grows beyond the prostate it can damage nearby organs, causing <a href="/wiki/Urinary_incontinence" title="Urinary incontinence">urinary</a> or <a href="/wiki/Fecal_incontinence" title="Fecal incontinence">fecal incontinence</a>, decreased ejaculate volumes, <a href="/wiki/Haematuria" class="mw-redirect" title="Haematuria">blood in the urine</a> or <a href="/wiki/Hematospermia" title="Hematospermia">ejaculate</a>, and kidney problems due to blockage of the <a href="/wiki/Ureter" title="Ureter">ureters</a>.<sup id="cite_ref-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;_22-3" class="reference"><a href="#cite_note-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;-22">&#91;22&#93;</a></sup><sup id="cite_ref-FOOTNOTEClinical_Overview2022&quot;Clinical_Presentation&quot;_23-0" class="reference"><a href="#cite_note-FOOTNOTEClinical_Overview2022&quot;Clinical_Presentation&quot;-23">&#91;23&#93;</a></sup><sup id="cite_ref-FOOTNOTELoebEastham2021&quot;Introduction&quot;_24-0" class="reference"><a href="#cite_note-FOOTNOTELoebEastham2021&quot;Introduction&quot;-24">&#91;24&#93;</a></sup> Prostate tumors often metastasize to nearby bones of the pelvis and back; there they can cause back pain or bone pain that doesn't improve with rest, <a href="/wiki/Fatigue" title="Fatigue">fatigue</a>, and/or unexplained weight loss.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup> Metastases can damage the bones around them, and around a quarter of those with metastatic prostate cancer develop a <a href="/wiki/Bone_fracture" title="Bone fracture">bone fracture</a>.<sup id="cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prostate_cancer&quot;_26-0" class="reference"><a href="#cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prostate_cancer&quot;-26">&#91;26&#93;</a></sup> Growing metastases can also <a href="/wiki/Spinal_cord_compression" title="Spinal cord compression">compress the spinal cord</a> causing weakness in the legs and feet, or limb paralysis.<sup id="cite_ref-FOOTNOTEClinical_Overview2022&quot;Clinical_Presentation&quot;_23-1" class="reference"><a href="#cite_note-FOOTNOTEClinical_Overview2022&quot;Clinical_Presentation&quot;-23">&#91;23&#93;</a></sup><sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:_Noncastrate&quot;_27-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:_Noncastrate&quot;-27">&#91;27&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Cause">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=2" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Prostatelead.jpg" class="image"><img alt="Prostatelead.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a1/Prostatelead.jpg/220px-Prostatelead.jpg" decoding="async" width="220" height="420" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/a/a1/Prostatelead.jpg 1.5x" data-file-width="289" data-file-height="552" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Prostatelead.jpg" class="internal" title="Enlarge"></a></div></div></div></div>
<p>Prostate cancer is caused by the accumulation of <a href="/wiki/Genetic_mutation" class="mw-redirect" title="Genetic mutation">genetic mutations</a> to the <a href="/wiki/DNA" title="DNA">DNA</a> of cells in the prostate. These mutations affect genes involved in cell growth, DNA damage repair, and <a href="/wiki/Cell_death" title="Cell death">cell death</a>. Changes to these genes can cause cells in the prostate to grow uncontrollably, resulting in a tumor.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup> Over time, the tumor may grow large enough to invade nearby organs such as the <a href="/wiki/Seminal_vesicles" title="Seminal vesicles">seminal vesicles</a> or <a href="/wiki/Bladder" title="Bladder">bladder</a>.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup> Eventually, tumor cells may develop the ability to travel through the <a href="/wiki/Lymphatic_system" title="Lymphatic system">lymphatic system</a> to nearby <a href="/wiki/Lymph_node" title="Lymph node">lymph nodes</a>, and/or through the <a href="/wiki/Bloodstream" class="mw-redirect" title="Bloodstream">bloodstream</a> to the bone marrow and (more rarely) other body sites.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Disease_progression&quot;_30-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Disease_progression&quot;-30">&#91;30&#93;</a></sup> At these new sites, the cancer cells disrupt normal body function and continue to grow. Metastases cause most of the discomfort associated with prostate cancer, and eventually can kill the affected person.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Disease_progression&quot;_30-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Disease_progression&quot;-30">&#91;30&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Risk_factors">Risk factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=3" title="Edit section: Risk factors">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Many factors increase one's risk of developing prostate cancer or progressing to advanced disease, including both genetic factors – that is a family history of prostate disease – and environmental factors.<sup id="cite_ref-FOOTNOTEStephensonAbouassalyKlein2021&quot;Risk_Factors&quot;_31-0" class="reference"><a href="#cite_note-FOOTNOTEStephensonAbouassalyKlein2021&quot;Risk_Factors&quot;-31">&#91;31&#93;</a></sup> These include both modifiable risk factors like diet, as well as non-modifiable risk factors like age and height.
</p>
<h3><span class="mw-headline" id="Age">Age</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=4" title="Edit section: Age">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Rates of prostate cancer rise with age. Disease is rare in those under 40.<sup id="cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Risk_Factors_for_Total_Prostate_Cancer&quot;_32-0" class="reference"><a href="#cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Risk_Factors_for_Total_Prostate_Cancer&quot;-32">&#91;32&#93;</a></sup> The overwhelming majority of cases are diagnosed in those over 60 years,<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;_33-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;-33">&#91;33&#93;</a></sup> with the average person diagnosed at 67 years old.<sup id="cite_ref-FOOTNOTEStephensonAbouassalyKlein2021&quot;Age_at_Diagnosis&quot;_34-0" class="reference"><a href="#cite_note-FOOTNOTEStephensonAbouassalyKlein2021&quot;Age_at_Diagnosis&quot;-34">&#91;34&#93;</a></sup> The average person who dies from prostate cancer is 77.<sup id="cite_ref-FOOTNOTEStephensonAbouassalyKlein2021&quot;Age_at_Diagnosis&quot;_34-1" class="reference"><a href="#cite_note-FOOTNOTEStephensonAbouassalyKlein2021&quot;Age_at_Diagnosis&quot;-34">&#91;34&#93;</a></sup> 
</p>
<h3><span class="mw-headline" id="Genetics">Genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=5" title="Edit section: Genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Up to 10% of prostate cancer cases are caused by inherited genes, including 40% of early-onset prostate cancers.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;-35">&#91;35&#93;</a></sup> Men with an affected first-degree relative (father or brother) have more than twice the risk of developing prostate cancer, and those with two first-degree relatives have a five-fold greater risk compared with men with no family history.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;-35">&#91;35&#93;</a></sup> Increased risk also runs in some ethnic groups, with <a href="/wiki/African-American" class="mw-redirect" title="African-American">African-American</a> men at particularly high risk – having prostate cancer at higher rates, and having more-aggressive prostate cancers.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-2" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;-35">&#91;35&#93;</a></sup> 
</p><p>Large <a href="/wiki/Genome-wide_association_studies" class="mw-redirect" title="Genome-wide association studies">genome-wide association studies</a> have identified over 100 gene variants associated with increased prostate cancer risk.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;_36-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;-36">&#91;36&#93;</a></sup> The greatest risk increase is associated with variations in <a href="/wiki/BRCA2" title="BRCA2">BRCA2</a> (up to an eight-fold increased risk) and <a href="/wiki/HOXB13" title="HOXB13">HOXB13</a> (three-fold increased risk), both of which are involved in repairing <a href="/wiki/DNA_damage" class="mw-redirect" title="DNA damage">DNA damage</a>.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;_36-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;-36">&#91;36&#93;</a></sup> Variants in other genes involved in DNA damage repair have also been associated with an increased risk of developing prostate cancer – particularly early-onset prostate cancer – including <a href="/wiki/BRCA1" title="BRCA1">BRCA1</a>, <a href="/wiki/ATM_serine/threonine_kinase" title="ATM serine/threonine kinase">ATM</a>, <a href="/wiki/NBS1" class="mw-redirect" title="NBS1">NBS1</a>, <a href="/wiki/MSH2" title="MSH2">MSH2</a>, <a href="/wiki/MSH6" title="MSH6">MSH6</a>, <a href="/wiki/PMS2" title="PMS2">PMS2</a>, <a href="/wiki/CHEK2" title="CHEK2">CHEK2</a>, <a href="/wiki/RAD51D" class="mw-redirect" title="RAD51D">RAD51D</a>, and <a href="/wiki/PALB2" title="PALB2">PALB2</a>.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;_36-2" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;-36">&#91;36&#93;</a></sup> Additionally, variants in the genome near the <a href="/wiki/Oncogene" title="Oncogene">oncogene</a> <a href="/wiki/MYC" title="MYC">MYC</a> are associated with increased risk.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;_36-3" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;-36">&#91;36&#93;</a></sup> As are <a href="/wiki/Single-nucleotide_polymorphism" title="Single-nucleotide polymorphism">single-nucleotide polymorphisms</a> in the <a href="/wiki/Vitamin_D_receptor" title="Vitamin D receptor">vitamin D receptor</a> common in African-Americans, and in the <a href="/wiki/Androgen_receptor" title="Androgen receptor">androgen receptor</a>, <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a>, and <a href="/wiki/CYP17" class="mw-redirect" title="CYP17">CYP17</a> involved in <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> synthesis and signaling.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-3" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;-35">&#91;35&#93;</a></sup> Together known gene variants are estimated to cause around 25% of prostate cancer cases.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-4" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;-35">&#91;35&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Body_and_lifestyle">Body and lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=6" title="Edit section: Body and lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Men who are taller are at a slightly increased risk for developing prostate cancer, as are men who are <a href="/wiki/Obese" class="mw-redirect" title="Obese">obese</a>.<sup id="cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Risk_Factors_for_Advanced_and_Fatal_Prostate_Cancer&quot;_37-0" class="reference"><a href="#cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Risk_Factors_for_Advanced_and_Fatal_Prostate_Cancer&quot;-37">&#91;37&#93;</a></sup> High levels of blood cholesterol are also associated with increased prostate cancer risk; consequently, those who take the cholesterol-lowering drugs, <a href="/wiki/Statin" title="Statin">statins</a>, have a reduced risk of advanced prostate cancer.<sup id="cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Statins&quot;_38-0" class="reference"><a href="#cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Statins&quot;-38">&#91;38&#93;</a></sup>
</p><p>Regular vigorous exercise may reduce one's chance of developing advanced prostate cancer, as can several dietary interventions.<sup id="cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Exercise&quot;_39-0" class="reference"><a href="#cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Exercise&quot;-39">&#91;39&#93;</a></sup> Those with a diet rich in cruciferous vegetables, <a href="/wiki/Fish" title="Fish">fish</a>, <a href="/wiki/Genistein" title="Genistein">genistein</a>, and/or <a href="/wiki/Lycopene" title="Lycopene">lycopene</a> (found in tomatoes) are at a reduced risk of symptomatic prostate cancer.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-5" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;-35">&#91;35&#93;</a></sup><sup id="cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Fish&quot;_40-0" class="reference"><a href="#cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Fish&quot;-40">&#91;40&#93;</a></sup> Conversely, those who consume high levels of dietary fats, <a href="/wiki/Polycyclic_aromatic_hydrocarbons" class="mw-redirect" title="Polycyclic aromatic hydrocarbons">polycyclic aromatic hydrocarbons</a> (from cooking red meats), or calcium may be at an increased risk of developing advanced prostate cancer.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-6" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;-35">&#91;35&#93;</a></sup><sup id="cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Calcium,_Dairy_Products,_and_Vitamin_D&quot;_41-0" class="reference"><a href="#cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Calcium,_Dairy_Products,_and_Vitamin_D&quot;-41">&#91;41&#93;</a></sup> Several dietary supplements have been studied and found not to impact prostate cancer risk, including <a href="/wiki/Selenium" title="Selenium">selenium</a>, <a href="/wiki/Vitamin_C" title="Vitamin C">vitamin C</a>, <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a>, and <a href="/wiki/Vitamin_E" title="Vitamin E">vitamin E</a>.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;No_Cancer_Diagnosis&quot;_42-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;No_Cancer_Diagnosis&quot;-42">&#91;42&#93;</a></sup><sup id="cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Calcium,_Dairy_Products,_and_Vitamin_D&quot;_41-1" class="reference"><a href="#cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Calcium,_Dairy_Products,_and_Vitamin_D&quot;-41">&#91;41&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Inflammation">Inflammation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=7" title="Edit section: Inflammation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Chronic inflammation can cause various cancers. Potential links between infection (or other sources of inflammation) and prostate cancer have been studied but none definitively found, with one large study finding no link between prostate cancer and a history of <a href="/wiki/Gonorrhea" title="Gonorrhea">gonorrhea</a>, <a href="/wiki/Syphilis" title="Syphilis">syphilis</a>, <a href="/wiki/Chlamydia" title="Chlamydia">chlamydia</a>, or infection with various <a href="/wiki/Human_papillomavirus" class="mw-redirect" title="Human papillomavirus">human papillomaviruses</a>.<sup id="cite_ref-FOOTNOTEStephensonAbouassalyKlein2021&quot;Inflammation_and_Infection&quot;_43-0" class="reference"><a href="#cite_note-FOOTNOTEStephensonAbouassalyKlein2021&quot;Inflammation_and_Infection&quot;-43">&#91;43&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=8" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Prostate cancer begins with accumulated mutations to prostate tissue that deregulate cell growth, replication, death, and <a href="/wiki/DNA_repair" title="DNA repair">DNA damage repair</a>.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetics&quot;_44-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetics&quot;-44">&#91;44&#93;</a></sup> Most prostate tumors begin in the outermost part of the prostate, called the "peripheral zone".<sup id="cite_ref-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;_45-0" class="reference"><a href="#cite_note-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;-45">&#91;45&#93;</a></sup> As cells begin to grow out of control, they form a small clump of disregulated cells called a <a href="/wiki/Prostatic_intraepithelial_neoplasia" class="mw-redirect" title="Prostatic intraepithelial neoplasia">prostatic intraepithelial neoplasia</a> (PIN).<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">&#91;46&#93;</a></sup> Some PINs continue to grow, forming layers of tissue that stop expressing genes common to their original tissue location – <a href="/wiki/TP63" title="TP63">p63</a>, <a href="/wiki/Cytokeratin_5" class="mw-redirect" title="Cytokeratin 5">cytokeratin 5</a>, and <a href="/wiki/Cytokeratin_14" class="mw-redirect" title="Cytokeratin 14">cytokeratin 14</a> – and begin expressing genes common to cells that makeup the innermost lining of the pancreatic duct – <a href="/wiki/Cytokeratin_8" class="mw-redirect" title="Cytokeratin 8">cytokeratin 8</a> and <a href="/wiki/Cytokeratin_18" class="mw-redirect" title="Cytokeratin 18">cytokeratin 18</a>.<sup id="cite_ref-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;_45-1" class="reference"><a href="#cite_note-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;-45">&#91;45&#93;</a></sup> These multilayered PINs also often overexpress the gene <a href="/wiki/AMACR" class="mw-redirect" title="AMACR">AMACR</a>, which is associated with prostate cancer progression.<sup id="cite_ref-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;_45-2" class="reference"><a href="#cite_note-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;-45">&#91;45&#93;</a></sup>
</p>
<div class="thumb tleft"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ec/Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg/220px-Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg.png" decoding="async" width="220" height="172" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ec/Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg/330px-Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ec/Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg/440px-Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg.png 2x" data-file-width="375" data-file-height="294" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Diagram_showing_prostate_cancer_that_has_spread_to_the_bones_CRUK_183.svg" class="internal" title="Enlarge"></a></div>Prostate cancer that has metastasized to the bone</div></div></div>
<p>Particularly large PINs can eventually grow into tumors. This is commonly accompanied by large-scale changes to the genome, with chromosome sequences being rearranged or copied repeatedly. Some genomic alterations are partiuclarly common in early prostate cancer, namely <a href="/wiki/Fusion_gene" title="Fusion gene">gene fusion</a> between <a href="/wiki/TMPRSS2" title="TMPRSS2">TMPRSS2</a> and the oncogene <a href="/wiki/ERG_(gene)" title="ERG (gene)">ERG</a> (up to 60% of prostate tumors), mutations that disable <a href="/wiki/SPOP" title="SPOP">SPOP</a> (up to 15% of tumors), and mutations that hyperactivate <a href="/wiki/FOXA1" title="FOXA1">FOXA1</a> (up to 5% of tumors).<sup id="cite_ref-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;_45-3" class="reference"><a href="#cite_note-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;-45">&#91;45&#93;</a></sup> 
</p><p>Metastatic prostate cancer tends to have more genetic mutations than localized disease.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;-47">&#91;47&#93;</a></sup> Many of these mutations are in genes that protect from DNA damage, such as <a href="/wiki/P53" title="P53">p53</a> (mutated in 8% of localized tumors, more than 27% of metastatic ones) and <a href="/wiki/RB1" class="mw-redirect" title="RB1">RB1</a> (1% of localized tumors, more than 5% of metastatic ones).<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;-47">&#91;47&#93;</a></sup> Similarly mutations in the DNA repair-related genes <a href="/wiki/BRCA2" title="BRCA2">BRCA2</a> and <a href="/wiki/ATM_(gene)" class="mw-redirect" title="ATM (gene)">ATM</a> are rare in localized disease but found in at least 7% and 5% of metastatic disease cases respectively.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-2" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;-47">&#91;47&#93;</a></sup>
</p><p>The transition from castrate-sensitive to castrate-resistant prostate cancer is also accompanied by the acquisition of various gene mutations. In castrate-resistant disease, more than 70% of tumors have mutations in the <a href="/wiki/Androgen_receptor" title="Androgen receptor">androgen receptor</a> signaling pathway – amplifications and gain-of-function mutations in the receptor gene itself, amplification of its activators (e.g. <a href="/wiki/FOXA1" title="FOXA1">FOXA1</a>), and/or inactivating mutations in its negative regulators (e.g. <a href="/wiki/ZBTB16" class="mw-redirect" title="ZBTB16">ZBTB16</a> and <a href="/wiki/NCOR1" class="mw-redirect" title="NCOR1">NCOR1</a>).<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-3" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;-47">&#91;47&#93;</a></sup> These androgen receptor disruptions are only found in up to 6% of biopsies of castrate-sensitive metastatic disease.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-4" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;-47">&#91;47&#93;</a></sup> Similarly, deletions of the tumor suppressor <a href="/wiki/PTEN_(gene)" title="PTEN (gene)">PTEN</a> are harbored by 12–17% of castrate-sensitive tumors, but over 40% of castrate-resistant tumors.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-5" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;-47">&#91;47&#93;</a></sup> Less commonly, tumors have aberrant activation of the <a href="/wiki/Wnt_signaling_pathway" title="Wnt signaling pathway">Wnt signaling pathway</a> via disruption of members <a href="/wiki/APC_(gene)" class="mw-redirect" title="APC (gene)">APC</a> (9% of tumors) or <a href="/wiki/CTNNB1" class="mw-redirect" title="CTNNB1">CTNNB1</a> (4% of tumors); dysregulation of the <a href="/wiki/Phosphoinositide_3-kinase" title="Phosphoinositide 3-kinase">PI3K</a> pathway via <a href="/w/index.php?title=PI3KCA&amp;action=edit&amp;redlink=1" class="new" title="PI3KCA (page does not exist)">PI3KCA</a>/<a href="/w/index.php?title=PI3KCB&amp;action=edit&amp;redlink=1" class="new" title="PI3KCB (page does not exist)">PI3KCB</a> mutations (6% of tumors) or <a href="/wiki/AKT1" title="AKT1">AKT1</a> (2% of tumors).<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-6" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;-47">&#91;47&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Screening">Screening</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=9" title="Edit section: Screening">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1033289096">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Prostate_cancer_screening" title="Prostate cancer screening">Prostate cancer screening</a></div>
<p>Prostate cancer <a href="/wiki/Screening_(medicine)" title="Screening (medicine)">screening</a> searches for cancers in those without symptoms. This is typically done through blood tests for levels of the protein <a href="/wiki/Prostate-specific_antigen" title="Prostate-specific antigen">Prostate-specific antigen</a> (PSA), which are elevated in those who have prostate cancer or other conditions affecting the prostate.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;_48-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;-48">&#91;48&#93;</a></sup><sup id="cite_ref-49" class="reference"><a href="#cite_note-49">&#91;49&#93;</a></sup> Several large studies have found that men screened for prostate cancer have a reduced risk of dying from the disease;<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;-50">&#91;50&#93;</a></sup> however, detection of cancer cases that would not have otherwise impacted health can cause anxiety, and lead to unneeded biopsies and treatments.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;_48-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;-48">&#91;48&#93;</a></sup> Major national health body guidelines offer differing recommendations, though no major health body currently recommends population-wide prostate cancer screening.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;_48-2" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;-48">&#91;48&#93;</a></sup>  
</p><p>Many national health bodies recommend prostate cancer screening in a subset of the population, typically adult men aged at least 40 who anticipate substantial remaining healthy lifespan, and who are well-informed of the risks of screening by their healthcare provider. The <a href="/wiki/United_States_Preventive_Services_Task_Force" title="United States Preventive Services Task Force">United States Preventive Services Task Force</a> and the <a href="/wiki/American_Urological_Association" title="American Urological Association">American Urological Association</a> recommend men 55–69 years of age be offered screening after counseling to inform them of its risk and benefits.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;-50">&#91;50&#93;</a></sup> Both recommend against PSA screening after age 70.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Table_2&quot;_51-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Table_2&quot;-51">&#91;51&#93;</a></sup> The <a href="/w/index.php?title=Canadian_Urological_Association&amp;action=edit&amp;redlink=1" class="new" title="Canadian Urological Association (page does not exist)">Canadian Urological Association</a> (CUA) recommends screening be offered to men at age 50, provided they have at least ten more years of expected lifespan. In men with a family history of prostate cancer, the CUA recommends screening be offered at age 45.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-2" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;-50">&#91;50&#93;</a></sup> Similarly, the <a href="/wiki/European_Association_of_Urology" title="European Association of Urology">European Association of Urology</a>, <a href="/w/index.php?title=European_Society_for_Radiotherapy_and_Oncology&amp;action=edit&amp;redlink=1" class="new" title="European Society for Radiotherapy and Oncology (page does not exist)">European Society for Radiotherapy and Oncology</a>, and <a href="/w/index.php?title=International_Society_of_Geriatric_Oncology&amp;action=edit&amp;redlink=1" class="new" title="International Society of Geriatric Oncology (page does not exist)">International Society of Geriatric Oncology</a> recommend PSA testing for men over 50 years, men with family history of prostate cancer or African ancestry over 45 years, and men with cancer-associated BRCA2 variants at 40 years; all provided they have a life expectancy of at least 10 more years.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-3" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;-50">&#91;50&#93;</a></sup> The <a href="/w/index.php?title=Japanese_Urological_Association&amp;action=edit&amp;redlink=1" class="new" title="Japanese Urological Association (page does not exist)">Japanese Urological Association</a> recommends PSA testing in men at least 50 years old, and men with a family history of prostate cancer starting at 40 years.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-4" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;-50">&#91;50&#93;</a></sup> The <a href="/w/index.php?title=Canadian_Task_Force_on_Preventive_Health_Care&amp;action=edit&amp;redlink=1" class="new" title="Canadian Task Force on Preventive Health Care (page does not exist)">Canadian Task Force on Preventive Health Care</a> recommends against prostate cancer screening.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-5" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;-50">&#91;50&#93;</a></sup> Despite roughly similar screening guidelines, uptake of screening also varies by geography – more than 80% of men are screened in the US and Western Europe, 20% of men in Japan, and screening is rare in regions with low <a href="/wiki/Human_development_index" class="mw-redirect" title="Human development index">human development index</a>.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-6" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;-50">&#91;50&#93;</a></sup>
</p><p>The nature of prostate cancer screening can also vary, but typically involves a blood test to assess PSA levels. The average person's blood has around 1 <a href="/wiki/Nanogram" class="mw-redirect" title="Nanogram">nanogram</a> (ng) of PSA per <a href="/wiki/Milliliter" class="mw-redirect" title="Milliliter">milliliter</a> (mL) of blood tested.<sup id="cite_ref-FOOTNOTECarlssonVickers2020&quot;3._Tailor_screening_frequency_based_on_PSA-level&quot;_52-0" class="reference"><a href="#cite_note-FOOTNOTECarlssonVickers2020&quot;3._Tailor_screening_frequency_based_on_PSA-level&quot;-52">&#91;52&#93;</a></sup> Those with PSA levels below average are very unlikely to develop dangerous prostate cancer over the next 8 to 10 years.<sup id="cite_ref-FOOTNOTECarlssonVickers2020&quot;3._Tailor_screening_frequency_based_on_PSA-level&quot;_52-1" class="reference"><a href="#cite_note-FOOTNOTECarlssonVickers2020&quot;3._Tailor_screening_frequency_based_on_PSA-level&quot;-52">&#91;52&#93;</a></sup> Those with higher than average PSA levels are often recommended to repeat the blood test 4–6 weeks later – PSA levels often fluctuate unrelated to prostate cancer.<sup id="cite_ref-FOOTNOTECarlssonVickers2020&quot;4._For_men_with_elevated_PSA_(≥3_ng/mL),_repeat_PSA.&quot;_53-0" class="reference"><a href="#cite_note-FOOTNOTECarlssonVickers2020&quot;4._For_men_with_elevated_PSA_(≥3_ng/mL),_repeat_PSA.&quot;-53">&#91;53&#93;</a></sup> Even for men with PSA above 3 ng/mL, just 30% will have prostate cancer, and just 10% a high-grade cancer that requires treatment.<sup id="cite_ref-FOOTNOTECarlssonVickers2020&quot;5._Use_secondary_tests_such_as_marker_or_imaging_before_biopsy.&quot;_54-0" class="reference"><a href="#cite_note-FOOTNOTECarlssonVickers2020&quot;5._Use_secondary_tests_such_as_marker_or_imaging_before_biopsy.&quot;-54">&#91;54&#93;</a></sup> Those with elevated PSA may undergo secondary screening blood tests that measure subtypes of PSA and other blood proteins to better-predict the likelihood that a person will develop aggressive prostate cancer; 4Kscore, Prostate Health Index, ExoDx Prostate Test, and SelectMDx are all available for this purpose.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Second-Line_Screening_Tests&quot;_55-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Second-Line_Screening_Tests&quot;-55">&#91;55&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=10" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Prostate_Needle_Biopsy.png" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Prostate_Needle_Biopsy.png/220px-Prostate_Needle_Biopsy.png" decoding="async" width="220" height="220" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Prostate_Needle_Biopsy.png/330px-Prostate_Needle_Biopsy.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Prostate_Needle_Biopsy.png/440px-Prostate_Needle_Biopsy.png 2x" data-file-width="1200" data-file-height="1200" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Prostate_Needle_Biopsy.png" class="internal" title="Enlarge"></a></div>Prostate needle biopsy</div></div></div>
<p>Men suspected of having prostate cancer may undergo several tests to help assess the prostate. One common procedure is the <a href="/wiki/Digital_rectal_examination" class="mw-redirect" title="Digital rectal examination">digital rectal examination</a>, in which a doctor inserts a lubricated finger into the <a href="/wiki/Rectum" title="Rectum">rectum</a> to feel the nearby prostate.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup><sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;_57-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;-57">&#91;57&#93;</a></sup> Tumors feel like stiff, irregularly shaped lumps against the rest of the prostate. Hardening of the prostate can also be due to <a href="/wiki/Benign_prostatic_hyperplasia" title="Benign prostatic hyperplasia">benign prostatic hyperplasia</a>; around 20–25% of those with abnormal findings on their rectal exams have prostate cancer.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Physical_Examination&quot;_58-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Physical_Examination&quot;-58">&#91;58&#93;</a></sup>
</p><p>A diagnosis of prostate cancer requires a <a href="/wiki/Biopsy" title="Biopsy">biopsy</a> of the prostate be taken and examined under a microscope by a pathologist. Prostate biopsies are typically taken by a needle passing through the rectum or <a href="/wiki/Transperineal_biopsy" title="Transperineal biopsy">perineum</a>, guided by <a href="/wiki/Transrectal_ultrasound" class="mw-redirect" title="Transrectal ultrasound">transrectal ultrasound</a> imaging, <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> (MRI), or a combination of the two.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Prostate_Biopsy&quot;_59-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Prostate_Biopsy&quot;-59">&#91;59&#93;</a></sup><sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;_57-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;-57">&#91;57&#93;</a></sup> Samples are taken from several regions of the prostate – 10–12 samples in all – to improve the chances of finding any tumors.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;_57-2" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;-57">&#91;57&#93;</a></sup> Biopsies are examined under a microscope by a <a href="/wiki/Pathology" title="Pathology">pathologist</a>, who determines the type and extent of cancerous cells present. Cancers are first classified based on their appearance under a microscope. Over 95% of prostate cancers are classified as <a href="/wiki/Adenocarcinoma" title="Adenocarcinoma">adenocarcinomas</a> (resembling <a href="/wiki/Gland" title="Gland">gland</a> tissue), with the rest largely <a href="/wiki/Squamous-cell_carcinoma" title="Squamous-cell carcinoma">squamous-cell carcinoma</a> (resembling <a href="/wiki/Squamous_cell" class="mw-redirect" title="Squamous cell">squamous cells</a>, a type of <a href="/wiki/Epithelial_cell" class="mw-redirect" title="Epithelial cell">epithelial cell</a>) and <a href="/wiki/Transitional_cell_carcinoma" title="Transitional cell carcinoma">transitional cell carcinoma</a> (resembling <a href="/wiki/Transitional_cell" class="mw-redirect" title="Transitional cell">transitional cells</a>).<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Pathology&quot;_60-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Pathology&quot;-60">&#91;60&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Prostatic_adenocarcinoma_with_perineural_invasion.JPG" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Prostatic_adenocarcinoma_with_perineural_invasion.JPG/220px-Prostatic_adenocarcinoma_with_perineural_invasion.JPG" decoding="async" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Prostatic_adenocarcinoma_with_perineural_invasion.JPG/330px-Prostatic_adenocarcinoma_with_perineural_invasion.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Prostatic_adenocarcinoma_with_perineural_invasion.JPG/440px-Prostatic_adenocarcinoma_with_perineural_invasion.JPG 2x" data-file-width="4272" data-file-height="2848" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Prostatic_adenocarcinoma_with_perineural_invasion.JPG" class="internal" title="Enlarge"></a></div><a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> showing a prostate cancer (conventional adenocarcinoma) with <a href="/wiki/Perineural_invasion" title="Perineural invasion">perineural invasion</a>. <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a>.</div></div></div>
<p>Next tumor samples are <a href="/wiki/Grading_(tumors)" title="Grading (tumors)">graded</a> based on how much the tumor tissue differs from normal prostate tissue; the more different the tumor appears, the faster the tumor is likely to grow. The <a href="/wiki/Gleason_grading_system" title="Gleason grading system">Gleason grading system</a> is commonly used, where the pathologist assigns a number from 1 (similar to prostate tissue) to 5 (least similar) for the most common pattern observed under the microscope, then does the same for the second-most common pattern. The sum of these two numbers is the Gleason score.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Pathology&quot;_60-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Pathology&quot;-60">&#91;60&#93;</a></sup> The total scores of 2 through 5 are no longer commonly used in practice, making the lowest score 6, and the highest score 10. Scores are commonly grouped into Gleason grade groups: a score of 6 or lower is Gleason grade group 1; a score of 7 with the first number (from the most common pattern) 3 and the second number 4 is grade group 2; the reverse – first number 4, second number 3 – is grade group 3; a score of 8 is grade group 4; a score of 9 or 10 is grade group 5.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Pathology&quot;_60-2" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Pathology&quot;-60">&#91;60&#93;</a></sup> Higher Gleason scores and higher grade groups represent cancer cases likely to be more aggressive with worse prognosis.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Pathology&quot;_60-3" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Pathology&quot;-60">&#91;60&#93;</a></sup>
</p><p>Extent of cancer spread is assessed by MRI or <a href="/wiki/PSMA_scan" title="PSMA scan">PSMA scan</a> – a <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">positron emission tomography</a> (PET) imaging technique where a <a href="/wiki/Radiopharmaceutical" title="Radiopharmaceutical">radiopharmaceutical</a> that binds the prostate protein <a href="/wiki/Prostate-specific_membrane_antigen" class="mw-redirect" title="Prostate-specific membrane antigen">prostate-specific membrane antigen</a> is used to detect metastases distant from the prostate.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Prostate_Cancer_Staging&quot;_61-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Prostate_Cancer_Staging&quot;-61">&#91;61&#93;</a></sup><sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;_57-3" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;-57">&#91;57&#93;</a></sup> <a href="/wiki/CT_scan" title="CT scan">CT scans</a> may also be used, but are less able to detect spread outside the prostate than MRI. <a href="/wiki/Bone_scintigraphy" title="Bone scintigraphy">Bone scintigraphy</a> is used to test for spread of cancer to bones.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Prostate_Cancer_Staging&quot;_61-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Prostate_Cancer_Staging&quot;-61">&#91;61&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="/wiki/File:Prostate_cancer_types.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/3/3c/Prostate_cancer_types.svg/300px-Prostate_cancer_types.svg.png" decoding="async" width="300" height="175" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/3c/Prostate_cancer_types.svg/450px-Prostate_cancer_types.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3c/Prostate_cancer_types.svg/600px-Prostate_cancer_types.svg.png 2x" data-file-width="1406" data-file-height="818" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Prostate_cancer_types.svg" class="internal" title="Enlarge"></a></div>Pie chart of <a href="/wiki/Histopathologic_diagnosis_of_prostate_cancer" title="Histopathologic diagnosis of prostate cancer">histopathologic subdiagnoses of prostate cancer</a>.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62">&#91;62&#93;</a></sup></div></div></div>
<h3><span class="mw-headline" id="Staging">Staging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=11" title="Edit section: Staging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Prostate_cancer_staging" title="Prostate cancer staging">Prostate cancer staging</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4e/Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg/220px-Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg.png" decoding="async" width="220" height="219" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4e/Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg/330px-Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4e/Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg/440px-Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg.png 2x" data-file-width="375" data-file-height="373" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Diagram_showing_T1-3_stages_of_prostate_cancer_CRUK_278.svg" class="internal" title="Enlarge"></a></div>Diagram showing T1-3 stages of prostate cancer.</div></div></div>
<p>After diagnosis of prostate cancer, the tumor is <a href="/wiki/Cancer_staging" title="Cancer staging">staged</a> to determine the extent of tumor growth and spread. Prostate cancer is typically staged using the <a href="/wiki/American_Joint_Committee_on_Cancer" title="American Joint Committee on Cancer">American Joint Committee on Cancer</a>'s (AJCC) three-component <a href="/wiki/TNM_staging_system" title="TNM staging system">TNM system</a>, with scores assigned for the extent of the tumor (T), spread to any <a href="/wiki/Lymph_node" title="Lymph node">lymph nodes</a> (N), and the presence of <a href="/wiki/Metastases" class="mw-redirect" title="Metastases">metastases</a> (M).<sup id="cite_ref-ACSStage_63-0" class="reference"><a href="#cite_note-ACSStage-63">&#91;63&#93;</a></sup> Scores of T1 and T2 represent tumors that remain within the prostate: T1 is for tumors not detectable by imaging or digital rectal exam; T2 is for tumors detectable by imaging or rectal exam, but still confined within the prostate.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;_64-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;-64">&#91;64&#93;</a></sup> T3 is for tumors that grow beyond the prostate – T3a for tumors with any extension outside the prostate; T3b for tumors that invade the adjacent <a href="/wiki/Seminal_vesicle" class="mw-redirect" title="Seminal vesicle">seminal vesicles</a>. T4 is for tumors that have grown into organs beyond the seminal vesicles.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;_64-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;-64">&#91;64&#93;</a></sup> The N and M scores are binary. N1 represents any spread to the nearby lymph nodes. M1 represents any metastases to other body sites.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;_64-2" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;-64">&#91;64&#93;</a></sup>
</p><p>The AJCC then combines the TNM scores, Gleason grade group, and results of the PSA blood test to categorize cancer cases into one of four stages, and their subdivisions. Cancer cases with localized tumors (T1 or T2), no spread (N0 and M0), Gleason grade group 1, and PSA less than 10 ng/mL are designated stage I. Those with localized tumors and PSA between 10 and 20 ng/mL are desigated stage II – subdivided into IIA for Gleason grade group 1, IIB for grade group 2, and IIC for grade group 3 or 4. Stage III is the designation for any of three higher risk factors: IIIA is for a PSA level about 20 ng/mL; IIIB is for T3 or T4 tumors; IIIC is for a Gleason grade group of 5. Stage IV is for cancers that have spread to lymph nodes (N1, stage IVA) or other organs (M1, stage IVB).<sup id="cite_ref-ACSStage_63-1" class="reference"><a href="#cite_note-ACSStage-63">&#91;63&#93;</a></sup> 
</p><p>The United Kingdom <a href="/wiki/National_Institute_for_Health_and_Care_Excellence" title="National Institute for Health and Care Excellence">National Institute for Health and Care Excellence</a> recommends a similar five-stage system called the Cambridge Prognostic Group, with stages CPG 1 to CPG 5.<sup id="cite_ref-:2_65-0" class="reference"><a href="#cite_note-:2-65">&#91;65&#93;</a></sup> CPG 1 is the same as AJCC stage I. Cases with localized tumors (T1 or T2) and either Gleason grade group 2 or higher PSA levels (10 to 20 ng/mL) are designated CPG 2. CPG 3 represents either Gleason grade group 3, or the combination of the CPG 2 criteria. CPG 4 is similar to AJCC stage 3 – any of Gleason grade group 4, PSA levels above 20 ng/mL, or a tumor that has grown beyond the prostate (T3). CPG 5 is for the highest risk cases: either a T4 tumor, Gleason grade group 5, or any two of the CPG 4 criteria.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66">&#91;66&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Prevention">Prevention</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=12" title="Edit section: Prevention">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>No drug or vaccine is approved by regulatory agencies for the prevention of prostate cancer. Several studies have shown <a href="/wiki/5%CE%B1-reductase_inhibitor" class="mw-redirect" title="5α-reductase inhibitor">5α-reductase inhibitors</a> to reduce the incidence of prostate cancer; however, whether they reduce disease is not clear.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;No_Cancer_Diagnosis&quot;_42-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;No_Cancer_Diagnosis&quot;-42">&#91;42&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=13" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Management_of_prostate_cancer" title="Management of prostate cancer">Management of prostate cancer</a></div>
<p>Treatment of prostate cancer varies widely based on how advanced the cancer is, the risk it may spread (based on histology), and the affected person's health, life expectancy, and personal preferences.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Management&quot;_67-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Management&quot;-67">&#91;67&#93;</a></sup> Those with localized disease at low risk for spread are often at greater threat from treatment side effects than disease effects, and so are monitored regularly by <a href="/wiki/Active_surveillance" class="mw-redirect" title="Active surveillance">active surveillance</a>, repeat testing for a worsening of their disease.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;_68-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;-68">&#91;68&#93;</a></sup> Those at higher risk may receive treatment to eliminate the tumor – typically <a href="/wiki/Prostatectomy" title="Prostatectomy">prostatectomy</a> (surgery to remove the prostate) or <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a>, sometimes alongside <a href="/wiki/Hormone_therapy" title="Hormone therapy">hormone therapy</a>.<sup id="cite_ref-ACSTreat_69-0" class="reference"><a href="#cite_note-ACSTreat-69">&#91;69&#93;</a></sup> Those with metastatic disease are treated with the above plus <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>, as well as additional radiation or other agents to alleviate the symptoms of metastatic tumors.<sup id="cite_ref-ACSTreat_69-1" class="reference"><a href="#cite_note-ACSTreat-69">&#91;69&#93;</a></sup> Throughout the treatment course, blood PSA levels are monitored to assess the effectiveness of treatments, and whether the disease is advancing.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70">&#91;70&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Localized_disease">Localized disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=14" title="Edit section: Localized disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Men diagnosed with low-risk cases of prostate cancer often defer treatment and are instead monitored regularly for cancer progression by active surveillance.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;_68-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;-68">&#91;68&#93;</a></sup> Active surveillance involves monitoring the tumor for growth at fixed intervals by PSA tests (around every six months), digital rectal exam (annually), and MRI or repeat biopsies (every one to three years).<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;_68-2" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;-68">&#91;68&#93;</a></sup> The goal of active surveillance is to postpone treatment, and avoid <a href="/wiki/Overtreatment" class="mw-redirect" title="Overtreatment">overtreatment</a> and its side effects, given a slow-growing or self-limited tumor that in most people is unlikely to cause problems.<sup id="cite_ref-71" class="reference"><a href="#cite_note-71">&#91;71&#93;</a></sup> Various risk calculating algorithms have been designed that attempt to predict a person with prostate cancer's risk of disease progression based on their clinical characteristics and test results. These include the Partin table and D'Amico risk grouping – which take into account a person's PSA levels, Gleason score, and TNM score – as well as the CAPRA score, which also takes into account an affected person's age and the percent of their prostate biopsies in which cancerous cells were found.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Table_1:_Prostate_cancer_risk_classification_at_diagnosis_and_after_treatment&quot;_72-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Table_1:_Prostate_cancer_risk_classification_at_diagnosis_and_after_treatment&quot;-72">&#91;72&#93;</a></sup>
</p><p>Those who elect to have therapy typically receive <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> or a <a href="/wiki/Prostatectomy" title="Prostatectomy">prostatectomy</a> (removal of the prostate).<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Clinically_Localized_Prostate_Cancer&quot;_73-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Clinically_Localized_Prostate_Cancer&quot;-73">&#91;73&#93;</a></sup> Radiation can be delivered by <a href="/wiki/Radiation_therapy#Intensity-modulated_radiation_therapy_(IMRT)" title="Radiation therapy">intensity-modulated radiation therapy</a>, which allows for high doses (&gt;80 <a href="/wiki/Gray_(unit)" title="Gray (unit)">Gy</a>) to be delivered to the prostate with relatively little radiation to other organs, or by <a href="/wiki/Brachytherapy" title="Brachytherapy">brachytherapy</a>, where a radioactive source is surgically placed next to the prostate.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;External_Beam_Radiation_Therapy&quot;_74-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;External_Beam_Radiation_Therapy&quot;-74">&#91;74&#93;</a></sup><sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Brachytherapy&quot;_75-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Brachytherapy&quot;-75">&#91;75&#93;</a></sup> Radiotherapy is typically given in several treatments over the course of eight to nine weeks.<sup id="cite_ref-FOOTNOTEBrawleyMohanNein2018&quot;Radiation_Therapy&quot;_76-0" class="reference"><a href="#cite_note-FOOTNOTEBrawleyMohanNein2018&quot;Radiation_Therapy&quot;-76">&#91;76&#93;</a></sup> Radiation damage to nearby organs can increase the risk of subsequent <a href="/wiki/Bladder_cancer" title="Bladder cancer">bladder cancer</a> and cause <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>, <a href="/wiki/Infertility" title="Infertility">infertility</a>, and gastronintestinal problems: <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, <a href="/wiki/Blood_in_stool" title="Blood in stool">bloody stools</a>, <a href="/wiki/Fecal_incontinence" title="Fecal incontinence">fecal incontinence</a>, and pain.<sup id="cite_ref-FOOTNOTEBrawleyMohanNein2018&quot;Radiation_Therapy&quot;_76-1" class="reference"><a href="#cite_note-FOOTNOTEBrawleyMohanNein2018&quot;Radiation_Therapy&quot;-76">&#91;76&#93;</a></sup> For those with relatively high-risk localized disease, combining radiation with androgen deprivation therapy improves overall survival.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;External_Beam_Radiation_Therapy&quot;_74-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;External_Beam_Radiation_Therapy&quot;-74">&#91;74&#93;</a></sup> 
</p><p>Radical prostatectomy aims to surgically remove the cancerous part of the prostate. This can be done through an incision above the penis (retropubic approach), below the scrotum (perineal approach), or through a small incision aided by <a href="/wiki/Laparoscopy" title="Laparoscopy">laparoscopy</a> or <a href="/wiki/Robot-assisted_surgery" title="Robot-assisted surgery">robot-assisted surgery</a>.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;-77">&#91;77&#93;</a></sup> The four approaches result in similar rates of cancer control and side effects, although the latter two result in less blood loss during surgery, and shorter hospital stays.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;-77">&#91;77&#93;</a></sup> Damage to nearby tissue during surgery can result in <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a> and <a href="/wiki/Urinary_incontinence" title="Urinary incontinence">urinary incontinence</a>. Erectile dysfunction is more likely in those who are older or had previous erectile issues.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-2" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;-77">&#91;77&#93;</a></sup> Incontinence is more common in those who are older and have shorter <a href="/wiki/Urethra" title="Urethra">urethras</a>.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-3" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;-77">&#91;77&#93;</a></sup> Both for cancer progression outcomes and surgical side effects, the skill and experience of the individual surgeon doing the procedure are among the greatest determinants of success.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-4" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;-77">&#91;77&#93;</a></sup> Radiotherapy and surgery appear to result in similar outcomes with respect to bowel, erectile and urinary function after five years.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">&#91;78&#93;</a></sup>
</p><p>Successful radiotherapy causes a drop in PSA levels due to destruction of the tumor, while prostatectomy causes PSA to drop to undetectable levels.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;_79-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;-79">&#91;79&#93;</a></sup> After treatment for localized prostate cancer, PSA levels are still monitored regularly. Up to half of those treated will eventually have a rise in PSA levels, suggesting the tumor or small metastases are growing again.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biochemical_recurrence_and_residual_disease&quot;_80-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biochemical_recurrence_and_residual_disease&quot;-80">&#91;80&#93;</a></sup> People with high or rising PSA levels are often offered another round of radiation therapy directed at the former tumor site. This reduces risk for further progression by 75%.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;_79-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;-79">&#91;79&#93;</a></sup> Those suspected of metastases can undergo PET scanning with sensitive <a href="/wiki/PET_radiotracer" title="PET radiotracer">radiotracers</a> C-11 choline, F-18 fluciclovine, and F-18 or Ga-68 attached to a PSMA-targeting drug, each of which is able to detect small metastases more sensitively than alternative imaging methods.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Rising_PSA_After_Definitive_Local_Therapy&quot;_81-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Rising_PSA_After_Definitive_Local_Therapy&quot;-81">&#91;81&#93;</a></sup><sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;_79-2" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;-79">&#91;79&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Metastatic_disease">Metastatic disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=15" title="Edit section: Metastatic disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>For those with metastatic disease, the standard of care is <a href="/wiki/Androgen_deprivation_therapy" title="Androgen deprivation therapy">androgen deprivation therapy</a>, drugs that reduce levels of <a href="/wiki/Androgen" title="Androgen">androgens</a> (male sex hormones) that prostate cells require in order to grow.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_hormone-sensitive_prostate_cancer&quot;_82-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_hormone-sensitive_prostate_cancer&quot;-82">&#91;82&#93;</a></sup> Various drugs are used to lower androgen levels by blocking the synthesis or action of <a href="/wiki/Testosterone" title="Testosterone">testosterone</a>, the primary androgen. The first line of treatment is typically <a href="/wiki/Gonadotropin-releasing_hormone_agonist" title="Gonadotropin-releasing hormone agonist">GnRH agonists</a> like <a href="/wiki/Leuprolide" class="mw-redirect" title="Leuprolide">leuprolide</a>, <a href="/wiki/Goserelin" title="Goserelin">goserelin</a>, <a href="/wiki/Triptorelin" title="Triptorelin">triptorelin</a>, or <a href="/wiki/Leuprolide_mesylate" class="mw-redirect" title="Leuprolide mesylate">leuprolide mesylate</a> by injection monthly or less frequently if needed.<sup id="cite_ref-83" class="reference"><a href="#cite_note-83">&#91;83&#93;</a></sup><sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_hormone-sensitive_prostate_cancer&quot;_82-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_hormone-sensitive_prostate_cancer&quot;-82">&#91;82&#93;</a></sup> GnRH agonists cause a brief rise in testosterone levels at treatment initiation, which can worsen disease in people with significant symptoms of metastases.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Testosterone-Lowering_Agents&quot;_84-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Testosterone-Lowering_Agents&quot;-84">&#91;84&#93;</a></sup> In these people, <a href="/wiki/Gonadotropin-releasing_hormone_antagonist" title="Gonadotropin-releasing hormone antagonist">GnRH antagonists</a> like <a href="/wiki/Degarelix" title="Degarelix">degarelix</a> or <a href="/wiki/Relugolix" title="Relugolix">relugolix</a> are given instead, and can also rapidly reduce testosterone levels.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Testosterone-Lowering_Agents&quot;_84-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Testosterone-Lowering_Agents&quot;-84">&#91;84&#93;</a></sup> Hormone therapy halts tumor growth in more than 95% of those treated,<sup id="cite_ref-FOOTNOTEAchardPutoraOmlinZilli2022&quot;Introduction&quot;_85-0" class="reference"><a href="#cite_note-FOOTNOTEAchardPutoraOmlinZilli2022&quot;Introduction&quot;-85">&#91;85&#93;</a></sup> with PSA levels returning to normal in up to 70%.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Outcomes_of_Androgen_Deprivation&quot;_86-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Outcomes_of_Androgen_Deprivation&quot;-86">&#91;86&#93;</a></sup>
</p><p>Despite reduced testosterone levels, eventually nearly all prostate cancers continue to grow – typically manifested by rising blood PSA levels, and metastases to nearby bones.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;-87">&#91;87&#93;</a></sup><sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_castration-resistant_prostate_cancer&quot;_88-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_castration-resistant_prostate_cancer&quot;-88">&#91;88&#93;</a></sup>  This is the most advanced stage of the disease, called castration-resistant prostate cancer (CRPC). CRPC is typically treated with systemic <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> alongside continued hormone therapy. The standard of care is <a href="/wiki/Docetaxel" title="Docetaxel">docetaxel</a> given every three weeks.<sup id="cite_ref-FOOTNOTETeoRathkopfKantoff2019&quot;Management_of_Metastatic_Castration-Resistant_Prostate_Cancer&quot;_89-0" class="reference"><a href="#cite_note-FOOTNOTETeoRathkopfKantoff2019&quot;Management_of_Metastatic_Castration-Resistant_Prostate_Cancer&quot;-89">&#91;89&#93;</a></sup> Most CRPC cases still rely somewhat on androgen signaling, and so certain <a href="/wiki/Antiandrogen" title="Antiandrogen">antiandrogen</a> drugs are often used, namely the androgen receptor antagonists <a href="/wiki/Enzalutamide" title="Enzalutamide">enzalutamide</a>, <a href="/wiki/Apalutamide" title="Apalutamide">apalutamide</a>, and <a href="/wiki/Darolutamide" title="Darolutamide">darolutamide</a>, as well as the testosterone production inhibitor <a href="/wiki/Abiraterone_acetate" title="Abiraterone acetate">abiraterone acetate</a> (which disrupts the balance of other hormones, and so is administered with <a href="/wiki/Prednisone" title="Prednisone">prednisone</a>).<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;-87">&#91;87&#93;</a></sup><sup id="cite_ref-FOOTNOTETeoRathkopfKantoff2019&quot;Abiraterone_Acetate&quot;_90-0" class="reference"><a href="#cite_note-FOOTNOTETeoRathkopfKantoff2019&quot;Abiraterone_Acetate&quot;-90">&#91;90&#93;</a></sup> Those whose cancer becomes resistant to docetaxel may receive the second-generation <a href="/wiki/Taxane" title="Taxane">taxane</a> drug <a href="/wiki/Cabazitaxel" title="Cabazitaxel">cabazitaxel</a>.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-2" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;-87">&#91;87&#93;</a></sup> An alternative is the <a href="/wiki/Cancer_immunotherapy#Cellular_immunotherapy" title="Cancer immunotherapy">cell therapy</a> procedure <a href="/wiki/Sipuleucel-T" title="Sipuleucel-T">Sipuleucel-T</a>, where the affected person's immune cells are removed, treated to more effectively target prostate cancer cells, and re-injected into the same person.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-3" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;-87">&#91;87&#93;</a></sup><sup id="cite_ref-FOOTNOTETeoRathkopfKantoff2019&quot;Abiraterone_Acetate&quot;_90-1" class="reference"><a href="#cite_note-FOOTNOTETeoRathkopfKantoff2019&quot;Abiraterone_Acetate&quot;-90">&#91;90&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Supportive_care">Supportive care</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=16" title="Edit section: Supportive care">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Bone metastases – present in around 85% of those with metastatic prostate cancer – are the primary cause of symptoms and death from metastatic prostate cancer.<sup id="cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_bone_metastases&quot;_91-0" class="reference"><a href="#cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_bone_metastases&quot;-91">&#91;91&#93;</a></sup><sup id="cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_SREs&quot;_92-0" class="reference"><a href="#cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_SREs&quot;-92">&#91;92&#93;</a></sup> Metastases can cause severe pain and bone weakening, with around 25% of those affected developing a bone fracture.<sup id="cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_SREs&quot;_92-1" class="reference"><a href="#cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_SREs&quot;-92">&#91;92&#93;</a></sup> Those with constant pain are often prescribed <a href="/wiki/Nonsteroidal_anti-inflammatory_drug" title="Nonsteroidal anti-inflammatory drug">nonsteroidal anti-inflammatory drugs</a>.<sup id="cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Analgesics_used_in_CIBP&quot;_93-0" class="reference"><a href="#cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Analgesics_used_in_CIBP&quot;-93">&#91;93&#93;</a></sup> However, people with bone metastases often experience "breakthrough pain", sudden bursts of severe pain that resolve within around 15 minutes, before <a href="/wiki/Analgesic" title="Analgesic">pain medications</a> can take effect.<sup id="cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Analgesics_used_in_CIBP&quot;_93-1" class="reference"><a href="#cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Analgesics_used_in_CIBP&quot;-93">&#91;93&#93;</a></sup> Single sites of pain can be treated with external beam radiation therapy to shrink nearby tumors.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;_94-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;-94">&#91;94&#93;</a></sup> More dispersed bone pain can be treated with radioactive compounds that disproportionately accumulate in bone, like <a href="/wiki/Radium-223" title="Radium-223">radium-223</a> and <a href="/wiki/Samarium_(153Sm)_lexidronam" title="Samarium (153Sm) lexidronam">samarium-153-EDTMP</a>, which help reduce the size of bone tumors. Similarly, the systemic chemotherapeutics used for metastatic prostate cancer can reduce pain as they shrink tumors.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;_94-1" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;-94">&#91;94&#93;</a></sup> Other bone modifying agents like <a href="/wiki/Zoledronic_acid" title="Zoledronic acid">zoledronic acid</a> and <a href="/wiki/Denosumab" title="Denosumab">denosumab</a> can reduce prostate cancer bone pain, even though they have little effect on tumor size.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;_94-2" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;-94">&#91;94&#93;</a></sup> Metastases can also compress the spinal cord in up to 12% of those with metastatic prostate cancer causing pain, weakness, numbness, and paralysis.<sup id="cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Cord_compression&quot;_95-0" class="reference"><a href="#cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Cord_compression&quot;-95">&#91;95&#93;</a></sup><sup id="cite_ref-MSCC_96-0" class="reference"><a href="#cite_note-MSCC-96">&#91;96&#93;</a></sup> Inflammation in the spine can be treated with high-dose steroids, as well as surgery and radiotherapy to shrink spinal tumors and relieve pressure on the spinal cord.<sup id="cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Cord_compression&quot;_95-1" class="reference"><a href="#cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Cord_compression&quot;-95">&#91;95&#93;</a></sup><sup id="cite_ref-MSCC_96-1" class="reference"><a href="#cite_note-MSCC-96">&#91;96&#93;</a></sup>
</p><p>Those with advanced prostate cancer often suffer fatigue, lethargy, and a generalized weakness. This is caused in part by gastrointestinal problems, with <a href="/wiki/Loss_of_appetite" class="mw-redirect" title="Loss of appetite">loss of appetite</a>, weight loss, nausea, and <a href="/wiki/Constipation" title="Constipation">constipation</a> all common. These are typically treated with appetite-increasing drugs – <a href="/wiki/Megestrol_acetate" title="Megestrol acetate">megestrol acetate</a> or corticosteroids – <a href="/wiki/Antiemetic" title="Antiemetic">antiemetics</a>, or treatments that focus on underlying gastrointestinal issues.<sup id="cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Gastrointestinal_symptoms&quot;_97-0" class="reference"><a href="#cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Gastrointestinal_symptoms&quot;-97">&#91;97&#93;</a></sup> General weakness can also be caused by <a href="/wiki/Anemia" title="Anemia">anemia</a>, itself caused by a combination of the disease itself, poor nutrition, and damage to the bone marrow from cancer treatments or bone metastases.<sup id="cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;General_debility&quot;_98-0" class="reference"><a href="#cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;General_debility&quot;-98">&#91;98&#93;</a></sup> Anemia can be improved various ways depending on the cause, or can be addressed directly with <a href="/wiki/Blood_transfusion" title="Blood transfusion">blood transfusions</a>.<sup id="cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;General_debility&quot;_98-1" class="reference"><a href="#cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;General_debility&quot;-98">&#91;98&#93;</a></sup> Organ damage and metastases in the lymph nodes can lead to uncomfortable accumulation of fluid (called <a href="/wiki/Lymphedema" title="Lymphedema">lymphedema</a>) in the genitals or lower limbs. These swellings can be extremely painful, curtailing an affected person's ability to urinate, have sex, or walk normally. Lymphedema can be treated by applying pressure to aid drainage, surgically draining pooled fluid, and cleaning and treating nearby damaged skin.<sup id="cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Lymphoedema&quot;_99-0" class="reference"><a href="#cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Lymphoedema&quot;-99">&#91;99&#93;</a></sup>
</p><p>People with prostate cancer are around twice as likely to experience <a href="/wiki/Anxiety" title="Anxiety">anxiety</a> or <a href="/wiki/Depression_(mood)" title="Depression (mood)">depression</a> compared to those without cancer.<sup id="cite_ref-FOOTNOTEMundleAfenyaAgarwal2021&quot;Estimates_of_anxiety,_depression,_and_distress&quot;_100-0" class="reference"><a href="#cite_note-FOOTNOTEMundleAfenyaAgarwal2021&quot;Estimates_of_anxiety,_depression,_and_distress&quot;-100">&#91;100&#93;</a></sup> When added to normal prostate cancer treatments, psychological interventions such as <a href="/wiki/Psychoeducation" title="Psychoeducation">psychoeducation</a> and <a href="/wiki/Cognitive_behavioural_therapy" class="mw-redirect" title="Cognitive behavioural therapy">cognitive behavioural therapy</a> can help reduce anxiety, depression, and general distress.<sup id="cite_ref-FOOTNOTEMundleAfenyaAgarwal2021&quot;Abstract&quot;_101-0" class="reference"><a href="#cite_note-FOOTNOTEMundleAfenyaAgarwal2021&quot;Abstract&quot;-101">&#91;101&#93;</a></sup>
</p><p>As those severely ill with metastatic prostate cancer near the end of their lives, most experience confusion and may <a href="/wiki/Hallucinate" class="mw-redirect" title="Hallucinate">hallucinate</a> and/or have trouble recognizing loved ones.<sup id="cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Delirium&quot;_102-0" class="reference"><a href="#cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Delirium&quot;-102">&#91;102&#93;</a></sup><sup id="cite_ref-PCUK_103-0" class="reference"><a href="#cite_note-PCUK-103">&#91;103&#93;</a></sup> Confusion is caused by various conditions, including <a href="/wiki/Kidney_failure" title="Kidney failure">kidney failure</a>, <a href="/wiki/Sepsis" title="Sepsis">sepsis</a>, <a href="/wiki/Dehydration" title="Dehydration">dehydration</a>, and as a side effect of various drugs, especially opioids.<sup id="cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Delirium&quot;_102-1" class="reference"><a href="#cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Delirium&quot;-102">&#91;102&#93;</a></sup> Most people sleep for long periods, and some feel drowsy when awake.<sup id="cite_ref-PCUK_103-1" class="reference"><a href="#cite_note-PCUK-103">&#91;103&#93;</a></sup> Restlessness is also common, sometimes caused by physical discomfort from constipation or <a href="/wiki/Urinary_retention" title="Urinary retention">urinary retention</a>, sometimes caused by anxiety.<sup id="cite_ref-PCUK_103-2" class="reference"><a href="#cite_note-PCUK-103">&#91;103&#93;</a></sup> In their last few days, affected mens' breathing may become shallow and slow, with long pauses between breaths. Breathing may be accompanied by a <a href="/wiki/Terminal_secretions" class="mw-redirect" title="Terminal secretions">rattling noise</a> as fluid lingers in the throat, but this is not uncomfortable for the affected person.<sup id="cite_ref-PCUK_103-3" class="reference"><a href="#cite_note-PCUK-103">&#91;103&#93;</a></sup><sup id="cite_ref-ASCO_104-0" class="reference"><a href="#cite_note-ASCO-104">&#91;104&#93;</a></sup> Their hands and feet may cool to the touch, and skin become blotchy or blue due to weaker blood circulation. Many stop eating and drinking, resulting in dry-feeling mouth, which can be aided by moistening the mouth and lips.<sup id="cite_ref-PCUK_103-4" class="reference"><a href="#cite_note-PCUK-103">&#91;103&#93;</a></sup> The person becomes less and less responsive, and eventually the heart and breathing stop.<sup id="cite_ref-ASCO_104-1" class="reference"><a href="#cite_note-ASCO-104">&#91;104&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=17" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The prognosis of diagnosed prostate cancer varies widely based on the cancer's grade and stage at the time of diagnosis; those with lower stage disease have vastly improved prognoses. Around 80% of prostate cancer diagnoses are in men whose cancer is still confined to the prostate. These men often survive long after diagnosis, with as many as 99% still alive 10 years from diagnosis.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Prognosis_and_survival&quot;_105-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Prognosis_and_survival&quot;-105">&#91;105&#93;</a></sup> Men whose cancer has metastasized to a nearby part of the body (around 15% of diagnoses) have poorer prognoses, with <a href="/wiki/Five-year_survival" class="mw-redirect" title="Five-year survival">five-year survival</a> rates of 60–80%.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Figure_3:_Prostate_cancer_stages_and_progression.&quot;_106-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Figure_3:_Prostate_cancer_stages_and_progression.&quot;-106">&#91;106&#93;</a></sup> Those with metastases in distant body sites (around 5% of diagnoses) have relatively poor prognoses, with five-year survival rates of 30–40%.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Figure_3:_Prostate_cancer_stages_and_progression.&quot;_106-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Figure_3:_Prostate_cancer_stages_and_progression.&quot;-106">&#91;106&#93;</a></sup> 
</p><p>Castration-resistant prostate cancer is incurable,<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Abstract&quot;_107-0" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Abstract&quot;-107">&#91;107&#93;</a></sup> and kills a majority of those whose disease reaches this stage.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-4" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;-87">&#91;87&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg/220px-Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg" decoding="async" width="220" height="145" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg/330px-Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg/440px-Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg 2x" data-file-width="4132" data-file-height="2724" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Prostate_cancer_with_Gleason_pattern_4_low_mag.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> of prostate <a href="/wiki/Adenocarcinoma" title="Adenocarcinoma">adenocarcinoma</a>, acinar type, the most common type of prostate cancer. Needle <a href="/wiki/Biopsy" title="Biopsy">biopsy</a>, <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a></div></div></div>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=18" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Prostate_cancer_world_map_-_Death_-_WHO2004.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a6/Prostate_cancer_world_map_-_Death_-_WHO2004.svg/290px-Prostate_cancer_world_map_-_Death_-_WHO2004.svg.png" decoding="async" width="290" height="128" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a6/Prostate_cancer_world_map_-_Death_-_WHO2004.svg/435px-Prostate_cancer_world_map_-_Death_-_WHO2004.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a6/Prostate_cancer_world_map_-_Death_-_WHO2004.svg/580px-Prostate_cancer_world_map_-_Death_-_WHO2004.svg.png 2x" data-file-width="940" data-file-height="415" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Prostate_cancer_world_map_-_Death_-_WHO2004.svg" class="internal" title="Enlarge"></a></div><a href="/wiki/Age_adjustment" title="Age adjustment">Age-standardized</a> death from prostate cancer per 100,000&#160;inhabitants in 2004.<sup id="cite_ref-108" class="reference"><a href="#cite_note-108">&#91;108&#93;</a></sup><style data-mw-deduplicate="TemplateStyles:r1054258005">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li{margin-left:0;padding-left:3.2em;text-indent:-3.2em}.mw-parser-output .refbegin-hanging-indents ul,.mw-parser-output .refbegin-hanging-indents ul li{list-style:none}@media(max-width:720px){.mw-parser-output .refbegin-hanging-indents>ul>li{padding-left:1.6em;text-indent:-1.6em}}.mw-parser-output .refbegin-columns{margin-top:0.3em}.mw-parser-output .refbegin-columns ul{margin-top:0}.mw-parser-output .refbegin-columns li{page-break-inside:avoid;break-inside:avoid-column}</style><div class="refbegin refbegin-columns references-column-count references-column-count-3" style="column-count: 3;"> <style data-mw-deduplicate="TemplateStyles:r981673959">.mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{}</style><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#b3b3b3; color:black;">&#160;</span>&#160;no data</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ffff65; color:black;">&#160;</span>&#160;&lt;4</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#fff200; color:black;">&#160;</span>&#160;4–8</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ffdc00; color:black;">&#160;</span>&#160;8–12</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ffc600; color:black;">&#160;</span>&#160;12–16</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ffb000; color:black;">&#160;</span>&#160;16–20</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ff9a00; color:black;">&#160;</span>&#160;20–24</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ff8400; color:black;">&#160;</span>&#160;24–28</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ff6e00; color:black;">&#160;</span>&#160;28–32</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ff5800; color:black;">&#160;</span>&#160;32–36</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ff4200; color:black;">&#160;</span>&#160;36–40</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#ff2c00; color:black;">&#160;</span>&#160;40–44</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"><div class="legend"><span class="legend-color mw-no-invert" style="background-color:#cb0000; color:white;">&#160;</span>&#160;&gt;44</div> </div></div></div></div>
<style data-mw-deduplicate="TemplateStyles:r1097763485">.mw-parser-output .ambox{border:1px solid #a2a9b1;border-left:10px solid #36c;background-color:#fbfbfb;box-sizing:border-box}.mw-parser-output .ambox+link+.ambox,.mw-parser-output .ambox+link+style+.ambox,.mw-parser-output .ambox+link+link+.ambox,.mw-parser-output .ambox+.mw-empty-elt+link+.ambox,.mw-parser-output .ambox+.mw-empty-elt+link+style+.ambox,.mw-parser-output .ambox+.mw-empty-elt+link+link+.ambox{margin-top:-1px}html body.mediawiki .mw-parser-output .ambox.mbox-small-left{margin:4px 1em 4px 0;overflow:hidden;width:238px;border-collapse:collapse;font-size:88%;line-height:1.25em}.mw-parser-output .ambox-speedy{border-left:10px solid #b32424;background-color:#fee7e6}.mw-parser-output .ambox-delete{border-left:10px solid #b32424}.mw-parser-output .ambox-content{border-left:10px solid #f28500}.mw-parser-output .ambox-style{border-left:10px solid #fc3}.mw-parser-output .ambox-move{border-left:10px solid #9932cc}.mw-parser-output .ambox-protection{border-left:10px solid #a2a9b1}.mw-parser-output .ambox .mbox-text{border:none;padding:0.25em 0.5em;width:100%}.mw-parser-output .ambox .mbox-image{border:none;padding:2px 0 2px 0.5em;text-align:center}.mw-parser-output .ambox .mbox-imageright{border:none;padding:2px 0.5em 2px 0;text-align:center}.mw-parser-output .ambox .mbox-empty-cell{border:none;padding:0;width:1px}.mw-parser-output .ambox .mbox-image-div{width:52px}html.client-js body.skin-minerva .mw-parser-output .mbox-text-span{margin-left:23px!important}@media(min-width:720px){.mw-parser-output .ambox{margin:0 10%}}</style><table class="box-Update plainlinks metadata ambox ambox-content ambox-Update" role="presentation"><tbody><tr><td class="mbox-image"><div class="mbox-image-div"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/42px-Ambox_current_red_Americas.svg.png" decoding="async" width="42" height="34" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/63px-Ambox_current_red_Americas.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/84px-Ambox_current_red_Americas.svg.png 2x" data-file-width="360" data-file-height="290" /></div></td><td class="mbox-text"><div class="mbox-text-span">This section needs to be <b>updated</b>.<span class="hide-when-compact"> Relevant discussion may be found on the <a href="/wiki/Talk:Prostate_cancer#Epidemiology" title="Talk:Prostate cancer">talk page</a>. Please help update this article to reflect recent events or newly available information.</span>  <span class="date-container"><i>(<span class="date">February 2023</span>)</i></span></div></td></tr></tbody></table>
<p>Prostate cancer is the second-most frequently diagnosed cancer in men (after <a href="/wiki/Lung_cancer" title="Lung cancer">lung cancer</a>), with 1.2 million new cases diagnosed each year and over 350,000 annual deaths.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;_33-1" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;-33">&#91;33&#93;</a></sup> Rates of prostate cancer rise with age. Due to this, prostate cancer rates are generally higher in parts of the world with higher life expectancy, which also tend to be areas with higher <a href="/wiki/Gross_domestic_product" title="Gross domestic product">gross domestic product</a> and higher <a href="/wiki/Human_development_index" class="mw-redirect" title="Human development index">human development index</a>.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;_33-2" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;-33">&#91;33&#93;</a></sup> Australia, Europe, North America, New Zealand, and parts of South America have the highest incidence. South Asia, Central Asia, and sub-Saharan Africa have the lowest incidence of prostate cancer; though incidence is increasing in these regions at among the fastest rates in the world.<sup id="cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;_33-3" class="reference"><a href="#cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;-33">&#91;33&#93;</a></sup> Prostate cancer is the most diagnosed cancer in men in over half of the world's countries, and the leading cause of cancer death in men in around a quarter of the countries.<sup id="cite_ref-FOOTNOTEBergengrenPekalaMatsoukasFainberg2023&quot;3.1_Epidemiology&quot;_109-0" class="reference"><a href="#cite_note-FOOTNOTEBergengrenPekalaMatsoukasFainberg2023&quot;3.1_Epidemiology&quot;-109">&#91;109&#93;</a></sup>
</p><p>A minority of men with prostate cancer will ever have symptoms of the disease or have their prostate cancer diagnosed. More than 70% of men <a href="/wiki/Autopsy" title="Autopsy">autopsied</a> in their 70s have cancer in their prostate; however, 1 in 8 men are diagnosed with prostate cancer, and around 1 in 40 die of the disease.<sup id="cite_ref-FOOTNOTEScherEastham2022&quot;Prostate_Cancer&quot;_110-0" class="reference"><a href="#cite_note-FOOTNOTEScherEastham2022&quot;Prostate_Cancer&quot;-110">&#91;110&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="United_States">United States</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=19" title="Edit section: United States">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1097763485"><table class="box-More_citations_needed_section plainlinks metadata ambox ambox-content ambox-Refimprove" role="presentation"><tbody><tr><td class="mbox-image"><div class="mbox-image-div"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" decoding="async" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" data-file-width="512" data-file-height="399" /></a></div></td><td class="mbox-text"><div class="mbox-text-span">This section <b>needs additional citations for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a></b>.<span class="hide-when-compact"> Please help <a class="external text" href="https://en.wikipedia.org/w/index.php?title=Prostate_cancer&amp;action=edit">improve this article</a> by <a href="/wiki/Help:Referencing_for_beginners" title="Help:Referencing for beginners">adding citations to reliable sources</a>&#32;in this section. Unsourced material may be challenged and removed.</span>  <span class="date-container"><i>(<span class="date">August 2020</span>)</i></span><span class="hide-when-compact"><i> (<small><a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove this template message</a></small>)</i></span></div></td></tr></tbody></table><div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Longterm_LineGraph_Site_062_Sex_1.png" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/7/7f/Longterm_LineGraph_Site_062_Sex_1.png/290px-Longterm_LineGraph_Site_062_Sex_1.png" decoding="async" width="290" height="107" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/7f/Longterm_LineGraph_Site_062_Sex_1.png/435px-Longterm_LineGraph_Site_062_Sex_1.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/7f/Longterm_LineGraph_Site_062_Sex_1.png/580px-Longterm_LineGraph_Site_062_Sex_1.png 2x" data-file-width="595" data-file-height="220" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Longterm_LineGraph_Site_062_Sex_1.png" class="internal" title="Enlarge"></a></div>New cases and deaths from prostate cancer in the United States per 100,000 males between 1975 and 2014</div></div></div>
<p>Prostate cancer is the third-leading cause of cancer death in men, exceeded by lung cancer and colorectal cancer. It accounts for 19% of all male cancers and 9% of male cancer-related deaths.<sup id="cite_ref-111" class="reference"><a href="#cite_note-111">&#91;111&#93;</a></sup>
</p><p>Age-adjusted incidence rates increased steadily from 1975 through 1992, with particularly dramatic increases associated with the spread of PSA screening in the late 1980s, later followed by a fall in incidence. A decline in early-stage incidence rates from 2011 to 2012 (19%) in men aged 50 years and older persisted through 2013 (6%).
</p><p>Declines in mortality rates in certain jurisdictions may reflect the interaction of PSA screening and improved treatment.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112">&#91;112&#93;</a></sup> The estimated lifetime risk is about 14.0%, and the lifetime mortality risk is 2.6%.<sup id="cite_ref-113" class="reference"><a href="#cite_note-113">&#91;113&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Canada">Canada</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=20" title="Edit section: Canada">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Prostate cancer is the third-leading type of cancer in Canadian men. In 2016, around 4,000 died and 21,600 men were diagnosed with prostate cancer.<sup id="cite_ref-Rendon2017_114-0" class="reference"><a href="#cite_note-Rendon2017-114">&#91;114&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Europe">Europe</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=21" title="Edit section: Europe">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In Europe in 2012, it was the third-most diagnosed cancer after breast and colorectal cancers at 417,000 cases.<sup id="cite_ref-115" class="reference"><a href="#cite_note-115">&#91;115&#93;</a></sup>
</p><p>In the United Kingdom, it is the second-most common cause of cancer death after lung cancer, where around 35,000 cases are diagnosed every year, of which around 10,000 are fatal.<sup id="cite_ref-116" class="reference"><a href="#cite_note-116">&#91;116&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=22" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The prostate was first described by <a href="/wiki/Venice" title="Venice">Venetian</a> anatomist <a href="/wiki/Niccol%C3%B2_Massa" title="Niccolò Massa">Niccolò Massa</a> in 1536, and illustrated by <a href="/wiki/Flanders" title="Flanders">Flemish</a> anatomist <a href="/wiki/Vesalius" class="mw-redirect" title="Vesalius">Andreas Vesalius</a> in 1538.<sup id="cite_ref-Ghabili2016_117-0" class="reference"><a href="#cite_note-Ghabili2016-117">&#91;117&#93;</a></sup> Prostate cancer was identified in 1853.<sup id="cite_ref-Nahon2011_118-0" class="reference"><a href="#cite_note-Nahon2011-118">&#91;118&#93;</a></sup><sup id="cite_ref-119" class="reference"><a href="#cite_note-119">&#91;119&#93;</a></sup> It was initially considered a rare disease, probably because of shorter <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancies</a> and poorer detection methods in the 19th century. The first treatments were surgeries to relieve urinary obstruction.<sup id="cite_ref-120" class="reference"><a href="#cite_note-120">&#91;120&#93;</a></sup>
</p><p>Removal of the gland was first described in 1851,<sup id="cite_ref-121" class="reference"><a href="#cite_note-121">&#91;121&#93;</a></sup> and radical perineal <a href="/wiki/Prostatectomy" title="Prostatectomy">prostatectomy</a> was first performed in 1904 by <a href="/wiki/Hugh_H._Young" title="Hugh H. Young">Hugh H. Young</a> at <a href="/wiki/Johns_Hopkins_Hospital" title="Johns Hopkins Hospital">Johns Hopkins Hospital</a>.<sup id="cite_ref-122" class="reference"><a href="#cite_note-122">&#91;122&#93;</a></sup><sup id="cite_ref-Nahon2011_118-1" class="reference"><a href="#cite_note-Nahon2011-118">&#91;118&#93;</a></sup>
</p><p>Surgical removal of the testes (<a href="/wiki/Orchiectomy" title="Orchiectomy">orchiectomy</a>) to treat prostate cancer was first performed in the 1890s, with limited success.<sup id="cite_ref-123" class="reference"><a href="#cite_note-123">&#91;123&#93;</a></sup> <a href="/wiki/Transurethral_resection_of_the_prostate" title="Transurethral resection of the prostate">Transurethral resection of the prostate</a> (TURP) replaced radical prostatectomy for symptomatic relief of obstruction in the middle of the 20th century because it could better preserve penile erectile function. Radical retropubic prostatectomy was developed in 1983 by Patrick Walsh.<sup id="cite_ref-124" class="reference"><a href="#cite_note-124">&#91;124&#93;</a></sup> This surgical approach allowed for removal of the prostate and lymph nodes with maintenance of penile function.
</p><p>In 1941, <a href="/wiki/Charles_B._Huggins" class="mw-redirect" title="Charles B. Huggins">Charles B. Huggins</a> published studies in which he used <a href="/wiki/Estrogen" title="Estrogen">estrogen</a> to oppose testosterone production in men with metastatic prostate cancer. This discovery of "chemical <a href="/wiki/Castration" title="Castration">castration</a>" won Huggins the 1966 <a href="/wiki/Nobel_Prize_in_Physiology_or_Medicine" title="Nobel Prize in Physiology or Medicine">Nobel Prize in Physiology or Medicine</a>.<sup id="cite_ref-125" class="reference"><a href="#cite_note-125">&#91;125&#93;</a></sup> The role of the <a href="/wiki/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">gonadotropin-releasing hormone</a> (GnRH) in reproduction was determined by <a href="/wiki/Andrzej_W._Schally" class="mw-redirect" title="Andrzej W. Schally">Andrzej W. Schally</a> and <a href="/wiki/Roger_Guillemin" title="Roger Guillemin">Roger Guillemin</a>, who shared the 1977 Nobel Prize in Physiology or Medicine for this work. GnRH receptor agonists, such as <a href="/wiki/Leuprorelin" title="Leuprorelin">leuprorelin</a> and <a href="/wiki/Goserelin" title="Goserelin">goserelin</a>, were subsequently developed and used to treat prostate cancer.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126">&#91;126&#93;</a></sup><sup id="cite_ref-127" class="reference"><a href="#cite_note-127">&#91;127&#93;</a></sup>
</p><p><a href="/wiki/Radiation_therapy" title="Radiation therapy">Radiation therapy</a> for prostate cancer was first developed in the early 20th century and initially consisted of intraprostatic <a href="/wiki/Radium" title="Radium">radium</a> implants. <a href="/wiki/External_beam_radiotherapy" title="External beam radiotherapy">External beam radiotherapy</a> became more popular as stronger [X-ray] radiation sources became available in the middle of the 20th century. <a href="/wiki/Brachytherapy" title="Brachytherapy">Brachytherapy</a> with implanted seeds (for prostate cancer) was first described in 1983.<sup id="cite_ref-128" class="reference"><a href="#cite_note-128">&#91;128&#93;</a></sup>
</p><p>Systemic <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> for prostate cancer was first studied in the 1970s. The initial regimen of <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a> and <a href="/wiki/5-fluorouracil" class="mw-redirect" title="5-fluorouracil">5-fluorouracil</a> was quickly joined by regimens using other systemic chemotherapy drugs.<sup id="cite_ref-129" class="reference"><a href="#cite_note-129">&#91;129&#93;</a></sup>
</p><p><a href="/wiki/Enzalutamide" title="Enzalutamide">Enzalutamide</a> gained FDA approval in 2012 for the treatment of castration-resistant prostate cancer (CRPC).<sup id="cite_ref-Xtandi-1_130-0" class="reference"><a href="#cite_note-Xtandi-1-130">&#91;130&#93;</a></sup><sup id="cite_ref-Xtandi-2_131-0" class="reference"><a href="#cite_note-Xtandi-2-131">&#91;131&#93;</a></sup> <a href="/wiki/Alpharadin" class="mw-redirect" title="Alpharadin">Alpharadin</a> won FDA approval in 2013, under the priority review program.<sup id="cite_ref-132" class="reference"><a href="#cite_note-132">&#91;132&#93;</a></sup>
</p><p>In 2006, a previously unknown retrovirus, <a href="/wiki/Xenotropic_MuLV-related_virus" class="mw-redirect" title="Xenotropic MuLV-related virus">Xenotropic MuLV-related virus</a> (XMRV), was associated with human prostate tumors,<sup id="cite_ref-pmid16609730_133-0" class="reference"><a href="#cite_note-pmid16609730-133">&#91;133&#93;</a></sup> but <i>PLOS Pathogens</i> retracted the article in 2012.<sup id="cite_ref-pmid16609730_133-1" class="reference"><a href="#cite_note-pmid16609730-133">&#91;133&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=23" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Men with prostate cancer generally encounter significant disparities in awareness, funding, media coverage, and research—and therefore, inferior treatment and poorer outcomes—compared to other cancers of equal prevalence.<sup id="cite_ref-Businessweek_2007-06-13_134-0" class="reference"><a href="#cite_note-Businessweek_2007-06-13-134">&#91;134&#93;</a></sup> In 2001, <i><a href="/wiki/The_Guardian" title="The Guardian">The Guardian</a></i> noted that Britain had 3,000 nurses specializing in <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>, compared to a single nurse for prostate cancer.<sup id="cite_ref-135" class="reference"><a href="#cite_note-135">&#91;135&#93;</a></sup> Waiting time between referral and diagnosis was two weeks for breast cancer but three months for prostate cancer.<sup id="cite_ref-136" class="reference"><a href="#cite_note-136">&#91;136&#93;</a></sup>
</p><p>A 2007 report by the U.S.-based <a href="/wiki/ZERO%E2%80%94The_Project_to_End_Prostate_Cancer" class="mw-redirect" title="ZERO—The Project to End Prostate Cancer">National Prostate Cancer Coalition</a> stated that prostate cancer drugs were outnumbered seven to one by breast cancer drugs.<sup id="cite_ref-137" class="reference"><a href="#cite_note-137">&#91;137&#93;</a></sup> <i><a href="/wiki/The_Times" title="The Times">The Times</a></i> also noted an "anti-male bias in cancer funding" with a four-to-one discrepancy in the United Kingdom by both the government and by cancer charities such as <a href="/wiki/Cancer_Research_UK" title="Cancer Research UK">Cancer Research UK</a>.<sup id="cite_ref-Businessweek_2007-06-13_134-1" class="reference"><a href="#cite_note-Businessweek_2007-06-13-134">&#91;134&#93;</a></sup><sup id="cite_ref-st16Oct2005_138-0" class="reference"><a href="#cite_note-st16Oct2005-138">&#91;138&#93;</a></sup> Critics cite such figures when claiming that women's health is favored over men's health.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139">&#91;139&#93;</a></sup>
</p><p>Disparities extend into detection, with governments failing to fund or mandate prostate cancer screening while fully supporting breast cancer programs. For example, a 2007 report found 49 U.S. states mandate insurance coverage for routine breast cancer screening, compared to 28 for prostate cancer.<sup id="cite_ref-140" class="reference"><a href="#cite_note-140">&#91;140&#93;</a></sup>
</p><p>Prostate cancer experiences significantly less media coverage than other, equally prevalent cancers, outcovered 2.6:1 by breast cancer.<sup id="cite_ref-Businessweek_2007-06-13_134-2" class="reference"><a href="#cite_note-Businessweek_2007-06-13-134">&#91;134&#93;</a></sup>
</p><p><a href="/wiki/Prostate_Cancer_Awareness_Month" class="mw-redirect" title="Prostate Cancer Awareness Month">Prostate Cancer Awareness Month</a> takes place in September in a number of countries. A light blue ribbon is used to promote the cause.<sup id="cite_ref-141" class="reference"><a href="#cite_note-141">&#91;141&#93;</a></sup><sup id="cite_ref-142" class="reference"><a href="#cite_note-142">&#91;142&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=24" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Castration-resistant_prostate_cancer">Castration-resistant prostate cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=25" title="Edit section: Castration-resistant prostate cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><i>Castration-resitant prostate cancer</i> is prostate cancer that progresses despite androgen depletion therapy.<sup id="cite_ref-143" class="reference"><a href="#cite_note-143">&#91;143&#93;</a></sup>
</p><p><a href="/wiki/Enzalutamide" title="Enzalutamide">Enzalutamide</a> is a <a href="/wiki/Nonsteroidal_antiandrogen" title="Nonsteroidal antiandrogen">nonsteroidal antiandrogen</a> (NSAA).<sup id="cite_ref-Xtandi-1_130-1" class="reference"><a href="#cite_note-Xtandi-1-130">&#91;130&#93;</a></sup><sup id="cite_ref-Xtandi-2_131-1" class="reference"><a href="#cite_note-Xtandi-2-131">&#91;131&#93;</a></sup> It has been used with abiraterone in studies involving <a href="/wiki/Whole_genome_sequencing" title="Whole genome sequencing">Whole genome sequencing</a> that have shown how androgen receptors acquire resistance to them, which determines the use of new therapies against this pathology such as degraders of the protein or of the <a href="/wiki/N-terminal" class="mw-redirect" title="N-terminal">N-terminal</a> domain of this receptor. This has been seen thanks to the sequencing of <a href="/wiki/Circulating_tumor_DNA" title="Circulating tumor DNA">circulating tumor DNA</a> in patients.<sup id="cite_ref-Herberts2022_144-0" class="reference"><a href="#cite_note-Herberts2022-144">&#91;144&#93;</a></sup>
</p><p><a href="/wiki/Alpharadin" class="mw-redirect" title="Alpharadin">Alpharadin</a> uses bone targeted <a href="/wiki/Radium-223" title="Radium-223">Radium-223</a> isotopes to kill cancer cells by <a href="/wiki/Alpha_radiation" class="mw-redirect" title="Alpha radiation">alpha radiation</a>.<sup id="cite_ref-145" class="reference"><a href="#cite_note-145">&#91;145&#93;</a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may rely on an unreliable or less reliable medical source. (November 2017)">unreliable medical source?</span></a></i>&#93;</sup>
</p><p><a href="/wiki/PARP_inhibitor" title="PARP inhibitor">PARP inhibitor</a> <a href="/wiki/Olaparib" title="Olaparib">olaparib</a> is an approved breast/ovarian cancer drug that is undergoing clinical trials.<sup id="cite_ref-PCWG3-Geet_146-0" class="reference"><a href="#cite_note-PCWG3-Geet-146">&#91;146&#93;</a></sup> Also in trials for CRPC are&#160;: <a href="/wiki/Checkpoint_inhibitor" title="Checkpoint inhibitor">checkpoint inhibitor</a> <a href="/wiki/Ipilimumab" title="Ipilimumab">ipilimumab</a>, <a href="/wiki/CYP17_inhibitor" class="mw-redirect" title="CYP17 inhibitor">CYP17 inhibitor</a> <a href="/wiki/Galeterone" title="Galeterone">galeterone</a> (TOK-001), and <a href="/wiki/Immunotherapy" title="Immunotherapy">immunotherapy</a> <a href="/wiki/PROSTVAC" class="mw-redirect" title="PROSTVAC">PROSTVAC</a>.<sup id="cite_ref-PCWG3-Geet_146-1" class="reference"><a href="#cite_note-PCWG3-Geet-146">&#91;146&#93;</a></sup>
</p><p>All medications for CRPC block <a href="/wiki/Androgen_receptor" title="Androgen receptor">androgen receptor</a> (AR) signaling via direct or indirect targeting of the AR <a href="/wiki/Nuclear_receptor" title="Nuclear receptor">ligand binding domain</a> (LBD). AR belongs to the steroid <a href="/wiki/Nuclear_receptor" title="Nuclear receptor">nuclear receptor</a> family.<sup id="cite_ref-Elshan2019_147-0" class="reference"><a href="#cite_note-Elshan2019-147">&#91;147&#93;</a></sup> Development of the prostate is dependent on androgen signaling mediated through AR, and AR is also important for disease progression.<sup id="cite_ref-148" class="reference"><a href="#cite_note-148">&#91;148&#93;</a></sup> Molecules that could successfully target alternative domains have emerged.<sup id="cite_ref-Elshan2019_147-1" class="reference"><a href="#cite_note-Elshan2019-147">&#91;147&#93;</a></sup> Such therapies could provide an advantage; particularly in treating prostate cancers that are resistant to current therapies.<sup id="cite_ref-Elshan2019_147-2" class="reference"><a href="#cite_note-Elshan2019-147">&#91;147&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Evolution">Evolution</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=26" title="Edit section: Evolution">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Sequencing techniques, in addition to reflecting the mechanisms of resistance to treatment, through the <a href="/wiki/Circulating_tumor_DNA" title="Circulating tumor DNA">circulating tumor DNA</a>, distinguish between the evolutionary history of this cancer when it metastasizes and the temporal subclonal dynamics, determining how the tumor is found when it is diagnosed.<sup id="cite_ref-Herberts2022_144-1" class="reference"><a href="#cite_note-Herberts2022-144">&#91;144&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Pre-clinical">Pre-clinical</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=27" title="Edit section: Pre-clinical">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Arachidonate_5-lipoxygenase" title="Arachidonate 5-lipoxygenase">Arachidonate 5-lipoxygenase</a> has been identified as playing a significant role in the survival of prostate cancer cells.<sup id="cite_ref-Primary_source_cited_in_1st_review_149-0" class="reference"><a href="#cite_note-Primary_source_cited_in_1st_review-149">&#91;149&#93;</a></sup><sup id="cite_ref-MEDRS_review_1_150-0" class="reference"><a href="#cite_note-MEDRS_review_1-150">&#91;150&#93;</a></sup><sup id="cite_ref-MEDRS_review_2_151-0" class="reference"><a href="#cite_note-MEDRS_review_2-151">&#91;151&#93;</a></sup> Medications that target this enzyme are undergoing development.<sup id="cite_ref-Primary_source_cited_in_1st_review_149-1" class="reference"><a href="#cite_note-Primary_source_cited_in_1st_review-149">&#91;149&#93;</a></sup><sup id="cite_ref-MEDRS_review_1_150-1" class="reference"><a href="#cite_note-MEDRS_review_1-150">&#91;150&#93;</a></sup><sup id="cite_ref-MEDRS_review_2_151-1" class="reference"><a href="#cite_note-MEDRS_review_2-151">&#91;151&#93;</a></sup> In particular, <a href="/wiki/Arachidonate_5-lipoxygenase_inhibitors" class="mw-redirect" title="Arachidonate 5-lipoxygenase inhibitors">arachidonate 5-lipoxygenase inhibitors</a> produce massive, rapid programmed cell death in prostate cancer cells.<sup id="cite_ref-Primary_source_cited_in_1st_review_149-2" class="reference"><a href="#cite_note-Primary_source_cited_in_1st_review-149">&#91;149&#93;</a></sup><sup id="cite_ref-MEDRS_review_1_150-2" class="reference"><a href="#cite_note-MEDRS_review_1-150">&#91;150&#93;</a></sup><sup id="cite_ref-MEDRS_review_2_151-2" class="reference"><a href="#cite_note-MEDRS_review_2-151">&#91;151&#93;</a></sup>
</p><p><a href="/wiki/Galectin-3" title="Galectin-3">Galectin-3</a> is another potential target.<sup id="cite_ref-Martínez-Bosch2019_152-0" class="reference"><a href="#cite_note-Martínez-Bosch2019-152">&#91;152&#93;</a></sup> Aberrant glycan profiles have been described in prostate cancer,<sup id="cite_ref-153" class="reference"><a href="#cite_note-153">&#91;153&#93;</a></sup><sup id="cite_ref-154" class="reference"><a href="#cite_note-154">&#91;154&#93;</a></sup> and studies have found specific links between the galectin signature and prostate cancer.<sup id="cite_ref-155" class="reference"><a href="#cite_note-155">&#91;155&#93;</a></sup><sup id="cite_ref-156" class="reference"><a href="#cite_note-156">&#91;156&#93;</a></sup>
</p><p>The <a href="/wiki/PIM1" title="PIM1">PIM kinase</a> family is another potential target for selective inhibition. A number of related drugs are under development. It has been suggested the most promising approach may be to co-target this family with other pathways including <a href="/wiki/PI3K/AKT/mTOR_pathway" title="PI3K/AKT/mTOR pathway">PI3K</a>.<sup id="cite_ref-Luszczak_2020_7_18-1" class="reference"><a href="#cite_note-Luszczak_2020_7-18">&#91;18&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Cancer_models">Cancer models</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=28" title="Edit section: Cancer models">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Scientists have established prostate cancer <a href="/wiki/Cell_lines" class="mw-redirect" title="Cell lines">cell lines</a> to investigate disease progression. <a href="/wiki/LNCaP" title="LNCaP">LNCaP</a>, PC-3 (<a href="/wiki/PC3" title="PC3">PC3</a>), and DU-145 (<a href="/wiki/DU145" title="DU145">DU145</a>) are commonly used prostate cancer cell lines.<sup id="cite_ref-157" class="reference"><a href="#cite_note-157">&#91;157&#93;</a></sup> The LNCaP cancer cell line was established from a human lymph node metastatic lesion of prostatic adenocarcinoma. PC-3 and DU-145 cells were established from human prostatic adenocarcinoma metastatic to bone and to brain, respectively. LNCaP cells express AR, but PC-3 and DU-145 cells express very little or no AR.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2022)">citation needed</span></a></i>&#93;</sup>
</p><p>The proliferation of LNCaP cells is <a href="/wiki/Androgen" title="Androgen">androgen</a>-dependent but the proliferation of PC-3 and DU-145 cells is <a href="/wiki/Androgen" title="Androgen">androgen</a>-insensitive. Elevation of AR expression is often observed in advanced prostate <a href="/wiki/Tumor" class="mw-redirect" title="Tumor">tumors</a> in patients.<sup id="cite_ref-158" class="reference"><a href="#cite_note-158">&#91;158&#93;</a></sup><sup id="cite_ref-159" class="reference"><a href="#cite_note-159">&#91;159&#93;</a></sup> Some androgen-independent LNCaP sublines have been developed from the ATCC androgen-dependent LNCaP cells after androgen deprivation for study of prostate cancer progression. These <a href="/wiki/Androgen" title="Androgen">androgen</a>-independent LNCaP cells have elevated <a href="/wiki/Androgen_receptor" title="Androgen receptor">AR</a> expression and express <a href="/wiki/Prostate_specific_antigen" class="mw-redirect" title="Prostate specific antigen">prostate specific antigen</a> upon androgen treatment. Paradoxically, androgens inhibit the proliferation of these androgen-independent prostate <a href="/wiki/Cancer" title="Cancer">cancer</a> cells.<sup id="cite_ref-160" class="reference"><a href="#cite_note-160">&#91;160&#93;</a></sup><sup id="cite_ref-161" class="reference"><a href="#cite_note-161">&#91;161&#93;</a></sup><sup id="cite_ref-162" class="reference"><a href="#cite_note-162">&#91;162&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Diagnosis_2">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=29" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>One active research area and non-clinically applied investigations involves non-invasive methods of tumor detection.<sup id="cite_ref-163" class="reference"><a href="#cite_note-163">&#91;163&#93;</a></sup> A molecular test that detects the presence of cell-associated <a href="/wiki/PCA3" title="PCA3">PCA3</a> mRNA in fluid obtained from the prostate and first-void urine sample is under investigation. PCA3 mRNA is expressed almost exclusively by prostate cells and has been shown to be highly over-expressed in prostate cancer cells. The test result is currently reported as a specimen ratio of PCA3 mRNA to PSA mRNA.<sup id="cite_ref-164" class="reference"><a href="#cite_note-164">&#91;164&#93;</a></sup>
</p><p>The PCA3 test attempts to help decide whether, in men suspected of having prostate cancer (especially if an initial biopsy fails to explain the elevated serum PSA), a biopsy/rebiopsy is needed. The higher the expression of PCA3 in the sample, the greater the likelihood of a positive biopsy.<sup id="cite_ref-pmid21176272_165-0" class="reference"><a href="#cite_note-pmid21176272-165">&#91;165&#93;</a></sup> The CDC's Evaluation of Genomic Applications in Practice and Prevention Working Group discourages clinical use.<sup id="cite_ref-166" class="reference"><a href="#cite_note-166">&#91;166&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=30" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a href="/wiki/Prostate_Cancer_Foundation" title="Prostate Cancer Foundation">Prostate Cancer Foundation</a></li>
<li><a href="/wiki/Testicular_cancer" title="Testicular cancer">Testicular cancer</a></li></ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=31" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-NCI2014TxPro-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-NCI2014TxPro_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NCI2014TxPro_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NCI2014TxPro_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NCI2014TxPro_1-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1133582631">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page1/Alpages">"Prostate Cancer Treatment (PDQ) – Health Professional Version"</a>. National Cancer Institute. 2014-04-11. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140705121331/http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page1/Alpages">Archived</a> from the original on 5 July 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Prostate+Cancer+Treatment+%28PDQ%29+%E2%80%93+Health+Professional+Version&amp;rft.pub=National+Cancer+Institute&amp;rft.date=2014-04-11&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2Fprostate%2FHealthProfessional%2Fpage1%2FAlpages&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-NCI2013TxPt-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-NCI2013TxPt_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NCI2013TxPt_2-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.gov/cancertopics/pdq/treatment/prostate/Patient/page1/AllPages">"Prostate Cancer Treatment (PDQ) – Patient Version"</a>. National Cancer Institute. 2014-04-08. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140705121244/http://www.cancer.gov/cancertopics/pdq/treatment/prostate/Patient/page1/AllPages">Archived</a> from the original on 5 July 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Prostate+Cancer+Treatment+%28PDQ%29+%E2%80%93+Patient+Version&amp;rft.pub=National+Cancer+Institute&amp;rft.date=2014-04-08&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2Fprostate%2FPatient%2Fpage1%2FAllPages&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-WCR2014-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-WCR2014_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WCR2014_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WCR2014_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-WCR2014_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-WCR2014_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-WCR2014_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-WCR2014_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-WCR2014_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-WCR2014_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-WCR2014_3-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-WCR2014_3-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation book cs1">"Chapter 5.11". <i>World Cancer Report</i>. World Health Organization. 2014. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-92-832-0429-9" title="Special:BookSources/978-92-832-0429-9"><bdi>978-92-832-0429-9</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+5.11&amp;rft.btitle=World+Cancer+Report&amp;rft.pub=World+Health+Organization&amp;rft.date=2014&amp;rft.isbn=978-92-832-0429-9&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-SEER2014-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-SEER2014_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-SEER2014_4-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://seer.cancer.gov/statfacts/html/prost.html">"SEER Stat Fact Sheets: Prostate Cancer"</a>. <i>NCI</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140706142501/http://seer.cancer.gov/statfacts/html/prost.html">Archived</a> from the original on 6 July 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">18 June</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NCI&amp;rft.atitle=SEER+Stat+Fact+Sheets%3A+Prostate+Cancer&amp;rft_id=http%3A%2F%2Fseer.cancer.gov%2Fstatfacts%2Fhtml%2Fprost.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Bray2018-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bray2018_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bray2018_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Bray2018_5-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBrayFerlaySoerjomataramSiegel2018" class="citation journal cs1">Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (November 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.3322%2Fcaac.21492">"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"</a>. <i>CA</i>. <b>68</b> (6): 394–424. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3322%2Fcaac.21492">10.3322/caac.21492</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30207593">30207593</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52188256">52188256</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CA&amp;rft.atitle=Global+cancer+statistics+2018%3A+GLOBOCAN+estimates+of+incidence+and+mortality+worldwide+for+36+cancers+in+185+countries&amp;rft.volume=68&amp;rft.issue=6&amp;rft.pages=394-424&amp;rft.date=2018-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52188256%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30207593&amp;rft_id=info%3Adoi%2F10.3322%2Fcaac.21492&amp;rft.aulast=Bray&amp;rft.aufirst=F&amp;rft.au=Ferlay%2C+J&amp;rft.au=Soerjomataram%2C+I&amp;rft.au=Siegel%2C+RL&amp;rft.au=Torre%2C+LA&amp;rft.au=Jemal%2C+A&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.3322%252Fcaac.21492&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087">"Prostate cancer - Symptoms and causes"</a>. <i>Mayo Clinic</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2023-02-11</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Mayo+Clinic&amp;rft.atitle=Prostate+cancer+-+Symptoms+and+causes&amp;rft_id=https%3A%2F%2Fwww.mayoclinic.org%2Fdiseases-conditions%2Fprostate-cancer%2Fsymptoms-causes%2Fsyc-20353087&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/prostate-cancer/about/what-is-prostate-cancer.html">"What Is Prostate Cancer?"</a>. <i>www.cancer.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2023-02-11</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cancer.org&amp;rft.atitle=What+Is+Prostate+Cancer%3F&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Fprostate-cancer%2Fabout%2Fwhat-is-prostate-cancer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLuiningCysouwMeijerHendrikse2022" class="citation journal cs1">Luining WI, Cysouw MC, Meijer D, Hendrikse NH, Boellaard R, Vis AN, Oprea-Lager DE (February 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909566">"Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer"</a>. <i>Cancers</i>. <b>14</b> (5): 1169. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fcancers14051169">10.3390/cancers14051169</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909566">8909566</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35267481">35267481</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancers&amp;rft.atitle=Targeting+PSMA+Revolutionizes+the+Role+of+Nuclear+Medicine+in+Diagnosis+and+Treatment+of+Prostate+Cancer&amp;rft.volume=14&amp;rft.issue=5&amp;rft.pages=1169&amp;rft.date=2022-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8909566%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35267481&amp;rft_id=info%3Adoi%2F10.3390%2Fcancers14051169&amp;rft.aulast=Luining&amp;rft.aufirst=WI&amp;rft.au=Cysouw%2C+MC&amp;rft.au=Meijer%2C+D&amp;rft.au=Hendrikse%2C+NH&amp;rft.au=Boellaard%2C+R&amp;rft.au=Vis%2C+AN&amp;rft.au=Oprea-Lager%2C+DE&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8909566&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKalishMcDougalMcKinlay2000" class="citation journal cs1">Kalish LA, McDougal WS, McKinlay JB (November 2000). "Family history and the risk of prostate cancer". <i>Urology</i>. <b>56</b> (5): 803–806. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0090-4295%2800%2900780-9">10.1016/S0090-4295(00)00780-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11068306">11068306</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Urology&amp;rft.atitle=Family+history+and+the+risk+of+prostate+cancer&amp;rft.volume=56&amp;rft.issue=5&amp;rft.pages=803-806&amp;rft.date=2000-11&amp;rft_id=info%3Adoi%2F10.1016%2FS0090-4295%2800%2900780-9&amp;rft_id=info%3Apmid%2F11068306&amp;rft.aulast=Kalish&amp;rft.aufirst=LA&amp;rft.au=McDougal%2C+WS&amp;rft.au=McKinlay%2C+JB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLeeKatabathinaBowersonMityul2016" class="citation journal cs1">Lee MV, Katabathina VS, Bowerson ML, Mityul MI, Shetty AS, Elsayes KM,  et&#160;al. (2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1148%2Frg.2017160144">"BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management"</a>. <i>Radiographics</i>. <b>37</b> (4): 1005–1023. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1148%2Frg.2017160144">10.1148/rg.2017160144</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28548905">28548905</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Radiographics&amp;rft.atitle=BRCA-associated+Cancers%3A+Role+of+Imaging+in+Screening%2C+Diagnosis%2C+and+Management&amp;rft.volume=37&amp;rft.issue=4&amp;rft.pages=1005-1023&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.1148%2Frg.2017160144&amp;rft_id=info%3Apmid%2F28548905&amp;rft.aulast=Lee&amp;rft.aufirst=MV&amp;rft.au=Katabathina%2C+VS&amp;rft.au=Bowerson%2C+ML&amp;rft.au=Mityul%2C+MI&amp;rft.au=Shetty%2C+AS&amp;rft.au=Elsayes%2C+KM&amp;rft.au=Balachandran%2C+A&amp;rft.au=Bhosale%2C+PR&amp;rft.au=McCullough%2C+AE&amp;rft.au=Menias%2C+CO&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1148%252Frg.2017160144&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-NCI2018TxPro-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-NCI2018TxPro_11-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq#section/all">"Prostate Cancer Treatment"</a>. <i>National Cancer Institute</i>. 6 February 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">1 March</span> 2018</span>. <q>Controversy exists regarding the value of screening... reported no clear evidence that screening for prostate cancer decreases the risk of death from prostate cancer</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Cancer+Institute&amp;rft.atitle=Prostate+Cancer+Treatment&amp;rft.date=2018-02-06&amp;rft_id=https%3A%2F%2Fwww.cancer.gov%2Ftypes%2Fprostate%2Fhp%2Fprostate-treatment-pdq%23section%2Fall&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Catalona2018-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-Catalona2018_12-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCatalona2018" class="citation journal cs1">Catalona WJ (March 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935113">"Prostate Cancer Screening"</a>. <i>The Medical Clinics of North America</i>. <b>102</b> (2): 199–214. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mcna.2017.11.001">10.1016/j.mcna.2017.11.001</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935113">5935113</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29406053">29406053</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Medical+Clinics+of+North+America&amp;rft.atitle=Prostate+Cancer+Screening&amp;rft.volume=102&amp;rft.issue=2&amp;rft.pages=199-214&amp;rft.date=2018-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5935113%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29406053&amp;rft_id=info%3Adoi%2F10.1016%2Fj.mcna.2017.11.001&amp;rft.aulast=Catalona&amp;rft.aufirst=WJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5935113&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-NHS2015Screen-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-NHS2015Screen_13-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nhs.uk/conditions/prostate-cancer/psa-testing/">"PSA testing"</a>. <i>nhs.uk</i>. 3 January 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">5 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=nhs.uk&amp;rft.atitle=PSA+testing&amp;rft.date=2015-01-03&amp;rft_id=https%3A%2F%2Fwww.nhs.uk%2Fconditions%2Fprostate-cancer%2Fpsa-testing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-USPSTF2018-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-USPSTF2018_14-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening1">"Final Recommendation Statement: Prostate Cancer: Screening"</a>. <i>www.uspreventiveservicestaskforce.org</i>. US Preventive Services Task Force (USPSTF)<span class="reference-accessdate">. Retrieved <span class="nowrap">30 August</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.uspreventiveservicestaskforce.org&amp;rft.atitle=Final+Recommendation+Statement%3A+Prostate+Cancer%3A+Screening&amp;rft_id=https%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2FPage%2FDocument%2FRecommendationStatementFinal%2Fprostate-cancer-screening1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGrossmanCurryOwensBibbins-Domingo2018" class="citation journal cs1">Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW,  et&#160;al. (May 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2018.3710">"Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement"</a>. <i>JAMA</i>. <b>319</b> (18): 1901–1913. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2018.3710">10.1001/jama.2018.3710</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29801017">29801017</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Screening+for+Prostate+Cancer%3A+US+Preventive+Services+Task+Force+Recommendation+Statement&amp;rft.volume=319&amp;rft.issue=18&amp;rft.pages=1901-1913&amp;rft.date=2018-05&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2018.3710&amp;rft_id=info%3Apmid%2F29801017&amp;rft.aulast=Grossman&amp;rft.aufirst=DC&amp;rft.au=Curry%2C+SJ&amp;rft.au=Owens%2C+DK&amp;rft.au=Bibbins-Domingo%2C+K&amp;rft.au=Caughey%2C+AB&amp;rft.au=Davidson%2C+KW&amp;rft.au=Doubeni%2C+CA&amp;rft.au=Ebell%2C+M&amp;rft.au=Epling%2C+JW&amp;rft.au=Kemper%2C+AR&amp;rft.au=Krist%2C+AH&amp;rft.au=Kubik%2C+M&amp;rft.au=Landefeld%2C+CS&amp;rft.au=Mangione%2C+CM&amp;rft.au=Silverstein%2C+M&amp;rft.au=Simon%2C+MA&amp;rft.au=Siu%2C+AL&amp;rft.au=Tseng%2C+CW&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1001%252Fjama.2018.3710&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCabarkapaPereraMcGrathLawrentschuk2016" class="citation journal cs1">Cabarkapa S, Perera M, McGrath S, Lawrentschuk N (December 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153437">"Prostate cancer screening with prostate-specific antigen: A guide to the guidelines"</a>. <i>Prostate International</i>. <b>4</b> (4): 125–129. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.prnil.2016.09.002">10.1016/j.prnil.2016.09.002</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153437">5153437</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27995110">27995110</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostate+International&amp;rft.atitle=Prostate+cancer+screening+with+prostate-specific+antigen%3A+A+guide+to+the+guidelines&amp;rft.volume=4&amp;rft.issue=4&amp;rft.pages=125-129&amp;rft.date=2016-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5153437%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27995110&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prnil.2016.09.002&amp;rft.aulast=Cabarkapa&amp;rft.aufirst=S&amp;rft.au=Perera%2C+M&amp;rft.au=McGrath%2C+S&amp;rft.au=Lawrentschuk%2C+N&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5153437&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Strat2011-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-Strat2011_17-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFStrattonGodwin2011" class="citation journal cs1">Stratton J, Godwin M (June 2011). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Ffampra%2Fcmq115">"The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis"</a>. <i>Family Practice</i>. <b>28</b> (3): 243–252. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Ffampra%2Fcmq115">10.1093/fampra/cmq115</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21273283">21273283</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Family+Practice&amp;rft.atitle=The+effect+of+supplemental+vitamins+and+minerals+on+the+development+of+prostate+cancer%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=28&amp;rft.issue=3&amp;rft.pages=243-252&amp;rft.date=2011-06&amp;rft_id=info%3Adoi%2F10.1093%2Ffampra%2Fcmq115&amp;rft_id=info%3Apmid%2F21273283&amp;rft.aulast=Stratton&amp;rft.aufirst=J&amp;rft.au=Godwin%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Ffampra%252Fcmq115&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Luszczak_2020_7-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Luszczak_2020_7_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Luszczak_2020_7_18-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLuszczakKumarSathyadevanSimpson2020" class="citation journal cs1">Luszczak S, Kumar C, Sathyadevan VK, Simpson BS, Gately KA, Whitaker HC, Heavey S (January 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992635">"PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer"</a>. <i>Signal Transduction and Targeted Therapy</i>. <b>5</b> (1): 7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41392-020-0109-y">10.1038/s41392-020-0109-y</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992635">6992635</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32296034">32296034</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Signal+Transduction+and+Targeted+Therapy&amp;rft.atitle=PIM+kinase+inhibition%3A+co-targeted+therapeutic+approaches+in+prostate+cancer&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=7&amp;rft.date=2020-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6992635%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32296034&amp;rft_id=info%3Adoi%2F10.1038%2Fs41392-020-0109-y&amp;rft.aulast=Luszczak&amp;rft.aufirst=S&amp;rft.au=Kumar%2C+C&amp;rft.au=Sathyadevan%2C+VK&amp;rft.au=Simpson%2C+BS&amp;rft.au=Gately%2C+KA&amp;rft.au=Whitaker%2C+HC&amp;rft.au=Heavey%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6992635&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-WCR2014Epi-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-WCR2014Epi_19-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation book cs1">"Chapter 1.1". <i>World Cancer Report</i>. World Health Organization. 2014. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-92-832-0429-9" title="Special:BookSources/978-92-832-0429-9"><bdi>978-92-832-0429-9</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+1.1&amp;rft.btitle=World+Cancer+Report&amp;rft.pub=World+Health+Organization&amp;rft.date=2014&amp;rft.isbn=978-92-832-0429-9&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Baade2009-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-Baade2009_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Baade2009_20-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBaadeYouldenKrnjacki2009" class="citation journal cs1">Baade PD, Youlden DR, Krnjacki LJ (February 2009). "International epidemiology of prostate cancer: geographical distribution and secular trends". <i>Molecular Nutrition &amp; Food Research</i>. <b>53</b> (2): 171–184. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmnfr.200700511">10.1002/mnfr.200700511</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19101947">19101947</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Nutrition+%26+Food+Research&amp;rft.atitle=International+epidemiology+of+prostate+cancer%3A+geographical+distribution+and+secular+trends&amp;rft.volume=53&amp;rft.issue=2&amp;rft.pages=171-184&amp;rft.date=2009-02&amp;rft_id=info%3Adoi%2F10.1002%2Fmnfr.200700511&amp;rft_id=info%3Apmid%2F19101947&amp;rft.aulast=Baade&amp;rft.aufirst=PD&amp;rft.au=Youlden%2C+DR&amp;rft.au=Krnjacki%2C+LJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/signs-symptoms.html">"Prostate Cancer Signs and Symptoms"</a>. American Cancer Society. 1 August 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">2023-05-21</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Prostate+Cancer+Signs+and+Symptoms&amp;rft.pub=American+Cancer+Society&amp;rft.date=2019-08-01&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Fprostate-cancer%2Fdetection-diagnosis-staging%2Fsigns-symptoms.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;_22-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTEMerrielFunstonHamilton2018&quot;Symptoms_and_Signs&quot;_22-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFMerrielFunstonHamilton2018">Merriel, Funston &amp; Hamilton 2018</a>, "Symptoms and Signs".</span>
</li>
<li id="cite_note-FOOTNOTEClinical_Overview2022&quot;Clinical_Presentation&quot;-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEClinical_Overview2022&quot;Clinical_Presentation&quot;_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEClinical_Overview2022&quot;Clinical_Presentation&quot;_23-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFClinical_Overview2022">Clinical Overview 2022</a>, "Clinical Presentation".</span>
</li>
<li id="cite_note-FOOTNOTELoebEastham2021&quot;Introduction&quot;-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTELoebEastham2021&quot;Introduction&quot;_24-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFLoebEastham2021">Loeb &amp; Eastham 2021</a>, "Introduction".</span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancerresearchuk.org/about-cancer/prostate-cancer/symptoms">"Symptoms of Prostate Cancer"</a>. Cancer Research UK. 15 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">21 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Symptoms+of+Prostate+Cancer&amp;rft.pub=Cancer+Research+UK&amp;rft.date=2022-03-15&amp;rft_id=https%3A%2F%2Fwww.cancerresearchuk.org%2Fabout-cancer%2Fprostate-cancer%2Fsymptoms&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prostate_cancer&quot;-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prostate_cancer&quot;_26-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFColemanCroucherPadhaniClézardin2020">Coleman et al. 2020</a>, "Prostate cancer".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:_Noncastrate&quot;-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:_Noncastrate&quot;_27-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Metastatic Disease: Noncastrate".</span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/types/prostate-cancer/causes-risks-prevention/what-causes.html">"What Causes Prostate Cancer?"</a>. American Cancer Society. 1 August 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">17 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=What+Causes+Prostate+Cancer%3F&amp;rft.pub=American+Cancer+Society&amp;rft.date=2019-08-01&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Ftypes%2Fprostate-cancer%2Fcauses-risks-prevention%2Fwhat-causes.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancerresearchuk.org/about-cancer/prostate-cancer/stages/locally-advanced-prostate-cancer">"Locally advanced prostate cancer"</a>. Cancer Research UK. 31 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">21 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Locally+advanced+prostate+cancer&amp;rft.pub=Cancer+Research+UK&amp;rft.date=2022-05-31&amp;rft_id=https%3A%2F%2Fwww.cancerresearchuk.org%2Fabout-cancer%2Fprostate-cancer%2Fstages%2Flocally-advanced-prostate-cancer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Disease_progression&quot;-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Disease_progression&quot;_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Disease_progression&quot;_30-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Disease progression".</span>
</li>
<li id="cite_note-FOOTNOTEStephensonAbouassalyKlein2021&quot;Risk_Factors&quot;-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEStephensonAbouassalyKlein2021&quot;Risk_Factors&quot;_31-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFStephensonAbouassalyKlein2021">Stephenson, Abouassaly &amp; Klein 2021</a>, "Risk Factors".</span>
</li>
<li id="cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Risk_Factors_for_Total_Prostate_Cancer&quot;-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Risk_Factors_for_Total_Prostate_Cancer&quot;_32-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFPernarEbotWilsonMucci2018">Pernar et al. 2018</a>, "Risk Factors for Total Prostate Cancer".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;_33-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;_33-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Epidemiology&quot;_33-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Epidemiology".</span>
</li>
<li id="cite_note-FOOTNOTEStephensonAbouassalyKlein2021&quot;Age_at_Diagnosis&quot;-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEStephensonAbouassalyKlein2021&quot;Age_at_Diagnosis&quot;_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEStephensonAbouassalyKlein2021&quot;Age_at_Diagnosis&quot;_34-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFStephensonAbouassalyKlein2021">Stephenson, Abouassaly &amp; Klein 2021</a>, "Age at Diagnosis".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Epidemiology&quot;_35-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Epidemiology".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;_36-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;_36-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetic_Predisposition&quot;_36-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Genetic Predisposition".</span>
</li>
<li id="cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Risk_Factors_for_Advanced_and_Fatal_Prostate_Cancer&quot;-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Risk_Factors_for_Advanced_and_Fatal_Prostate_Cancer&quot;_37-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFPernarEbotWilsonMucci2018">Pernar et al. 2018</a>, "Risk Factors for Advanced and Fatal Prostate Cancer".</span>
</li>
<li id="cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Statins&quot;-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Statins&quot;_38-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFPernarEbotWilsonMucci2018">Pernar et al. 2018</a>, "Statins".</span>
</li>
<li id="cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Exercise&quot;-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Exercise&quot;_39-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFPernarEbotWilsonMucci2018">Pernar et al. 2018</a>, "Exercise".</span>
</li>
<li id="cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Fish&quot;-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Fish&quot;_40-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFPernarEbotWilsonMucci2018">Pernar et al. 2018</a>, "Fish".</span>
</li>
<li id="cite_note-FOOTNOTEPernarEbotWilsonMucci2018&quot;Calcium,_Dairy_Products,_and_Vitamin_D&quot;-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Calcium,_Dairy_Products,_and_Vitamin_D&quot;_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEPernarEbotWilsonMucci2018&quot;Calcium,_Dairy_Products,_and_Vitamin_D&quot;_41-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFPernarEbotWilsonMucci2018">Pernar et al. 2018</a>, "Calcium, Dairy Products, and Vitamin D".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;No_Cancer_Diagnosis&quot;-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;No_Cancer_Diagnosis&quot;_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;No_Cancer_Diagnosis&quot;_42-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "No Cancer Diagnosis".</span>
</li>
<li id="cite_note-FOOTNOTEStephensonAbouassalyKlein2021&quot;Inflammation_and_Infection&quot;-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEStephensonAbouassalyKlein2021&quot;Inflammation_and_Infection&quot;_43-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFStephensonAbouassalyKlein2021">Stephenson, Abouassaly &amp; Klein 2021</a>, "Inflammation and Infection".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetics&quot;-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Genetics&quot;_44-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Genetics".</span>
</li>
<li id="cite_note-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;_45-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;_45-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTESandhuMooreChiongBeltran2021&quot;The_biology_of_prostate_cancer&quot;_45-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFSandhuMooreChiongBeltran2021">Sandhu et al. 2021</a>, "The biology of prostate cancer".</span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/diagnosis-staging/tests/understanding-your-pathology-report/prostate-pathology/high-grade-prostatic-intraepithelial-neoplasia.html">"Understanding Your Pathology Report: Prostatic Intraepithelial Neoplasia (PIN) and Intraductal Carcinoma"</a>. American Cancer Society<span class="reference-accessdate">. Retrieved <span class="nowrap">25 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Understanding+Your+Pathology+Report%3A+Prostatic+Intraepithelial+Neoplasia+%28PIN%29+and+Intraductal+Carcinoma&amp;rft.pub=American+Cancer+Society&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Fdiagnosis-staging%2Ftests%2Funderstanding-your-pathology-report%2Fprostate-pathology%2Fhigh-grade-prostatic-intraepithelial-neoplasia.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_disease&quot;_47-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Metastatic disease".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;-48"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;_48-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;_48-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Screening_and_early_detection&quot;_48-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Screening and early detection".</span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cdc.gov/cancer/prostate/basic_info/screening.htm">"What Is Screening for Prostate Cancer"</a>. U.S. Centers for Disease Control and Prevention. 25 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">17 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=What+Is+Screening+for+Prostate+Cancer&amp;rft.pub=U.S.+Centers+for+Disease+Control+and+Prevention&amp;rft.date=2022-08-25&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fprostate%2Fbasic_info%2Fscreening.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Box_1:_Screening_for_prostate_cancer_in_different_regions&quot;_50-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Box 1: Screening for prostate cancer in different regions".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Table_2&quot;-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Table_2&quot;_51-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Table 2".</span>
</li>
<li id="cite_note-FOOTNOTECarlssonVickers2020&quot;3._Tailor_screening_frequency_based_on_PSA-level&quot;-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTECarlssonVickers2020&quot;3._Tailor_screening_frequency_based_on_PSA-level&quot;_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTECarlssonVickers2020&quot;3._Tailor_screening_frequency_based_on_PSA-level&quot;_52-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFCarlssonVickers2020">Carlsson &amp; Vickers 2020</a>, "3. Tailor screening frequency based on PSA-level".</span>
</li>
<li id="cite_note-FOOTNOTECarlssonVickers2020&quot;4._For_men_with_elevated_PSA_(≥3_ng/mL),_repeat_PSA.&quot;-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTECarlssonVickers2020&quot;4._For_men_with_elevated_PSA_(≥3_ng/mL),_repeat_PSA.&quot;_53-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFCarlssonVickers2020">Carlsson &amp; Vickers 2020</a>, "4. For men with elevated PSA (≥3 ng/mL), repeat PSA.".</span>
</li>
<li id="cite_note-FOOTNOTECarlssonVickers2020&quot;5._Use_secondary_tests_such_as_marker_or_imaging_before_biopsy.&quot;-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTECarlssonVickers2020&quot;5._Use_secondary_tests_such_as_marker_or_imaging_before_biopsy.&quot;_54-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFCarlssonVickers2020">Carlsson &amp; Vickers 2020</a>, "5. Use secondary tests such as marker or imaging before biopsy.".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Second-Line_Screening_Tests&quot;-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Second-Line_Screening_Tests&quot;_55-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Second-Line Screening Tests".</span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/how-diagnosed.html">"Tests to Diagnose and Stage Prostate Cancer"</a>. American Cancer Society. 21 February 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">18 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Tests+to+Diagnose+and+Stage+Prostate+Cancer&amp;rft.pub=American+Cancer+Society&amp;rft.date=2023-02-21&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Ftypes%2Fprostate-cancer%2Fdetection-diagnosis-staging%2Fhow-diagnosed.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;-57"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;_57-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;_57-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;_57-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Diagnosis&quot;_57-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Diagnosis".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Physical_Examination&quot;-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Physical_Examination&quot;_58-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Physical Examination".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Prostate_Biopsy&quot;-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Prostate_Biopsy&quot;_59-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Prostate Biopsy".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Pathology&quot;-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Pathology&quot;_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Pathology&quot;_60-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Pathology&quot;_60-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Pathology&quot;_60-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Pathology".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Prostate_Cancer_Staging&quot;-61"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Prostate_Cancer_Staging&quot;_61-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Prostate_Cancer_Staging&quot;_61-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Prostate Cancer Staging".</span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text">References for pie chart are located in table in the article <a href="/wiki/Histopathologic_diagnosis_of_prostate_cancer" title="Histopathologic diagnosis of prostate cancer">Histopathologic diagnosis of prostate cancer</a>: Incidences<sup class="noprint Inline-Template" style="margin-left:0.1em; white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Manual_of_Style" title="Wikipedia:Manual of Style"><span title="&#39;&#39;incidence&#39;&#39; is normally used only in the singular form, perhaps &#39;&#39;incidence&#39;&#39;, &#39;&#39;incidents&#39;&#39;, or &#39;&#39;instances&#39;&#39; was intended (September 2022)">spelling?</span></a></i>&#93;</sup> generally include cases where the pattern is found admixed with usual <a href="/wiki/Acinar_adenocarcinoma" title="Acinar adenocarcinoma">acinar adenocarcinoma</a>.</span>
</li>
<li id="cite_note-ACSStage-63"><span class="mw-cite-backlink">^ <a href="#cite_ref-ACSStage_63-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ACSStage_63-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/staging.html">"Prostate Cancer Staging"</a>. American Cancer Society. 8 October 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">14 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Prostate+Cancer+Staging&amp;rft.pub=American+Cancer+Society&amp;rft.date=2021-10-08&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Ftypes%2Fprostate-cancer%2Fdetection-diagnosis-staging%2Fstaging.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;-64"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;_64-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;_64-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Table_87-1_TNM_Classification&quot;_64-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Table 87-1 TNM Classification".</span>
</li>
<li id="cite_note-:2-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-:2_65-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nice.org.uk/guidance/ng131/chapter/Recommendations#assessment-and-diagnosis">"Prostate cancer: diagnosis and management. NICE guideline &#91;NG131&#93;"</a>. <i>National Institute for Health and Care Excellence (NICE)</i>. 9 May 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">2022-10-03</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Institute+for+Health+and+Care+Excellence+%28NICE%29&amp;rft.atitle=Prostate+cancer%3A+diagnosis+and+management.+NICE+guideline+%5BNG131%5D&amp;rft.date=2019-05-09&amp;rft_id=https%3A%2F%2Fwww.nice.org.uk%2Fguidance%2Fng131%2Fchapter%2FRecommendations%23assessment-and-diagnosis&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancerresearchuk.org/about-cancer/prostate-cancer/stages/cambridge-prognostic-group-cpg">"Prostate cancer risk groups and the Cambridge Prognostic Group (CPG)"</a>. Cancer Research UK. 24 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">25 June</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Prostate+cancer+risk+groups+and+the+Cambridge+Prognostic+Group+%28CPG%29&amp;rft.pub=Cancer+Research+UK&amp;rft.date=2022-05-24&amp;rft_id=https%3A%2F%2Fwww.cancerresearchuk.org%2Fabout-cancer%2Fprostate-cancer%2Fstages%2Fcambridge-prognostic-group-cpg&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Management&quot;-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Management&quot;_67-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Management".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;-68"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;_68-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;_68-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Active_surveillance&quot;_68-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Active surveillance".</span>
</li>
<li id="cite_note-ACSTreat-69"><span class="mw-cite-backlink">^ <a href="#cite_ref-ACSTreat_69-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ACSTreat_69-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/types/prostate-cancer/treating/by-stage.html">"Initial Treatment of Prostate Cancer, by Stage and Risk Group"</a>. American Cancer Society. 9 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">28 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Initial+Treatment+of+Prostate+Cancer%2C+by+Stage+and+Risk+Group&amp;rft.pub=American+Cancer+Society&amp;rft.date=2022-08-09&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Ftypes%2Fprostate-cancer%2Ftreating%2Fby-stage.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/types/prostate-cancer/treating/psa-levels-after-treatment.html">"Following PSA Levels During and After Prostate Cancer Treatment"</a>. American Cancer Society. 1 August 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">28 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Following+PSA+Levels+During+and+After+Prostate+Cancer+Treatment&amp;rft.pub=American+Cancer+Society&amp;rft.date=2019-08-01&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Ftypes%2Fprostate-cancer%2Ftreating%2Fpsa-levels-after-treatment.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFEllisHwangMorrowKimminau2021" class="citation journal cs1">Ellis SD, Hwang S, Morrow E, Kimminau KS, Goonan K, Petty L,  et&#160;al. (May 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165996">"Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists"</a>. <i>BMC Cancer</i>. <b>21</b> (1): 649. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs12885-021-08386-3">10.1186/s12885-021-08386-3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165996">8165996</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34058998">34058998</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Cancer&amp;rft.atitle=Perceived+barriers+to+the+adoption+of+active+surveillance+in+low-risk+prostate+cancer%3A+a+qualitative+analysis+of+community+and+academic+urologists&amp;rft.volume=21&amp;rft.issue=1&amp;rft.pages=649&amp;rft.date=2021-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8165996%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34058998&amp;rft_id=info%3Adoi%2F10.1186%2Fs12885-021-08386-3&amp;rft.aulast=Ellis&amp;rft.aufirst=SD&amp;rft.au=Hwang%2C+S&amp;rft.au=Morrow%2C+E&amp;rft.au=Kimminau%2C+KS&amp;rft.au=Goonan%2C+K&amp;rft.au=Petty%2C+L&amp;rft.au=Ellerbeck%2C+E&amp;rft.au=Thrasher%2C+JB&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8165996&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Table_1:_Prostate_cancer_risk_classification_at_diagnosis_and_after_treatment&quot;-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Table_1:_Prostate_cancer_risk_classification_at_diagnosis_and_after_treatment&quot;_72-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Table 1: Prostate cancer risk classification at diagnosis and after treatment".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Clinically_Localized_Prostate_Cancer&quot;-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Clinically_Localized_Prostate_Cancer&quot;_73-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Clinically Localized Prostate Cancer".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;External_Beam_Radiation_Therapy&quot;-74"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;External_Beam_Radiation_Therapy&quot;_74-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;External_Beam_Radiation_Therapy&quot;_74-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "External Beam Radiation Therapy".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Brachytherapy&quot;-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Brachytherapy&quot;_75-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Brachytherapy".</span>
</li>
<li id="cite_note-FOOTNOTEBrawleyMohanNein2018&quot;Radiation_Therapy&quot;-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEBrawleyMohanNein2018&quot;Radiation_Therapy&quot;_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEBrawleyMohanNein2018&quot;Radiation_Therapy&quot;_76-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFBrawleyMohanNein2018">Brawley, Mohan &amp; Nein 2018</a>, "Radiation Therapy".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;-77"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Radical_prostatectomy&quot;_77-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Radical prostatectomy".</span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWallisGlaserHuHuland2018" class="citation journal cs1">Wallis CJ, Glaser A, Hu JC, Huland H, Lawrentschuk N, Moon D,  et&#160;al. (January 2018). <a rel="nofollow" class="external text" href="http://eprints.whiterose.ac.uk/118323/1/EU%20Collab%20Review%20v9%20clean.pdf">"Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review"</a> <span class="cs1-format">(PDF)</span>. <i>European Urology</i>. <b>73</b> (1): 11–20. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.eururo.2017.05.055">10.1016/j.eururo.2017.05.055</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28610779">28610779</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Urology&amp;rft.atitle=Survival+and+Complications+Following+Surgery+and+Radiation+for+Localized+Prostate+Cancer%3A+An+International+Collaborative+Review&amp;rft.volume=73&amp;rft.issue=1&amp;rft.pages=11-20&amp;rft.date=2018-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2017.05.055&amp;rft_id=info%3Apmid%2F28610779&amp;rft.aulast=Wallis&amp;rft.aufirst=CJ&amp;rft.au=Glaser%2C+A&amp;rft.au=Hu%2C+JC&amp;rft.au=Huland%2C+H&amp;rft.au=Lawrentschuk%2C+N&amp;rft.au=Moon%2C+D&amp;rft.au=Murphy%2C+DG&amp;rft.au=Nguyen%2C+PL&amp;rft.au=Resnick%2C+MJ&amp;rft.au=Nam%2C+RK&amp;rft_id=http%3A%2F%2Feprints.whiterose.ac.uk%2F118323%2F1%2FEU%2520Collab%2520Review%2520v9%2520clean.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;-79"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;_79-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;_79-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biocehmical_recurrence_and_residual_disease&quot;_79-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Biocehmical recurrence and residual disease".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biochemical_recurrence_and_residual_disease&quot;-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Biochemical_recurrence_and_residual_disease&quot;_80-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Biochemical recurrence and residual disease".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Rising_PSA_After_Definitive_Local_Therapy&quot;-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Rising_PSA_After_Definitive_Local_Therapy&quot;_81-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Rising PSA After Definitive Local Therapy".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_hormone-sensitive_prostate_cancer&quot;-82"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_hormone-sensitive_prostate_cancer&quot;_82-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_hormone-sensitive_prostate_cancer&quot;_82-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Metastatic hormone-sensitive prostate cancer".</span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/cancer/types/prostate-cancer/treating/hormone-therapy.html">"Hormone Therapy for Prostate Cancer"</a>. American Cancer Society. 9 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">15 May</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Hormone+Therapy+for+Prostate+Cancer&amp;rft.pub=American+Cancer+Society&amp;rft.date=2022-08-09&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fcancer%2Ftypes%2Fprostate-cancer%2Ftreating%2Fhormone-therapy.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Testosterone-Lowering_Agents&quot;-84"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Testosterone-Lowering_Agents&quot;_84-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Testosterone-Lowering_Agents&quot;_84-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Testosterone-Lowering Agents".</span>
</li>
<li id="cite_note-FOOTNOTEAchardPutoraOmlinZilli2022&quot;Introduction&quot;-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEAchardPutoraOmlinZilli2022&quot;Introduction&quot;_85-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFAchardPutoraOmlinZilli2022">Achard et al. 2022</a>, "Introduction".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Outcomes_of_Androgen_Deprivation&quot;-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Outcomes_of_Androgen_Deprivation&quot;_86-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Outcomes of Androgen Deprivation".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;-87"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Metastatic_Disease:Castrate&quot;_87-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Metastatic Disease:Castrate".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_castration-resistant_prostate_cancer&quot;-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Metastatic_castration-resistant_prostate_cancer&quot;_88-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Metastatic castration-resistant prostate cancer".</span>
</li>
<li id="cite_note-FOOTNOTETeoRathkopfKantoff2019&quot;Management_of_Metastatic_Castration-Resistant_Prostate_Cancer&quot;-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTETeoRathkopfKantoff2019&quot;Management_of_Metastatic_Castration-Resistant_Prostate_Cancer&quot;_89-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFTeoRathkopfKantoff2019">Teo, Rathkopf &amp; Kantoff 2019</a>, "Management of Metastatic Castration-Resistant Prostate Cancer".</span>
</li>
<li id="cite_note-FOOTNOTETeoRathkopfKantoff2019&quot;Abiraterone_Acetate&quot;-90"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTETeoRathkopfKantoff2019&quot;Abiraterone_Acetate&quot;_90-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTETeoRathkopfKantoff2019&quot;Abiraterone_Acetate&quot;_90-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFTeoRathkopfKantoff2019">Teo, Rathkopf &amp; Kantoff 2019</a>, "Abiraterone Acetate".</span>
</li>
<li id="cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_bone_metastases&quot;-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_bone_metastases&quot;_91-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFColemanCroucherPadhaniClézardin2020">Coleman et al. 2020</a>, "Prevalence of bone metastases".</span>
</li>
<li id="cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_SREs&quot;-92"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_SREs&quot;_92-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Prevalence_of_SREs&quot;_92-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFColemanCroucherPadhaniClézardin2020">Coleman et al. 2020</a>, "Prevalence of SREs".</span>
</li>
<li id="cite_note-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Analgesics_used_in_CIBP&quot;-93"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Analgesics_used_in_CIBP&quot;_93-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEColemanCroucherPadhaniClézardin2020&quot;Analgesics_used_in_CIBP&quot;_93-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFColemanCroucherPadhaniClézardin2020">Coleman et al. 2020</a>, "Analgesics used in CIBP".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;-94"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;_94-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;_94-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Pain_Management&quot;_94-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Pain Management".</span>
</li>
<li id="cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Cord_compression&quot;-95"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Cord_compression&quot;_95-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Cord_compression&quot;_95-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFThompsonWoodFeuer2007">Thompson, Wood &amp; Feuer 2007</a>, "Cord compression".</span>
</li>
<li id="cite_note-MSCC-96"><span class="mw-cite-backlink">^ <a href="#cite_ref-MSCC_96-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MSCC_96-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://prostatecanceruk.org/prostate-information-and-support/advanced-prostate-cancer/metastatic-spinal-cord-compression-mscc?scrollTo=symptoms-of-MSCC">"What is metastatic spinal cord compression (MSCC)"</a>. Prostate Cancer UK. June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">25 June</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=What+is+metastatic+spinal+cord+compression+%28MSCC%29&amp;rft.pub=Prostate+Cancer+UK&amp;rft.date=2022-06&amp;rft_id=https%3A%2F%2Fprostatecanceruk.org%2Fprostate-information-and-support%2Fadvanced-prostate-cancer%2Fmetastatic-spinal-cord-compression-mscc%3FscrollTo%3Dsymptoms-of-MSCC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Gastrointestinal_symptoms&quot;-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Gastrointestinal_symptoms&quot;_97-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFThompsonWoodFeuer2007">Thompson, Wood &amp; Feuer 2007</a>, "Gastrointestinal symptoms".</span>
</li>
<li id="cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;General_debility&quot;-98"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;General_debility&quot;_98-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;General_debility&quot;_98-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFThompsonWoodFeuer2007">Thompson, Wood &amp; Feuer 2007</a>, "General debility".</span>
</li>
<li id="cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Lymphoedema&quot;-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Lymphoedema&quot;_99-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFThompsonWoodFeuer2007">Thompson, Wood &amp; Feuer 2007</a>, "Lymphoedema".</span>
</li>
<li id="cite_note-FOOTNOTEMundleAfenyaAgarwal2021&quot;Estimates_of_anxiety,_depression,_and_distress&quot;-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEMundleAfenyaAgarwal2021&quot;Estimates_of_anxiety,_depression,_and_distress&quot;_100-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFMundleAfenyaAgarwal2021">Mundle, Afenya &amp; Agarwal 2021</a>, "Estimates of anxiety, depression, and distress".</span>
</li>
<li id="cite_note-FOOTNOTEMundleAfenyaAgarwal2021&quot;Abstract&quot;-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEMundleAfenyaAgarwal2021&quot;Abstract&quot;_101-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFMundleAfenyaAgarwal2021">Mundle, Afenya &amp; Agarwal 2021</a>, "Abstract".</span>
</li>
<li id="cite_note-FOOTNOTEThompsonWoodFeuer2007&quot;Delirium&quot;-102"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Delirium&quot;_102-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTEThompsonWoodFeuer2007&quot;Delirium&quot;_102-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFThompsonWoodFeuer2007">Thompson, Wood &amp; Feuer 2007</a>, "Delirium".</span>
</li>
<li id="cite_note-PCUK-103"><span class="mw-cite-backlink">^ <a href="#cite_ref-PCUK_103-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PCUK_103-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-PCUK_103-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-PCUK_103-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-PCUK_103-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://prostatecanceruk.org/prostate-information-and-support/advanced-prostate-cancer/dying-from-prostate-cancer/what-to-expect">"Dying from prostate cancer – What to expect"</a>. Prostate Cancer UK. July 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">25 June</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Dying+from+prostate+cancer+%E2%80%93+What+to+expect&amp;rft.pub=Prostate+Cancer+UK&amp;rft.date=2018-07&amp;rft_id=https%3A%2F%2Fprostatecanceruk.org%2Fprostate-information-and-support%2Fadvanced-prostate-cancer%2Fdying-from-prostate-cancer%2Fwhat-to-expect&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-ASCO-104"><span class="mw-cite-backlink">^ <a href="#cite_ref-ASCO_104-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ASCO_104-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.net/navigating-cancer-care/advanced-cancer/care-through-final-days">"Care Through the Final Days"</a>. American Society of Clinical Oncology. November 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">25 June</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Care+Through+the+Final+Days&amp;rft.pub=American+Society+of+Clinical+Oncology&amp;rft.date=2022-11&amp;rft_id=https%3A%2F%2Fwww.cancer.net%2Fnavigating-cancer-care%2Fadvanced-cancer%2Fcare-through-final-days&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Prognosis_and_survival&quot;-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Prognosis_and_survival&quot;_105-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Prognosis and survival".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Figure_3:_Prostate_cancer_stages_and_progression.&quot;-106"><span class="mw-cite-backlink">^ <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Figure_3:_Prostate_cancer_stages_and_progression.&quot;_106-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Figure_3:_Prostate_cancer_stages_and_progression.&quot;_106-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Figure 3: Prostate cancer stages and progression.".</span>
</li>
<li id="cite_note-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Abstract&quot;-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTERebelloOingKnudsenLoeb2021&quot;Abstract&quot;_107-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFRebelloOingKnudsenLoeb2021">Rebello et al. 2021</a>, "Abstract".</span>
</li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html">"WHO Disease and injury country estimates"</a>. <i>World Health Organization</i>. 2009. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20091111101009/http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html">Archived</a> from the original on 2009-11-11<span class="reference-accessdate">. Retrieved <span class="nowrap">Nov 11,</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Health+Organization&amp;rft.atitle=WHO+Disease+and+injury+country+estimates&amp;rft.date=2009&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fhealthinfo%2Fglobal_burden_disease%2Festimates_country%2Fen%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-FOOTNOTEBergengrenPekalaMatsoukasFainberg2023&quot;3.1_Epidemiology&quot;-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEBergengrenPekalaMatsoukasFainberg2023&quot;3.1_Epidemiology&quot;_109-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFBergengrenPekalaMatsoukasFainberg2023">Bergengren et al. 2023</a>, "3.1 Epidemiology".</span>
</li>
<li id="cite_note-FOOTNOTEScherEastham2022&quot;Prostate_Cancer&quot;-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-FOOTNOTEScherEastham2022&quot;Prostate_Cancer&quot;_110-0">^</a></b></span> <span class="reference-text"><a href="#CITEREFScherEastham2022">Scher &amp; Eastham 2022</a>, "Prostate Cancer".</span>
</li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTaitt2018" class="citation journal cs1">Taitt HE (November 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199451">"Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location"</a>. <i>American Journal of Men's Health</i>. <b>12</b> (6): 1807–1823. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1557988318798279">10.1177/1557988318798279</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199451">6199451</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30203706">30203706</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Men%27s+Health&amp;rft.atitle=Global+Trends+and+Prostate+Cancer%3A+A+Review+of+Incidence%2C+Detection%2C+and+Mortality+as+Influenced+by+Race%2C+Ethnicity%2C+and+Geographic+Location&amp;rft.volume=12&amp;rft.issue=6&amp;rft.pages=1807-1823&amp;rft.date=2018-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6199451%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30203706&amp;rft_id=info%3Adoi%2F10.1177%2F1557988318798279&amp;rft.aulast=Taitt&amp;rft.aufirst=HE&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6199451&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPDQ_Screening_and_Prevention_Editorial_Board2002" class="citation cs2">PDQ Screening and Prevention Editorial Board (2002), <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK65945/">"Prostate Cancer Screening (PDQ®): Health Professional Version"</a>, <i>PDQ Cancer Information Summaries</i>, Bethesda (MD): National Cancer Institute (US), <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26389383">26389383</a><span class="reference-accessdate">, retrieved <span class="nowrap">2022-05-25</span></span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PDQ+Cancer+Information+Summaries&amp;rft.atitle=Prostate+Cancer+Screening+%28PDQ%C2%AE%29%3A+Health+Professional+Version&amp;rft.date=2002&amp;rft_id=info%3Apmid%2F26389383&amp;rft.au=PDQ+Screening+and+Prevention+Editorial+Board&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK65945%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cancer.org/healthy/cancer-causes/general-info/lifetime-probability-of-developing-or-dying-from-cancer.html">"Lifetime Risk of Developing or Dying From Cancer"</a>. <i>www.cancer.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2022-05-25</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cancer.org&amp;rft.atitle=Lifetime+Risk+of+Developing+or+Dying+From+Cancer&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Fhealthy%2Fcancer-causes%2Fgeneral-info%2Flifetime-probability-of-developing-or-dying-from-cancer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Rendon2017-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rendon2017_114-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRendonMasonMarzoukFinelli2017" class="citation journal cs1">Rendon RA, Mason RJ, Marzouk K, Finelli A, Saad F, So A,  et&#160;al. (October 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659858">"Canadian Urological Association recommendations on prostate cancer screening and early diagnosis"</a>. <i>Canadian Urological Association Journal</i>. <b>11</b> (10): 298–309. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.5489%2Fcuaj.4888">10.5489/cuaj.4888</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659858">5659858</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29381452">29381452</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Canadian+Urological+Association+Journal&amp;rft.atitle=Canadian+Urological+Association+recommendations+on+prostate+cancer+screening+and+early+diagnosis&amp;rft.volume=11&amp;rft.issue=10&amp;rft.pages=298-309&amp;rft.date=2017-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5659858%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29381452&amp;rft_id=info%3Adoi%2F10.5489%2Fcuaj.4888&amp;rft.aulast=Rendon&amp;rft.aufirst=RA&amp;rft.au=Mason%2C+RJ&amp;rft.au=Marzouk%2C+K&amp;rft.au=Finelli%2C+A&amp;rft.au=Saad%2C+F&amp;rft.au=So%2C+A&amp;rft.au=Violette%2C+P&amp;rft.au=Breau%2C+RH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5659858&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFerlaySteliarova-FoucherLortet-TieulentRosso2013" class="citation journal cs1">Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H,  et&#160;al. (April 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejca.2012.12.027">"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012"</a>. <i>European Journal of Cancer</i>. <b>49</b> (6): 1374–1403. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejca.2012.12.027">10.1016/j.ejca.2012.12.027</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23485231">23485231</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Cancer&amp;rft.atitle=Cancer+incidence+and+mortality+patterns+in+Europe%3A+estimates+for+40+countries+in+2012&amp;rft.volume=49&amp;rft.issue=6&amp;rft.pages=1374-1403&amp;rft.date=2013-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejca.2012.12.027&amp;rft_id=info%3Apmid%2F23485231&amp;rft.aulast=Ferlay&amp;rft.aufirst=J&amp;rft.au=Steliarova-Foucher%2C+E&amp;rft.au=Lortet-Tieulent%2C+J&amp;rft.au=Rosso%2C+S&amp;rft.au=Coebergh%2C+JW&amp;rft.au=Comber%2C+H&amp;rft.au=Forman%2C+D&amp;rft.au=Bray%2C+F&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.ejca.2012.12.027&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/">"Prostate cancer statistics"</a>. <i>Cancer Research UK</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20141006052815/http://www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/">Archived</a> from the original on 6 October 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">3 October</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Cancer+Research+UK&amp;rft.atitle=Prostate+cancer+statistics&amp;rft_id=http%3A%2F%2Fwww.cancerresearchuk.org%2Fcancer-info%2Fcancerstats%2Ftypes%2Fprostate%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Ghabili2016-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ghabili2016_117-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGhabiliTosoianSchaefferPavlovich2016" class="citation journal cs1">Ghabili K, Tosoian JJ, Schaeffer EM, Pavlovich CP, Golzari SE, Khajir G,  et&#160;al. (November 2016). "The History of Prostate Cancer From Antiquity: Review of Paleopathological Studies". <i>Urology</i>. <b>97</b>: 8–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.urology.2016.08.032">10.1016/j.urology.2016.08.032</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27591810">27591810</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Urology&amp;rft.atitle=The+History+of+Prostate+Cancer+From+Antiquity%3A+Review+of+Paleopathological+Studies&amp;rft.volume=97&amp;rft.pages=8-12&amp;rft.date=2016-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.urology.2016.08.032&amp;rft_id=info%3Apmid%2F27591810&amp;rft.aulast=Ghabili&amp;rft.aufirst=K&amp;rft.au=Tosoian%2C+JJ&amp;rft.au=Schaeffer%2C+EM&amp;rft.au=Pavlovich%2C+CP&amp;rft.au=Golzari%2C+SE&amp;rft.au=Khajir%2C+G&amp;rft.au=Andreas%2C+D&amp;rft.au=Benzon%2C+B&amp;rft.au=Vuica-Ross%2C+M&amp;rft.au=Ross%2C+AE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Nahon2011-118"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nahon2011_118-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nahon2011_118-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFNahonWaddingtonDoreyAdams2011" class="citation journal cs1">Nahon I, Waddington G, Dorey G, Adams R (2011). "The history of urologic surgery: from reeds to robotics". <i>Urologic Nursing</i>. <b>31</b> (3): 173–180. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.7257%2F1053-816X.2011.31.3.173">10.7257/1053-816X.2011.31.3.173</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21805756">21805756</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Urologic+Nursing&amp;rft.atitle=The+history+of+urologic+surgery%3A+from+reeds+to+robotics&amp;rft.volume=31&amp;rft.issue=3&amp;rft.pages=173-180&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.7257%2F1053-816X.2011.31.3.173&amp;rft_id=info%3Apmid%2F21805756&amp;rft.aulast=Nahon&amp;rft.aufirst=I&amp;rft.au=Waddington%2C+G&amp;rft.au=Dorey%2C+G&amp;rft.au=Adams%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAdams1853" class="citation journal cs1">Adams J (1853). "The case of scirrhous of the prostate gland with corresponding affliction of the lymphatic glands in the lumbar region and in the pelvis". <i>Lancet</i>. <b>1</b> (1547): 393–94. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2802%2968759-8">10.1016/S0140-6736(02)68759-8</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=The+case+of+scirrhous+of+the+prostate+gland+with+corresponding+affliction+of+the+lymphatic+glands+in+the+lumbar+region+and+in+the+pelvis&amp;rft.volume=1&amp;rft.issue=1547&amp;rft.pages=393-94&amp;rft.date=1853&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2802%2968759-8&amp;rft.aulast=Adams&amp;rft.aufirst=J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLytton2001" class="citation journal cs1">Lytton B (June 2001). "Prostate cancer: a brief history and the discovery of hormonal ablation treatment". <i>The Journal of Urology</i>. <b>165</b> (6 Pt 1): 1859–1862. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0022-5347%2805%2966228-3">10.1016/S0022-5347(05)66228-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11371867">11371867</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=Prostate+cancer%3A+a+brief+history+and+the+discovery+of+hormonal+ablation+treatment&amp;rft.volume=165&amp;rft.issue=6+Pt+1&amp;rft.pages=1859-1862&amp;rft.date=2001-06&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-5347%2805%2966228-3&amp;rft_id=info%3Apmid%2F11371867&amp;rft.aulast=Lytton&amp;rft.aufirst=B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSamuel_David_Gross1851" class="citation book cs1"><a href="/wiki/Samuel_David_Gross" class="mw-redirect" title="Samuel David Gross">Samuel David Gross</a> (1851). <a rel="nofollow" class="external text" href="https://archive.org/details/apracticaltreat06grosgoog"><i>A Practical Treatise On the Diseases and Injuries of the Urinary Bladder, the Prostate Gland, and the Urethra</i></a>. Philadelphia: Blanchard and Lea.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=A+Practical+Treatise+On+the+Diseases+and+Injuries+of+the+Urinary+Bladder%2C+the+Prostate+Gland%2C+and+the+Urethra&amp;rft.place=Philadelphia&amp;rft.pub=Blanchard+and+Lea&amp;rft.date=1851&amp;rft.au=Samuel+David+Gross&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fapracticaltreat06grosgoog&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYoung1905" class="citation journal cs1">Young HH (1905). "Four cases of radical prostatectomy". <i>Johns Hopkins Bull</i>. <b>16</b>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Johns+Hopkins+Bull.&amp;rft.atitle=Four+cases+of+radical+prostatectomy&amp;rft.volume=16&amp;rft.date=1905&amp;rft.aulast=Young&amp;rft.aufirst=HH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFOkoyeSaikali2022" class="citation book cs1">Okoye E, Saikali SW (2022). <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK562336/">"Orchiectomy"</a>. <i>StatPearls</i>. Treasure Island (FL): StatPearls Publishing. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32966007">32966007</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2022-04-28</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Orchiectomy&amp;rft.btitle=StatPearls&amp;rft.place=Treasure+Island+%28FL%29&amp;rft.pub=StatPearls+Publishing&amp;rft.date=2022&amp;rft_id=info%3Apmid%2F32966007&amp;rft.aulast=Okoye&amp;rft.aufirst=E&amp;rft.au=Saikali%2C+SW&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK562336%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWalshLeporEggleston1983" class="citation journal cs1">Walsh PC, Lepor H, Eggleston JC (1983). "Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations". <i>The Prostate</i>. <b>4</b> (5): 473–485. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fpros.2990040506">10.1002/pros.2990040506</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6889192">6889192</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:30740301">30740301</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Prostate&amp;rft.atitle=Radical+prostatectomy+with+preservation+of+sexual+function%3A+anatomical+and+pathological+considerations&amp;rft.volume=4&amp;rft.issue=5&amp;rft.pages=473-485&amp;rft.date=1983&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A30740301%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F6889192&amp;rft_id=info%3Adoi%2F10.1002%2Fpros.2990040506&amp;rft.aulast=Walsh&amp;rft.aufirst=PC&amp;rft.au=Lepor%2C+H&amp;rft.au=Eggleston%2C+JC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHugginsHodges1941" class="citation journal cs1">Huggins CB, Hodges CV (1941). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170630121943/http://cancerres.aacrjournals.org/content/1/4/293">"Studies on prostate cancer: 1. The effects of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate"</a>. <i>Cancer Res</i>. <b>1</b> (4): 293. Archived from <a rel="nofollow" class="external text" href="http://cancerres.aacrjournals.org/content/1/4/293">the original</a> on 2017-06-30<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-09-02</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Res&amp;rft.atitle=Studies+on+prostate+cancer%3A+1.+The+effects+of+castration%2C+of+estrogen+and+androgen+injection+on+serum+phosphatases+in+metastatic+carcinoma+of+the+prostate&amp;rft.volume=1&amp;rft.issue=4&amp;rft.pages=293&amp;rft.date=1941&amp;rft.aulast=Huggins&amp;rft.aufirst=CB&amp;rft.au=Hodges%2C+CV&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcontent%2F1%2F4%2F293&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSchallyKastinArimura1971" class="citation journal cs1">Schally AV, Kastin AJ, Arimura A (November 1971). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0015-0282%2816%2938580-6">"Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies"</a>. <i>Fertility and Sterility</i>. <b>22</b> (11): 703–721. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0015-0282%2816%2938580-6">10.1016/S0015-0282(16)38580-6</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/4941683">4941683</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.atitle=Hypothalamic+follicle-stimulating+hormone+%28FSH%29+and+luteinizing+hormone+%28LH%29-regulating+hormone%3A+structure%2C+physiology%2C+and+clinical+studies&amp;rft.volume=22&amp;rft.issue=11&amp;rft.pages=703-721&amp;rft.date=1971-11&amp;rft_id=info%3Adoi%2F10.1016%2FS0015-0282%2816%2938580-6&amp;rft_id=info%3Apmid%2F4941683&amp;rft.aulast=Schally&amp;rft.aufirst=AV&amp;rft.au=Kastin%2C+AJ&amp;rft.au=Arimura%2C+A&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252FS0015-0282%252816%252938580-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTolisAckmanStellosMehta1982" class="citation journal cs1">Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT,  et&#160;al. (March 1982). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346035">"Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>79</b> (5): 1658–1662. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1982PNAS...79.1658T">1982PNAS...79.1658T</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.79.5.1658">10.1073/pnas.79.5.1658</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC346035">346035</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6461861">6461861</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Tumor+growth+inhibition+in+patients+with+prostatic+carcinoma+treated+with+luteinizing+hormone-releasing+hormone+agonists&amp;rft.volume=79&amp;rft.issue=5&amp;rft.pages=1658-1662&amp;rft.date=1982-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC346035%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F6461861&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.79.5.1658&amp;rft_id=info%3Abibcode%2F1982PNAS...79.1658T&amp;rft.aulast=Tolis&amp;rft.aufirst=G&amp;rft.au=Ackman%2C+D&amp;rft.au=Stellos%2C+A&amp;rft.au=Mehta%2C+A&amp;rft.au=Labrie%2C+F&amp;rft.au=Fazekas%2C+AT&amp;rft.au=Comaru-Schally%2C+AM&amp;rft.au=Schally%2C+AV&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC346035&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDenmeadeIsaacs2002" class="citation journal cs1">Denmeade SR, Isaacs JT (May 2002). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124639">"A history of prostate cancer treatment"</a>. <i>Nature Reviews. Cancer</i>. <b>2</b> (5): 389–396. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrc801">10.1038/nrc801</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124639">4124639</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12044015">12044015</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Cancer&amp;rft.atitle=A+history+of+prostate+cancer+treatment&amp;rft.volume=2&amp;rft.issue=5&amp;rft.pages=389-396&amp;rft.date=2002-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4124639%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12044015&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc801&amp;rft.aulast=Denmeade&amp;rft.aufirst=SR&amp;rft.au=Isaacs%2C+JT&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4124639&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-129">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFScottJohnsonSchmidtGibbons1975" class="citation journal cs1">Scott WW, Johnson DE, Schmidt JE, Gibbons RP, Prout GR, Joiner JR,  et&#160;al. (December 1975). "Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study". <i>The Journal of Urology</i>. <b>114</b> (6): 909–911. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0022-5347%2817%2967172-6">10.1016/S0022-5347(17)67172-6</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/1104900">1104900</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=Chemotherapy+of+advanced+prostatic+carcinoma+with+cyclophosphamide+or+5-fluorouracil%3A+results+of+first+national+randomized+study&amp;rft.volume=114&amp;rft.issue=6&amp;rft.pages=909-911&amp;rft.date=1975-12&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-5347%2817%2967172-6&amp;rft_id=info%3Apmid%2F1104900&amp;rft.aulast=Scott&amp;rft.aufirst=WW&amp;rft.au=Johnson%2C+DE&amp;rft.au=Schmidt%2C+JE&amp;rft.au=Gibbons%2C+RP&amp;rft.au=Prout%2C+GR&amp;rft.au=Joiner%2C+JR&amp;rft.au=Saroff%2C+J&amp;rft.au=Murphy%2C+GP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Xtandi-1-130"><span class="mw-cite-backlink">^ <a href="#cite_ref-Xtandi-1_130-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Xtandi-1_130-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20131002031203/https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm317838.htm">"FDA approves new treatment for a type of late stage prostate cancer"</a> (Press release). Food and Drug Administration. 2012-08-31. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm317838.htm">the original</a> on 2013-10-02.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+new+treatment+for+a+type+of+late+stage+prostate+cancer&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2012-08-31&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm317838.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Xtandi-2-131"><span class="mw-cite-backlink">^ <a href="#cite_ref-Xtandi-2_131-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Xtandi-2_131-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAzvolinsky2012" class="citation web cs1">Azvolinsky A (September 4, 2012). <a rel="nofollow" class="external text" href="http://www.cancernetwork.com/prostate-cancer/content/article/10165/2099887">"FDA Approves Enzalutamide (Xtandi) for Late-Stage Prostate Cancer"</a>. CancerNetwork. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120913055443/http://www.cancernetwork.com/prostate-cancer/content/article/10165/2099887">Archived</a> from the original on September 13, 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Approves+Enzalutamide+%28Xtandi%29+for+Late-Stage+Prostate+Cancer&amp;rft.pub=CancerNetwork&amp;rft.date=2012-09-04&amp;rft.aulast=Azvolinsky&amp;rft.aufirst=A&amp;rft_id=http%3A%2F%2Fwww.cancernetwork.com%2Fprostate-cancer%2Fcontent%2Farticle%2F10165%2F2099887&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-132">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130604012752/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352363.htm">"FDA approves new drug for advanced prostate cancer"</a> (Press release). Food and Drug Administration. 15 May 2013. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352363.htm">the original</a> on 4 June 2013.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+new+drug+for+advanced+prostate+cancer&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2013-05-15&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm352363.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16609730-133"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16609730_133-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16609730_133-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFUrismanMolinaroFischerPlummer2006" class="citation journal cs1">Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA,  et&#160;al. (March 2006). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434790">"Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant"</a>. <i>PLOS Pathogens</i>. <b>2</b> (3): e25. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.ppat.0020025">10.1371/journal.ppat.0020025</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434790">1434790</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16609730">16609730</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+Pathogens&amp;rft.atitle=Identification+of+a+novel+Gammaretrovirus+in+prostate+tumors+of+patients+homozygous+for+R462Q+RNASEL+variant&amp;rft.volume=2&amp;rft.issue=3&amp;rft.pages=e25&amp;rft.date=2006-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1434790%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F16609730&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.ppat.0020025&amp;rft.aulast=Urisman&amp;rft.aufirst=A&amp;rft.au=Molinaro%2C+RJ&amp;rft.au=Fischer%2C+N&amp;rft.au=Plummer%2C+SJ&amp;rft.au=Casey%2C+G&amp;rft.au=Klein%2C+EA&amp;rft.au=Malathi%2C+K&amp;rft.au=Magi-Galluzzi%2C+C&amp;rft.au=Tubbs%2C+RR&amp;rft.au=Ganem%2C+D&amp;rft.au=Silverman%2C+RH&amp;rft.au=DeRisi%2C+JL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1434790&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span> <span class="" style="font-size:0.95em; font-weight:bold; color: #555;"> (Retracted,&#160;see <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fannotation%2F7e2efc01-2e9b-4e9b-aef0-87ab0e4e4732">10.1371/annotation/7e2efc01-2e9b-4e9b-aef0-87ab0e4e4732</a>)</span></span>
</li>
<li id="cite_note-Businessweek_2007-06-13-134"><span class="mw-cite-backlink">^ <a href="#cite_ref-Businessweek_2007-06-13_134-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Businessweek_2007-06-13_134-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Businessweek_2007-06-13_134-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFArnst2007" class="citation web cs1">Arnst C (2007-06-13). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110806185800/http://www.businessweek.com/technology/content/jun2007/tc20070612_953676.htm">"A Gender Gap in Cancer"</a>. Businessweek.com. Archived from <a rel="nofollow" class="external text" href="http://www.businessweek.com/technology/content/jun2007/tc20070612_953676.htm">the original</a> on 2011-08-06<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-08-29</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+Gender+Gap+in+Cancer&amp;rft.pub=Businessweek.com&amp;rft.date=2007-06-13&amp;rft.aulast=Arnst&amp;rft.aufirst=C&amp;rft_id=http%3A%2F%2Fwww.businessweek.com%2Ftechnology%2Fcontent%2Fjun2007%2Ftc20070612_953676.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-135">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBailey2000" class="citation journal cs1">Bailey K (Apr 12–18, 2000). "The nurse's role in promoting breast awareness". <i>Nursing Standard</i>. <b>14</b> (30): 34–36. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.7748%2Fns2000.04.14.30.34.c2811">10.7748/ns2000.04.14.30.34.c2811</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11973892">11973892</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nursing+Standard&amp;rft.atitle=The+nurse%27s+role+in+promoting+breast+awareness&amp;rft.volume=14&amp;rft.issue=30&amp;rft.pages=34-36&amp;rft.date=2000-04-12%2F2000-04-18&amp;rft_id=info%3Adoi%2F10.7748%2Fns2000.04.14.30.34.c2811&amp;rft_id=info%3Apmid%2F11973892&amp;rft.aulast=Bailey&amp;rft.aufirst=K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBrowne2001" class="citation news cs1">Browne A (2001-10-07). <a rel="nofollow" class="external text" href="https://www.theguardian.com/society/2001/oct/07/cancercare">"Cancer bias puts breasts first"</a>. <i>The Guardian</i>. London. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161226194151/https://www.theguardian.com/society/2001/oct/07/cancercare">Archived</a> from the original on 2016-12-26.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Cancer+bias+puts+breasts+first&amp;rft.date=2001-10-07&amp;rft.aulast=Browne&amp;rft.aufirst=A&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fsociety%2F2001%2Foct%2F07%2Fcancercare&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFagerlundCormioPalangiLewin2015" class="citation journal cs1">Fagerlund A, Cormio L, Palangi L, Lewin R, Santanelli di Pompeo F, Elander A, Selvaggi G (2015-08-26). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550398">"Gynecomastia in Patients with Prostate Cancer: A Systematic Review"</a>. <i>PLOS ONE</i>. <b>10</b> (8): e0136094. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2015PLoSO..1036094F">2015PLoSO..1036094F</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0136094">10.1371/journal.pone.0136094</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550398">4550398</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26308532">26308532</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Gynecomastia+in+Patients+with+Prostate+Cancer%3A+A+Systematic+Review&amp;rft.volume=10&amp;rft.issue=8&amp;rft.pages=e0136094&amp;rft.date=2015-08-26&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4550398%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26308532&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0136094&amp;rft_id=info%3Abibcode%2F2015PLoSO..1036094F&amp;rft.aulast=Fagerlund&amp;rft.aufirst=A&amp;rft.au=Cormio%2C+L&amp;rft.au=Palangi%2C+L&amp;rft.au=Lewin%2C+R&amp;rft.au=Santanelli+di+Pompeo%2C+F&amp;rft.au=Elander%2C+A&amp;rft.au=Selvaggi%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4550398&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-st16Oct2005-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-st16Oct2005_138-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTempleton2005" class="citation news cs1">Templeton SK (2005-10-16). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110524065813/http://www.timesonline.co.uk/tol/news/uk/article579050.ece">"Men lose out in battle for cancer cash"</a>. <i>Sunday Times</i>. Archived from <a rel="nofollow" class="external text" href="http://www.timesonline.co.uk/tol/news/uk/article579050.ece">the original</a> on 2011-05-24.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sunday+Times&amp;rft.atitle=Men+lose+out+in+battle+for+cancer+cash&amp;rft.date=2005-10-16&amp;rft.aulast=Templeton&amp;rft.aufirst=SK&amp;rft_id=http%3A%2F%2Fwww.timesonline.co.uk%2Ftol%2Fnews%2Fuk%2Farticle579050.ece&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFarrellSterba2008" class="citation book cs1">Farrell W, Sterba JP (2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=mRkqAAAAYAAJ&amp;q=prostate"><i>Does feminism discriminate against men?: a debate</i></a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-19-531283-6" title="Special:BookSources/978-0-19-531283-6"><bdi>978-0-19-531283-6</bdi></a><span class="reference-accessdate">. Retrieved <span class="nowrap">2011-08-29</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Does+feminism+discriminate+against+men%3F%3A+a+debate&amp;rft.date=2008&amp;rft.isbn=978-0-19-531283-6&amp;rft.aulast=Farrell&amp;rft.aufirst=W&amp;rft.au=Sterba%2C+JP&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DmRkqAAAAYAAJ%26q%3Dprostate&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.zerocancer.org/site/DocServer/2007_Prostate_Cancer_Gap2.pdf?docID=681">"The Prostate Cancer Gap. A Crisis in Men's Health"</a> <span class="cs1-format">(PDF)</span>. <i>National Prostate Cancer Coalition</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Prostate+Cancer+Coalition.&amp;rft.atitle=The+Prostate+Cancer+Gap.+A+Crisis+in+Men%27s+Health&amp;rft_id=http%3A%2F%2Fwww.zerocancer.org%2Fsite%2FDocServer%2F2007_Prostate_Cancer_Gap2.pdf%3FdocID%3D681&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span><sup class="noprint Inline-Template"><span style="white-space: nowrap;">&#91;<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title="&#160;Dead link tagged October 2022">permanent dead link</span></a></i>&#93;</span></sup></span>
</li>
<li id="cite_note-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-141">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.tampabay.com/news/health/men-dont-wait-until-theres-a-problem-to-see-a-doctor/2284568">"Men, don't wait until there's a problem to see a doctor"</a>. <i><a href="/wiki/Tampa_Bay_Times" title="Tampa Bay Times">Tampa Bay Times</a></i>. 7 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">2019-08-27</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Tampa+Bay+Times&amp;rft.atitle=Men%2C+don%27t+wait+until+there%27s+a+problem+to+see+a+doctor&amp;rft.date=2016-07-07&amp;rft_id=https%3A%2F%2Fwww.tampabay.com%2Fnews%2Fhealth%2Fmen-dont-wait-until-theres-a-problem-to-see-a-doctor%2F2284568&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMinium2017" class="citation web cs1">Minium H (5 December 2017). <a rel="nofollow" class="external text" href="https://www.pilotonline.com/sports/college/old-dominion/article_49677cfc-0a25-5abf-b4a8-00d44b8cbbe5.html">"Men need to hear the story of ODU coach Jeff Jones' recovery from prostate cancer"</a>. <i><a href="/wiki/The_Virginian-Pilot" title="The Virginian-Pilot">The Virginian-Pilot</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-08-27</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Virginian-Pilot&amp;rft.atitle=Men+need+to+hear+the+story+of+ODU+coach+Jeff+Jones%27+recovery+from+prostate+cancer&amp;rft.date=2017-12-05&amp;rft.aulast=Minium&amp;rft.aufirst=H&amp;rft_id=https%3A%2F%2Fwww.pilotonline.com%2Fsports%2Fcollege%2Fold-dominion%2Farticle_49677cfc-0a25-5abf-b4a8-00d44b8cbbe5.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text">Saad F, Hotte SJ. Guidelines for the management of castrate-resistant prostate cancer. Can Urol Assoc J. 2010 Dec;4(6):380-4. doi: 10.5489/cuaj.10167. PMID 21191494; PMCID: PMC2997826.</span>
</li>
<li id="cite_note-Herberts2022-144"><span class="mw-cite-backlink">^ <a href="#cite_ref-Herberts2022_144-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Herberts2022_144-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHerbertsAnnalaSipolaNg2022" class="citation journal cs1">Herberts, Cameron; Annala, Matti; Sipola, Joonatan; Ng, Sarah W. S.; Chen, Xinyi E.; Nurminen, Anssi; Korhonen, Olga V.; Munzur, Aslı D.; Beja, Kevin; Schönlau, Elena; Bernales, Cecily Q.; Ritch, Elie; Bacon, Jack V. W.; Lack, Nathan A.; Nykter, Matti (August 2022). <a rel="nofollow" class="external text" href="https://www.nature.com/articles/s41586-022-04975-9">"Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer"</a>. <i>Nature</i>. <b>608</b> (7921): 199–208. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2022Natur.608..199H">2022Natur.608..199H</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41586-022-04975-9">10.1038/s41586-022-04975-9</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/1476-4687">1476-4687</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35859180">35859180</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:250730778">250730778</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Deep+whole-genome+ctDNA+chronology+of+treatment-resistant+prostate+cancer&amp;rft.volume=608&amp;rft.issue=7921&amp;rft.pages=199-208&amp;rft.date=2022-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A250730778%23id-name%3DS2CID&amp;rft_id=info%3Abibcode%2F2022Natur.608..199H&amp;rft.issn=1476-4687&amp;rft_id=info%3Adoi%2F10.1038%2Fs41586-022-04975-9&amp;rft_id=info%3Apmid%2F35859180&amp;rft.aulast=Herberts&amp;rft.aufirst=Cameron&amp;rft.au=Annala%2C+Matti&amp;rft.au=Sipola%2C+Joonatan&amp;rft.au=Ng%2C+Sarah+W.+S.&amp;rft.au=Chen%2C+Xinyi+E.&amp;rft.au=Nurminen%2C+Anssi&amp;rft.au=Korhonen%2C+Olga+V.&amp;rft.au=Munzur%2C+Asl%C4%B1+D.&amp;rft.au=Beja%2C+Kevin&amp;rft.au=Sch%C3%B6nlau%2C+Elena&amp;rft.au=Bernales%2C+Cecily+Q.&amp;rft.au=Ritch%2C+Elie&amp;rft.au=Bacon%2C+Jack+V.+W.&amp;rft.au=Lack%2C+Nathan+A.&amp;rft.au=Nykter%2C+Matti&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41586-022-04975-9&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110811081805/http://algeta.com/xml_press_underside.asp?xml=http%3A%2F%2Fcws.huginonline.com%2FA%2F134655%2FPR%2F201106%2F1521246.xml&amp;m=34572&amp;s=34686&amp;ss=&amp;d=2011-06-06">"Positive Outcome of Interim Analysis of pivotal Alpharadin study: Primary endpoint met in Phase III ALSYMPCA study"</a> (Press release). Algeta ASA. 2011-06-06. Archived from the original on 2011-08-11<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-07-04</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Positive+Outcome+of+Interim+Analysis+of+pivotal+Alpharadin+study%3A+Primary+endpoint+met+in+Phase+III+ALSYMPCA+study&amp;rft.pub=Algeta+ASA&amp;rft.date=2011-06-06&amp;rft_id=http%3A%2F%2Falgeta.com%2Fxml_press_underside.asp%3Fxml%3Dhttp%3A%2F%2Fcws.huginonline.com%2FA%2F134655%2FPR%2F201106%2F1521246.xml%26m%3D34572%26s%3D34686%26ss%3D%26d%3D2011-06-06&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_press_release" title="Template:Cite press release">cite press release</a>}}</code>:  CS1 maint: unfit URL (<a href="/wiki/Category:CS1_maint:_unfit_URL" title="Category:CS1 maint: unfit URL">link</a>)</span></span>
</li>
<li id="cite_note-PCWG3-Geet-146"><span class="mw-cite-backlink">^ <a href="#cite_ref-PCWG3-Geet_146-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PCWG3-Geet_146-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGeethakumariCooksonKelly2016" class="citation journal cs1">Geethakumari PR, Cookson MS, Kelly WK (February 2016). <a rel="nofollow" class="external text" href="http://www.cancernetwork.com/oncology-journal/evolving-biology-castration-resistant-prostate-cancer-review-recommendations-PCWG3">"The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3"</a>. <i>Oncology</i>. <b>30</b> (2): 187–95, 199. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26888794">26888794</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160222235842/http://www.cancernetwork.com/oncology-journal/evolving-biology-castration-resistant-prostate-cancer-review-recommendations-PCWG3">Archived</a> from the original on 22 February 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncology&amp;rft.atitle=The+Evolving+Biology+of+Castration-Resistant+Prostate+Cancer%3A+Review+of+Recommendations+From+the+Prostate+Cancer+Clinical+Trials+Working+Group+3&amp;rft.volume=30&amp;rft.issue=2&amp;rft.pages=187-95%2C+199&amp;rft.date=2016-02&amp;rft_id=info%3Apmid%2F26888794&amp;rft.aulast=Geethakumari&amp;rft.aufirst=PR&amp;rft.au=Cookson%2C+MS&amp;rft.au=Kelly%2C+WK&amp;rft_id=http%3A%2F%2Fwww.cancernetwork.com%2Foncology-journal%2Fevolving-biology-castration-resistant-prostate-cancer-review-recommendations-PCWG3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Elshan2019-147"><span class="mw-cite-backlink">^ <a href="#cite_ref-Elshan2019_147-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Elshan2019_147-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Elshan2019_147-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFElshanRettigJung2019" class="citation journal cs1">Elshan NG, Rettig MB, Jung ME (May 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608750">"Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain"</a>. <i>Medicinal Research Reviews</i>. <b>39</b> (3): 910–960. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmed.21548">10.1002/med.21548</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6608750">6608750</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30565725">30565725</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medicinal+Research+Reviews&amp;rft.atitle=Molecules+targeting+the+androgen+receptor+%28AR%29+signaling+axis+beyond+the+AR-Ligand+binding+domain&amp;rft.volume=39&amp;rft.issue=3&amp;rft.pages=910-960&amp;rft.date=2019-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6608750%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30565725&amp;rft_id=info%3Adoi%2F10.1002%2Fmed.21548&amp;rft.aulast=Elshan&amp;rft.aufirst=NG&amp;rft.au=Rettig%2C+MB&amp;rft.au=Jung%2C+ME&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6608750&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-148">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSuzukiUedaIchikawaIto2003" class="citation journal cs1">Suzuki H, Ueda T, Ichikawa T, Ito H (June 2003). <a rel="nofollow" class="external text" href="https://doi.org/10.1677%2Ferc.0.0100209">"Androgen receptor involvement in the progression of prostate cancer"</a>. <i>Endocrine-Related Cancer</i>. <b>10</b> (2): 209–216. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1677%2Ferc.0.0100209">10.1677/erc.0.0100209</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12790784">12790784</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrine-Related+Cancer&amp;rft.atitle=Androgen+receptor+involvement+in+the+progression+of+prostate+cancer&amp;rft.volume=10&amp;rft.issue=2&amp;rft.pages=209-216&amp;rft.date=2003-06&amp;rft_id=info%3Adoi%2F10.1677%2Ferc.0.0100209&amp;rft_id=info%3Apmid%2F12790784&amp;rft.aulast=Suzuki&amp;rft.aufirst=H&amp;rft.au=Ueda%2C+T&amp;rft.au=Ichikawa%2C+T&amp;rft.au=Ito%2C+H&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1677%252Ferc.0.0100209&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Primary_source_cited_in_1st_review-149"><span class="mw-cite-backlink">^ <a href="#cite_ref-Primary_source_cited_in_1st_review_149-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Primary_source_cited_in_1st_review_149-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Primary_source_cited_in_1st_review_149-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGhoshMyers1998" class="citation journal cs1">Ghosh J, Myers CE (October 1998). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC23752">"Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>95</b> (22): 13182–13187. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1998PNAS...9513182G">1998PNAS...9513182G</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.95.22.13182">10.1073/pnas.95.22.13182</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC23752">23752</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9789062">9789062</a>. <q>Inhibition of 5-lipoxygenase by MK886 completely blocks 5-HETE production and induces massive apoptosis in both hormone-responsive (LNCaP) and -nonresponsive (PC3) human prostate cancer cells. This cell death is very rapid</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Inhibition+of+arachidonate+5-lipoxygenase+triggers+massive+apoptosis+in+human+prostate+cancer+cells&amp;rft.volume=95&amp;rft.issue=22&amp;rft.pages=13182-13187&amp;rft.date=1998-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC23752%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9789062&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.95.22.13182&amp;rft_id=info%3Abibcode%2F1998PNAS...9513182G&amp;rft.aulast=Ghosh&amp;rft.aufirst=J&amp;rft.au=Myers%2C+CE&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC23752&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-MEDRS_review_1-150"><span class="mw-cite-backlink">^ <a href="#cite_ref-MEDRS_review_1_150-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MEDRS_review_1_150-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MEDRS_review_1_150-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGreeneHuangSerhanPanigrahy2011" class="citation journal cs1">Greene ER, Huang S, Serhan CN, Panigrahy D (November 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051344">"Regulation of inflammation in cancer by eicosanoids"</a>. <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>96</b> (1–4): 27–36. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.prostaglandins.2011.08.004">10.1016/j.prostaglandins.2011.08.004</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051344">4051344</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21864702">21864702</a>. <q>The 5-lipoxygenase (5-LOX) pathway is implicated in the development and progression of human cancers. 5-LOX, whose crystal structure was recently identified (118), is a key enzyme in metabolizing arachidonic acid to leukotrienes. 5-LOX can be induced by proinflammatory stimuli and is expressed in epithelial cancers including lung, prostate, breast, and colon (113). Hence, 5-LOX inhibitors have been targeted for their chemopreventive effects. Inhibition of 5-LOX activity is shown to block prostate cancer cell proliferation as well as carcinogen-induced lung tumorigenesis (119, 120).&#160;... Both 5-HETE and 12-HETE are also products of lipoxygenase and are involved in tumor progression (12). Exogenous 5-HETE can stimulate the proliferation of prostate cancer cells and act as a survival factor (137, 138). These results require relatively high concentrations (at a concentration of 10 μM). Blocking the formation of 5-HETE, by inhibiting 5-lipoxygenase, results in massive apoptosis of human prostate cancer cells (139).</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Regulation+of+inflammation+in+cancer+by+eicosanoids&amp;rft.volume=96&amp;rft.issue=1%E2%80%934&amp;rft.pages=27-36&amp;rft.date=2011-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4051344%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21864702&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2011.08.004&amp;rft.aulast=Greene&amp;rft.aufirst=ER&amp;rft.au=Huang%2C+S&amp;rft.au=Serhan%2C+CN&amp;rft.au=Panigrahy%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4051344&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-MEDRS_review_2-151"><span class="mw-cite-backlink">^ <a href="#cite_ref-MEDRS_review_2_151-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MEDRS_review_2_151-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MEDRS_review_2_151-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBishayeeKhuda-Bukhsh2013" class="citation journal cs1">Bishayee K, Khuda-Bukhsh AR (September 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fabbs%2Fgmt064">"5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy"</a>. <i>Acta Biochimica et Biophysica Sinica</i>. <b>45</b> (9): 709–719. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fabbs%2Fgmt064">10.1093/abbs/gmt064</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23752617">23752617</a>. <q>Recent studies demonstrated the involvement of growth factors, such as epidermal growth factor (EGF) and neurotensin in the 5-LOX-mediated tumor progression in prostate cancer [22,23]. Recent studies with 5-LOX siRNA [10] and specific blocker of 5-LOX [24] revealed the relation of this gene with the tumor cell proliferation.&#160;... Meclofenamate sodium (MS) is known for its anti-inflammatory activity, and apart from this, Boctor et al. [37] reported that it caused reduction in the formation of 5-HETE in human leucocytes when used. MS can thus be considered a dual inhibitor of 5-LOX and COX pathways of arachidonic acid cascade. Further investigation with this substance revealed that it could interfere with the LT receptors in the lung carcinoma [38]. In a recent study, a group of scientists have shown the effect of MS on prostate cancer cells both in vitro and in vivo [39], and their result suggests a profound reduction in the tumor growth and cancer metastasis.&#160;... While the commonly used inhibitors produced strong cytotoxicity, notably, zileuton, the only commercialized 5-LOX inhibitor, failed to induce an anti-proliferative or cytotoxic response in all other types of tumor cells where 5-LOX was in inactive state (e.g. HeLa cells).  But where 5-LOX was in active state, zileuton could effectively inhibit progression, as in case of prostate cancer.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Biochimica+et+Biophysica+Sinica&amp;rft.atitle=5-lipoxygenase+antagonist+therapy%3A+a+new+approach+towards+targeted+cancer+chemotherapy&amp;rft.volume=45&amp;rft.issue=9&amp;rft.pages=709-719&amp;rft.date=2013-09&amp;rft_id=info%3Adoi%2F10.1093%2Fabbs%2Fgmt064&amp;rft_id=info%3Apmid%2F23752617&amp;rft.aulast=Bishayee&amp;rft.aufirst=K&amp;rft.au=Khuda-Bukhsh%2C+AR&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fabbs%252Fgmt064&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-Martínez-Bosch2019-152"><span class="mw-cite-backlink"><b><a href="#cite_ref-Martínez-Bosch2019_152-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMartínez-BoschRodriguez-VidaJuanpereLloreta2019" class="citation journal cs1">Martínez-Bosch N, Rodriguez-Vida A, Juanpere N, Lloreta J, Rovira A, Albanell J,  et&#160;al. (July 2019). "Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities". <i>Nature Reviews. Urology</i>. <b>16</b> (7): 433–445. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41585-019-0183-5">10.1038/s41585-019-0183-5</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/10261%2F201560">10261/201560</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31015643">31015643</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:128360958">128360958</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Urology&amp;rft.atitle=Galectins+in+prostate+and+bladder+cancer%3A+tumorigenic+roles+and+clinical+opportunities&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=433-445&amp;rft.date=2019-07&amp;rft_id=info%3Ahdl%2F10261%2F201560&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A128360958%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31015643&amp;rft_id=info%3Adoi%2F10.1038%2Fs41585-019-0183-5&amp;rft.aulast=Mart%C3%ADnez-Bosch&amp;rft.aufirst=N&amp;rft.au=Rodriguez-Vida%2C+A&amp;rft.au=Juanpere%2C+N&amp;rft.au=Lloreta%2C+J&amp;rft.au=Rovira%2C+A&amp;rft.au=Albanell%2C+J&amp;rft.au=Bellmunt%2C+J&amp;rft.au=Navarro%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-153">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMunkleyMillsElliott2016" class="citation journal cs1">Munkley J, Mills IG, Elliott DJ (June 2016). <a rel="nofollow" class="external text" href="https://eprint.ncl.ac.uk/fulltext.aspx?url=219656/13FDD2AE-20DB-42AD-A50E-911D4F1FAD05.pdf&amp;pub_id=219656">"The role of glycans in the development and progression of prostate cancer"</a>. <i>Nature Reviews. Urology</i>. <b>13</b> (6): 324–333. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrurol.2016.65">10.1038/nrurol.2016.65</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27091662">27091662</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25916024">25916024</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Urology&amp;rft.atitle=The+role+of+glycans+in+the+development+and+progression+of+prostate+cancer&amp;rft.volume=13&amp;rft.issue=6&amp;rft.pages=324-333&amp;rft.date=2016-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25916024%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27091662&amp;rft_id=info%3Adoi%2F10.1038%2Fnrurol.2016.65&amp;rft.aulast=Munkley&amp;rft.aufirst=J&amp;rft.au=Mills%2C+IG&amp;rft.au=Elliott%2C+DJ&amp;rft_id=https%3A%2F%2Feprint.ncl.ac.uk%2Ffulltext.aspx%3Furl%3D219656%2F13FDD2AE-20DB-42AD-A50E-911D4F1FAD05.pdf%26pub_id%3D219656&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-154">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDrakeJonesPowersNyalwidhe2015" class="citation book cs1">Drake RR, Jones EE, Powers TW, Nyalwidhe JO (2015). "Altered glycosylation in prostate cancer".  In Drake RR, Ball LE (eds.). <i>Glycosylation and Cancer</i>. Advances in Cancer Research Vol. 126. Vol.&#160;126. pp.&#160;345–82. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fbs.acr.2014.12.001">10.1016/bs.acr.2014.12.001</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-12-801381-6" title="Special:BookSources/978-0-12-801381-6"><bdi>978-0-12-801381-6</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25727153">25727153</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Altered+glycosylation+in+prostate+cancer&amp;rft.btitle=Glycosylation+and+Cancer&amp;rft.series=Advances+in+Cancer+Research+Vol.+126&amp;rft.pages=345-82&amp;rft.date=2015&amp;rft_id=info%3Apmid%2F25727153&amp;rft_id=info%3Adoi%2F10.1016%2Fbs.acr.2014.12.001&amp;rft.isbn=978-0-12-801381-6&amp;rft.aulast=Drake&amp;rft.aufirst=RR&amp;rft.au=Jones%2C+EE&amp;rft.au=Powers%2C+TW&amp;rft.au=Nyalwidhe%2C+JO&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-155"><span class="mw-cite-backlink"><b><a href="#cite_ref-155">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLaderachGentiliniGiribaldiDelgado2013" class="citation journal cs1">Laderach DJ, Gentilini LD, Giribaldi L, Delgado VC, Nugnes L, Croci DO,  et&#160;al. (January 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1158%2F0008-5472.CAN-12-1260">"A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease"</a>. <i>Cancer Research</i>. <b>73</b> (1): 86–96. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1158%2F0008-5472.CAN-12-1260">10.1158/0008-5472.CAN-12-1260</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23108139">23108139</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=A+unique+galectin+signature+in+human+prostate+cancer+progression+suggests+galectin-1+as+a+key+target+for+treatment+of+advanced+disease&amp;rft.volume=73&amp;rft.issue=1&amp;rft.pages=86-96&amp;rft.date=2013-01&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-12-1260&amp;rft_id=info%3Apmid%2F23108139&amp;rft.aulast=Laderach&amp;rft.aufirst=DJ&amp;rft.au=Gentilini%2C+LD&amp;rft.au=Giribaldi%2C+L&amp;rft.au=Delgado%2C+VC&amp;rft.au=Nugnes%2C+L&amp;rft.au=Croci%2C+DO&amp;rft.au=Al+Nakouzi%2C+N&amp;rft.au=Sacca%2C+P&amp;rft.au=Casas%2C+G&amp;rft.au=Mazza%2C+O&amp;rft.au=Shipp%2C+MA&amp;rft.au=Vazquez%2C+E&amp;rft.au=Chauchereau%2C+A&amp;rft.au=Kutok%2C+JL&amp;rft.au=Rodig%2C+SJ&amp;rft.au=Elola%2C+MT&amp;rft.au=Compagno%2C+D&amp;rft.au=Rabinovich%2C+GA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1158%252F0008-5472.CAN-12-1260&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-156"><span class="mw-cite-backlink"><b><a href="#cite_ref-156">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCompagnoGentiliniJaworskiPérez2014" class="citation journal cs1">Compagno D, Gentilini LD, Jaworski FM, Pérez IG, Contrufo G, Laderach DJ (October 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fglycob%2Fcwu055">"Glycans and galectins in prostate cancer biology, angiogenesis and metastasis"</a>. <i>Glycobiology</i>. <b>24</b> (10): 899–906. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fglycob%2Fcwu055">10.1093/glycob/cwu055</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24939371">24939371</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Glycobiology&amp;rft.atitle=Glycans+and+galectins+in+prostate+cancer+biology%2C+angiogenesis+and+metastasis&amp;rft.volume=24&amp;rft.issue=10&amp;rft.pages=899-906&amp;rft.date=2014-10&amp;rft_id=info%3Adoi%2F10.1093%2Fglycob%2Fcwu055&amp;rft_id=info%3Apmid%2F24939371&amp;rft.aulast=Compagno&amp;rft.aufirst=D&amp;rft.au=Gentilini%2C+LD&amp;rft.au=Jaworski%2C+FM&amp;rft.au=P%C3%A9rez%2C+IG&amp;rft.au=Contrufo%2C+G&amp;rft.au=Laderach%2C+DJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fglycob%252Fcwu055&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-157">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAlimirahChenBasrawalaXin2006" class="citation journal cs1">Alimirah F, Chen J, Basrawala Z, Xin H, Choubey D (April 2006). "DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation". <i>FEBS Letters</i>. <b>580</b> (9): 2294–2300. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.febslet.2006.03.041">10.1016/j.febslet.2006.03.041</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16580667">16580667</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:21777101">21777101</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FEBS+Letters&amp;rft.atitle=DU-145+and+PC-3+human+prostate+cancer+cell+lines+express+androgen+receptor%3A+implications+for+the+androgen+receptor+functions+and+regulation&amp;rft.volume=580&amp;rft.issue=9&amp;rft.pages=2294-2300&amp;rft.date=2006-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21777101%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16580667&amp;rft_id=info%3Adoi%2F10.1016%2Fj.febslet.2006.03.041&amp;rft.aulast=Alimirah&amp;rft.aufirst=F&amp;rft.au=Chen%2C+J&amp;rft.au=Basrawala%2C+Z&amp;rft.au=Xin%2C+H&amp;rft.au=Choubey%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-158">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLinjaSavinainenSaramäkiTammela2001" class="citation journal cs1">Linja MJ, Savinainen KJ, Saramäki OR, Tammela TL, Vessella RL, Visakorpi T (May 2001). <a rel="nofollow" class="external text" href="http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=11325816">"Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer"</a>. <i>Cancer Research</i>. <b>61</b> (9): 3550–3555. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11325816">11325816</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Amplification+and+overexpression+of+androgen+receptor+gene+in+hormone-refractory+prostate+cancer&amp;rft.volume=61&amp;rft.issue=9&amp;rft.pages=3550-3555&amp;rft.date=2001-05&amp;rft_id=info%3Apmid%2F11325816&amp;rft.aulast=Linja&amp;rft.aufirst=MJ&amp;rft.au=Savinainen%2C+KJ&amp;rft.au=Saram%C3%A4ki%2C+OR&amp;rft.au=Tammela%2C+TL&amp;rft.au=Vessella%2C+RL&amp;rft.au=Visakorpi%2C+T&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D11325816&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-159"><span class="mw-cite-backlink"><b><a href="#cite_ref-159">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFordGregoryKimSmitherman2003" class="citation journal cs1">Ford OH, Gregory CW, Kim D, Smitherman AB, Mohler JL (November 2003). "Androgen receptor gene amplification and protein expression in recurrent prostate cancer". <i>The Journal of Urology</i>. <b>170</b> (5): 1817–1821. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F01.ju.0000091873.09677.f4">10.1097/01.ju.0000091873.09677.f4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14532783">14532783</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.atitle=Androgen+receptor+gene+amplification+and+protein+expression+in+recurrent+prostate+cancer&amp;rft.volume=170&amp;rft.issue=5&amp;rft.pages=1817-1821&amp;rft.date=2003-11&amp;rft_id=info%3Adoi%2F10.1097%2F01.ju.0000091873.09677.f4&amp;rft_id=info%3Apmid%2F14532783&amp;rft.aulast=Ford&amp;rft.aufirst=OH&amp;rft.au=Gregory%2C+CW&amp;rft.au=Kim%2C+D&amp;rft.au=Smitherman%2C+AB&amp;rft.au=Mohler%2C+JL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-160"><span class="mw-cite-backlink"><b><a href="#cite_ref-160">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKokontisTakakuraHayLiao1994" class="citation journal cs1">Kokontis J, Takakura K, Hay N, Liao S (March 1994). <a rel="nofollow" class="external text" href="http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=7511045">"Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation"</a>. <i>Cancer Research</i>. <b>54</b> (6): 1566–1573. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7511045">7511045</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Increased+androgen+receptor+activity+and+altered+c-myc+expression+in+prostate+cancer+cells+after+long-term+androgen+deprivation&amp;rft.volume=54&amp;rft.issue=6&amp;rft.pages=1566-1573&amp;rft.date=1994-03&amp;rft_id=info%3Apmid%2F7511045&amp;rft.aulast=Kokontis&amp;rft.aufirst=J&amp;rft.au=Takakura%2C+K&amp;rft.au=Hay%2C+N&amp;rft.au=Liao%2C+S&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D7511045&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-161"><span class="mw-cite-backlink"><b><a href="#cite_ref-161">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFUmekitaHiipakkaKokontisLiao1996" class="citation journal cs1">Umekita Y, Hiipakka RA, Kokontis JM, Liao S (October 1996). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38139">"Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>93</b> (21): 11802–11807. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1996PNAS...9311802U">1996PNAS...9311802U</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.93.21.11802">10.1073/pnas.93.21.11802</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC38139">38139</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/8876218">8876218</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Human+prostate+tumor+growth+in+athymic+mice%3A+inhibition+by+androgens+and+stimulation+by+finasteride&amp;rft.volume=93&amp;rft.issue=21&amp;rft.pages=11802-11807&amp;rft.date=1996-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC38139%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F8876218&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.93.21.11802&amp;rft_id=info%3Abibcode%2F1996PNAS...9311802U&amp;rft.aulast=Umekita&amp;rft.aufirst=Y&amp;rft.au=Hiipakka%2C+RA&amp;rft.au=Kokontis%2C+JM&amp;rft.au=Liao%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC38139&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-162"><span class="mw-cite-backlink"><b><a href="#cite_ref-162">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKokontisHsuChuuDang2005" class="citation journal cs1">Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S (December 2005). "Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity". <i>The Prostate</i>. <b>65</b> (4): 287–298. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fpros.20285">10.1002/pros.20285</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16015608">16015608</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22349673">22349673</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Prostate&amp;rft.atitle=Role+of+androgen+receptor+in+the+progression+of+human+prostate+tumor+cells+to+androgen+independence+and+insensitivity&amp;rft.volume=65&amp;rft.issue=4&amp;rft.pages=287-298&amp;rft.date=2005-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22349673%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16015608&amp;rft_id=info%3Adoi%2F10.1002%2Fpros.20285&amp;rft.aulast=Kokontis&amp;rft.aufirst=JM&amp;rft.au=Hsu%2C+S&amp;rft.au=Chuu%2C+CP&amp;rft.au=Dang%2C+M&amp;rft.au=Fukuchi%2C+J&amp;rft.au=Hiipakka%2C+RA&amp;rft.au=Liao%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-163"><span class="mw-cite-backlink"><b><a href="#cite_ref-163">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sciencedirect.com/topics/computer-science/tumor-detection">"Tumor Detection - an overview | ScienceDirect Topics"</a>. <i>www.sciencedirect.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2022-04-29</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.sciencedirect.com&amp;rft.atitle=Tumor+Detection+-+an+overview+%7C+ScienceDirect+Topics&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Ftopics%2Fcomputer-science%2Ftumor-detection&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-164"><span class="mw-cite-backlink"><b><a href="#cite_ref-164">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sciencedirect.com/topics/medicine-and-dentistry/pca3">"PCA3 - an overview | ScienceDirect Topics"</a>. <i>www.sciencedirect.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2022-04-29</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.sciencedirect.com&amp;rft.atitle=PCA3+-+an+overview+%7C+ScienceDirect+Topics&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Ftopics%2Fmedicine-and-dentistry%2Fpca3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid21176272-165"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21176272_165-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBourdoumisPapatsorisChrisofosEfstathiou2010" class="citation journal cs1">Bourdoumis A, Papatsoris AG, Chrisofos M, Efstathiou E, Skolarikos A, Deliveliotis C (2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1590%2FS1677-55382010000600003">"The novel prostate cancer antigen 3 (PCA3) biomarker"</a>. <i>International Braz J Urol</i>. <b>36</b> (6): 665–8, discussion 669. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1590%2FS1677-55382010000600003">10.1590/S1677-55382010000600003</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21176272">21176272</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Braz+J+Urol&amp;rft.atitle=The+novel+prostate+cancer+antigen+3+%28PCA3%29+biomarker&amp;rft.volume=36&amp;rft.issue=6&amp;rft.pages=665-8%2C+discussion+669&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1590%2FS1677-55382010000600003&amp;rft_id=info%3Apmid%2F21176272&amp;rft.aulast=Bourdoumis&amp;rft.aufirst=A&amp;rft.au=Papatsoris%2C+AG&amp;rft.au=Chrisofos%2C+M&amp;rft.au=Efstathiou%2C+E&amp;rft.au=Skolarikos%2C+A&amp;rft.au=Deliveliotis%2C+C&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1590%252FS1677-55382010000600003&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
<li id="cite_note-166"><span class="mw-cite-backlink"><b><a href="#cite_ref-166">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cdc.gov/egappreviews/recommendations/PCA3.html">"Does PCA3 Testing for the Diagnosis and Management of Prostate Cancer improve patient health outcomes"</a>. <i>Centers for Disease Control and Prevention</i>. 2018-11-19<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-08-09</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Centers+for+Disease+Control+and+Prevention&amp;rft.atitle=Does+PCA3+Testing+for+the+Diagnosis+and+Management+of+Prostate+Cancer+improve+patient+health+outcomes&amp;rft.date=2018-11-19&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fegappreviews%2Frecommendations%2FPCA3.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></span>
</li>
</ol></div></div>
<h3><span class="mw-headline" id="Works_cited">Works cited</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=32" title="Edit section: Works cited">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1054258005"><div class="refbegin refbegin-columns references-column-width" style="column-width: 32em">
<ul><li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAchardPutoraOmlinZilli2022" class="citation journal cs1">Achard V, Putora PM, Omlin A, Zilli T, Fischer S (2022). "Metastatic Prostate Cancer: Treatment Options". <i>Oncology</i>. <b>100</b> (1): 48–59. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000519861">10.1159/000519861</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34781285">34781285</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncology&amp;rft.atitle=Metastatic+Prostate+Cancer%3A+Treatment+Options&amp;rft.volume=100&amp;rft.issue=1&amp;rft.pages=48-59&amp;rft.date=2022&amp;rft_id=info%3Adoi%2F10.1159%2F000519861&amp;rft_id=info%3Apmid%2F34781285&amp;rft.aulast=Achard&amp;rft.aufirst=V&amp;rft.au=Putora%2C+PM&amp;rft.au=Omlin%2C+A&amp;rft.au=Zilli%2C+T&amp;rft.au=Fischer%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBergengrenPekalaMatsoukasFainberg2023" class="citation journal cs1">Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, Bray F, Brawley O, Luckenbaugh AN, Mucci L, Morgan TM, Carlsson SV (May 2023). "2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review". <i>Eur Urol</i>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.eururo.2023.04.021">10.1016/j.eururo.2023.04.021</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/37202314">37202314</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Eur+Urol&amp;rft.atitle=2022+Update+on+Prostate+Cancer+Epidemiology+and+Risk+Factors-A+Systematic+Review&amp;rft.date=2023-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2023.04.021&amp;rft_id=info%3Apmid%2F37202314&amp;rft.aulast=Bergengren&amp;rft.aufirst=O&amp;rft.au=Pekala%2C+KR&amp;rft.au=Matsoukas%2C+K&amp;rft.au=Fainberg%2C+J&amp;rft.au=Mungovan%2C+SF&amp;rft.au=Bratt%2C+O&amp;rft.au=Bray%2C+F&amp;rft.au=Brawley%2C+O&amp;rft.au=Luckenbaugh%2C+AN&amp;rft.au=Mucci%2C+L&amp;rft.au=Morgan%2C+TM&amp;rft.au=Carlsson%2C+SV&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBrawleyMohanNein2018" class="citation journal cs1">Brawley S, Mohan R, Nein CD (June 2018). "Localized Prostate Cancer: Treatment Options". <i>Am Fam Physician</i>. <b>97</b> (12): 798–805. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30216009">30216009</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+Fam+Physician&amp;rft.atitle=Localized+Prostate+Cancer%3A+Treatment+Options&amp;rft.volume=97&amp;rft.issue=12&amp;rft.pages=798-805&amp;rft.date=2018-06&amp;rft_id=info%3Apmid%2F30216009&amp;rft.aulast=Brawley&amp;rft.aufirst=S&amp;rft.au=Mohan%2C+R&amp;rft.au=Nein%2C+CD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCarlssonVickers2020" class="citation journal cs1">Carlsson SV, Vickers AJ (November 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287565">"Screening for Prostate Cancer"</a>. <i>Med Clin North Am</i>. <b>104</b> (6): 1051–1062. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mcna.2020.08.007">10.1016/j.mcna.2020.08.007</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287565">8287565</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33099450">33099450</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Med+Clin+North+Am&amp;rft.atitle=Screening+for+Prostate+Cancer&amp;rft.volume=104&amp;rft.issue=6&amp;rft.pages=1051-1062&amp;rft.date=2020-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8287565%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33099450&amp;rft_id=info%3Adoi%2F10.1016%2Fj.mcna.2020.08.007&amp;rft.aulast=Carlsson&amp;rft.aufirst=SV&amp;rft.au=Vickers%2C+AJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8287565&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFColemanCroucherPadhaniClézardin2020" class="citation journal cs1">Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R, Costa L (October 2020). "Bone metastases". <i>Nat Rev Dis Primers</i>. <b>6</b> (1): 83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41572-020-00216-3">10.1038/s41572-020-00216-3</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="https://hdl.handle.net/20.500.11820%2F6bac9e59-0afa-4b4a-bebf-4e747b889917">20.500.11820/6bac9e59-0afa-4b4a-bebf-4e747b889917</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33060614">33060614</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:222350837">222350837</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat+Rev+Dis+Primers&amp;rft.atitle=Bone+metastases&amp;rft.volume=6&amp;rft.issue=1&amp;rft.pages=83&amp;rft.date=2020-10&amp;rft_id=info%3Ahdl%2F20.500.11820%2F6bac9e59-0afa-4b4a-bebf-4e747b889917&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A222350837%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33060614&amp;rft_id=info%3Adoi%2F10.1038%2Fs41572-020-00216-3&amp;rft.aulast=Coleman&amp;rft.aufirst=RE&amp;rft.au=Croucher%2C+PI&amp;rft.au=Padhani%2C+AR&amp;rft.au=Cl%C3%A9zardin%2C+P&amp;rft.au=Chow%2C+E&amp;rft.au=Fallon%2C+M&amp;rft.au=Guise%2C+T&amp;rft.au=Colangeli%2C+S&amp;rft.au=Capanna%2C+R&amp;rft.au=Costa%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDesaiMcManusSharifi2021" class="citation journal cs1">Desai K, McManus JM, Sharifi N (May 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152444">"Hormonal Therapy for Prostate Cancer"</a>. <i>Endocr Rev</i>. <b>42</b> (3): 354–373. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fendrev%2Fbnab002">10.1210/endrev/bnab002</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152444">8152444</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33480983">33480983</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocr+Rev&amp;rft.atitle=Hormonal+Therapy+for+Prostate+Cancer&amp;rft.volume=42&amp;rft.issue=3&amp;rft.pages=354-373&amp;rft.date=2021-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8152444%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33480983&amp;rft_id=info%3Adoi%2F10.1210%2Fendrev%2Fbnab002&amp;rft.aulast=Desai&amp;rft.aufirst=K&amp;rft.au=McManus%2C+JM&amp;rft.au=Sharifi%2C+N&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8152444&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFClinical_Overview2022" class="citation encyclopaedia cs1">Hessen MT, ed. (August 2022). "Prostate Cancer". <i>Clinical Overviews</i>. Point of Care. Elsevier.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Prostate+Cancer&amp;rft.btitle=Clinical+Overviews&amp;rft.series=Point+of+Care&amp;rft.pub=Elsevier&amp;rft.date=2022-08&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLoebEastham2021" class="citation book cs1">Loeb S, Eastham JA (2021). "Diagnosis and Staging of Prostate Cancer".  In Partin AW, Dmochowski RR, Kavoussi LR, Peters CA (eds.). <i>Cambell-Walsh-Wein Urology</i> (12&#160;ed.). Elsevier. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-323-54642-3" title="Special:BookSources/978-0-323-54642-3"><bdi>978-0-323-54642-3</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Diagnosis+and+Staging+of+Prostate+Cancer&amp;rft.btitle=Cambell-Walsh-Wein+Urology&amp;rft.edition=12&amp;rft.pub=Elsevier&amp;rft.date=2021&amp;rft.isbn=978-0-323-54642-3&amp;rft.aulast=Loeb&amp;rft.aufirst=S&amp;rft.au=Eastham%2C+JA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMerrielFunstonHamilton2018" class="citation journal cs1">Merriel SW, Funston G, Hamilton W (September 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133140">"Prostate Cancer in Primary Care"</a>. <i>Adv Ther</i>. <b>35</b> (9): 1285–1294. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs12325-018-0766-1">10.1007/s12325-018-0766-1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133140">6133140</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30097885">30097885</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Adv+Ther&amp;rft.atitle=Prostate+Cancer+in+Primary+Care&amp;rft.volume=35&amp;rft.issue=9&amp;rft.pages=1285-1294&amp;rft.date=2018-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6133140%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30097885&amp;rft_id=info%3Adoi%2F10.1007%2Fs12325-018-0766-1&amp;rft.aulast=Merriel&amp;rft.aufirst=SW&amp;rft.au=Funston%2C+G&amp;rft.au=Hamilton%2C+W&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6133140&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMundleAfenyaAgarwal2021" class="citation journal cs1">Mundle R, Afenya E, Agarwal N (September 2021). "The effectiveness of psychological intervention for depression, anxiety, and distress in prostate cancer: a systematic review of literature". <i>Prostate Cancer Prostatic Dis</i>. <b>24</b> (3): 674–687. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41391-021-00342-3">10.1038/s41391-021-00342-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33750905">33750905</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostate+Cancer+Prostatic+Dis&amp;rft.atitle=The+effectiveness+of+psychological+intervention+for+depression%2C+anxiety%2C+and+distress+in+prostate+cancer%3A+a+systematic+review+of+literature&amp;rft.volume=24&amp;rft.issue=3&amp;rft.pages=674-687&amp;rft.date=2021-09&amp;rft_id=info%3Adoi%2F10.1038%2Fs41391-021-00342-3&amp;rft_id=info%3Apmid%2F33750905&amp;rft.aulast=Mundle&amp;rft.aufirst=R&amp;rft.au=Afenya%2C+E&amp;rft.au=Agarwal%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPernarEbotWilsonMucci2018" class="citation journal cs1">Pernar CH, Ebot EM, Wilson KM, Mucci LA (December 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280714">"The Epidemiology of Prostate Cancer"</a>. <i>Cold Spring Harb Perspect Med</i>. <b>8</b> (12): a030361. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1101%2Fcshperspect.a030361">10.1101/cshperspect.a030361</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280714">6280714</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29311132">29311132</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cold+Spring+Harb+Perspect+Med&amp;rft.atitle=The+Epidemiology+of+Prostate+Cancer&amp;rft.volume=8&amp;rft.issue=12&amp;rft.pages=a030361&amp;rft.date=2018-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6280714%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29311132&amp;rft_id=info%3Adoi%2F10.1101%2Fcshperspect.a030361&amp;rft.aulast=Pernar&amp;rft.aufirst=CH&amp;rft.au=Ebot%2C+EM&amp;rft.au=Wilson%2C+KM&amp;rft.au=Mucci%2C+LA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6280714&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRebelloOingKnudsenLoeb2021" class="citation journal cs1">Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, Gillessen S, Van der Kwast T, Bristow RG (February 2021). "Prostate cancer". <i>Nat Rev Dis Primers</i>. <b>7</b> (1): 9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41572-020-00243-0">10.1038/s41572-020-00243-0</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33542230">33542230</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:231794303">231794303</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat+Rev+Dis+Primers&amp;rft.atitle=Prostate+cancer&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=9&amp;rft.date=2021-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A231794303%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33542230&amp;rft_id=info%3Adoi%2F10.1038%2Fs41572-020-00243-0&amp;rft.aulast=Rebello&amp;rft.aufirst=RJ&amp;rft.au=Oing%2C+C&amp;rft.au=Knudsen%2C+KE&amp;rft.au=Loeb%2C+S&amp;rft.au=Johnson%2C+DC&amp;rft.au=Reiter%2C+RE&amp;rft.au=Gillessen%2C+S&amp;rft.au=Van+der+Kwast%2C+T&amp;rft.au=Bristow%2C+RG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFScherEastham2022" class="citation book cs1">Scher HI, Eastham JA (2022). "87: Benign and Malignant Diseases of the Prostate".  In Loscalzo J, Fauci A, Kasper D,  et&#160;al. (eds.). <i><a href="/wiki/Harrison%27s_Principles_of_Internal_Medicine" title="Harrison&#39;s Principles of Internal Medicine">Harrison's Principles of Internal Medicine</a></i> (21&#160;ed.). McGraw Hill. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-264-26850-4" title="Special:BookSources/978-1-264-26850-4"><bdi>978-1-264-26850-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=87%3A+Benign+and+Malignant+Diseases+of+the+Prostate&amp;rft.btitle=Harrison%27s+Principles+of+Internal+Medicine&amp;rft.edition=21&amp;rft.pub=McGraw+Hill&amp;rft.date=2022&amp;rft.isbn=978-1-264-26850-4&amp;rft.aulast=Scher&amp;rft.aufirst=HI&amp;rft.au=Eastham%2C+JA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFStephensonAbouassalyKlein2021" class="citation book cs1">Stephenson AJ, Abouassaly R, Klein EA (2021). "Epidemiology, Etiology, and Prevention of Prostate Cancer".  In Partin AW, Dmochowski RR, Kavoussi LR, Peters CA (eds.). <i>Cambell-Walsh-Wein Urology</i> (12&#160;ed.). Elsevier. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-323-54642-3" title="Special:BookSources/978-0-323-54642-3"><bdi>978-0-323-54642-3</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Epidemiology%2C+Etiology%2C+and+Prevention+of+Prostate+Cancer&amp;rft.btitle=Cambell-Walsh-Wein+Urology&amp;rft.edition=12&amp;rft.pub=Elsevier&amp;rft.date=2021&amp;rft.isbn=978-0-323-54642-3&amp;rft.aulast=Stephenson&amp;rft.aufirst=AJ&amp;rft.au=Abouassaly%2C+R&amp;rft.au=Klein%2C+EA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSandhuMooreChiongBeltran2021" class="citation journal cs1">Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG (September 2021). "Prostate cancer". <i>Lancet</i>. <b>398</b> (10305): 1075–1090. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2821%2900950-8">10.1016/S0140-6736(21)00950-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34370973">34370973</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:236941733">236941733</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Prostate+cancer&amp;rft.volume=398&amp;rft.issue=10305&amp;rft.pages=1075-1090&amp;rft.date=2021-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A236941733%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F34370973&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2821%2900950-8&amp;rft.aulast=Sandhu&amp;rft.aufirst=S&amp;rft.au=Moore%2C+CM&amp;rft.au=Chiong%2C+E&amp;rft.au=Beltran%2C+H&amp;rft.au=Bristow%2C+RG&amp;rft.au=Williams%2C+SG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTeoRathkopfKantoff2019" class="citation journal cs1">Teo MY, Rathkopf DE, Kantoff P (January 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441973">"Treatment of Advanced Prostate Cancer"</a>. <i>Annu Rev Med</i>. <b>70</b>: 479–499. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1146%2Fannurev-med-051517-011947">10.1146/annurev-med-051517-011947</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441973">6441973</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30691365">30691365</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annu+Rev+Med&amp;rft.atitle=Treatment+of+Advanced+Prostate+Cancer&amp;rft.volume=70&amp;rft.pages=479-499&amp;rft.date=2019-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6441973%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30691365&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev-med-051517-011947&amp;rft.aulast=Teo&amp;rft.aufirst=MY&amp;rft.au=Rathkopf%2C+DE&amp;rft.au=Kantoff%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6441973&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFThompsonWoodFeuer2007" class="citation journal cs1">Thompson JC, Wood J, Feuer D (2007). "Prostate cancer: palliative care and pain relief". <i>Br Med Bull</i>. <b>83</b>: 341–54. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbmb%2Fldm018">10.1093/bmb/ldm018</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17628024">17628024</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br+Med+Bull&amp;rft.atitle=Prostate+cancer%3A+palliative+care+and+pain+relief&amp;rft.volume=83&amp;rft.pages=341-54&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1093%2Fbmb%2Fldm018&amp;rft_id=info%3Apmid%2F17628024&amp;rft.aulast=Thompson&amp;rft.aufirst=JC&amp;rft.au=Wood%2C+J&amp;rft.au=Feuer%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li></ul>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Prostate_cancer&amp;action=edit&amp;section=33" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1134653256">.mw-parser-output .side-box{margin:4px 0;box-sizing:border-box;border:1px solid #aaa;font-size:88%;line-height:1.25em;background-color:#f9f9f9;display:flow-root}.mw-parser-output .side-box-abovebelow,.mw-parser-output .side-box-text{padding:0.25em 0.9em}.mw-parser-output .side-box-image{padding:2px 0 2px 0.9em;text-align:center}.mw-parser-output .side-box-imageright{padding:2px 0.9em 2px 0;text-align:center}@media(min-width:500px){.mw-parser-output .side-box-flex{display:flex;align-items:center}.mw-parser-output .side-box-text{flex:1}}@media(min-width:720px){.mw-parser-output .side-box{width:238px}.mw-parser-output .side-box-right{clear:right;float:right;margin-left:1em}.mw-parser-output .side-box-left{margin-right:1em}}</style><style data-mw-deduplicate="TemplateStyles:r1097092911">.mw-parser-output .sister-box .side-box-abovebelow{padding:0.75em 0;text-align:center}.mw-parser-output .sister-box .side-box-abovebelow>b{display:block}.mw-parser-output .sister-box .side-box-text>ul{border-top:1px solid #aaa;padding:0.75em 0;width:217px;margin:0 auto}.mw-parser-output .sister-box .side-box-text>ul>li{min-height:31px}.mw-parser-output .sister-logo{display:inline-block;width:31px;line-height:31px;vertical-align:middle;text-align:center}.mw-parser-output .sister-link{display:inline-block;margin-left:4px;width:182px;vertical-align:middle}</style><div role="navigation" aria-labelledby="sister-projects" class="side-box metadata side-box-right sister-box sistersitebox plainlinks"><style data-mw-deduplicate="TemplateStyles:r1126788409">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style>
<div class="side-box-abovebelow">
<b>Prostate cancer</b>  at Wikipedia's <a href="/wiki/Wikipedia:Wikimedia_sister_projects" title="Wikipedia:Wikimedia sister projects"><span id="sister-projects">sister projects</span></a></div>
<div class="side-box-flex">
<div class="side-box-text plainlist"><ul><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/0/06/Wiktionary-logo-v2.svg/27px-Wiktionary-logo-v2.svg.png" decoding="async" width="27" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/en/thumb/0/06/Wiktionary-logo-v2.svg/41px-Wiktionary-logo-v2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/0/06/Wiktionary-logo-v2.svg/54px-Wiktionary-logo-v2.svg.png 2x" data-file-width="391" data-file-height="391" /></span><span class="sister-link"><a href="https://en.wiktionary.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="wikt:Special:Search/Prostate cancer">Definitions</a> from Wiktionary</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/20px-Commons-logo.svg.png" decoding="async" width="20" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/40px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></span><span class="sister-link"><a href="https://commons.wikimedia.org/wiki/Category:Prostate_cancer" class="extiw" title="c:Category:Prostate cancer">Media</a> from Commons</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/27px-Wikinews-logo.svg.png" decoding="async" width="27" height="15" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/41px-Wikinews-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/54px-Wikinews-logo.svg.png 2x" data-file-width="759" data-file-height="415" /></span><span class="sister-link"><a href="https://en.wikinews.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="n:Special:Search/Prostate cancer">News</a> from Wikinews</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/23px-Wikiquote-logo.svg.png" decoding="async" width="23" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/35px-Wikiquote-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/46px-Wikiquote-logo.svg.png 2x" data-file-width="300" data-file-height="355" /></span><span class="sister-link"><a href="https://en.wikiquote.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="q:Special:Search/Prostate cancer">Quotations</a> from Wikiquote</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/26px-Wikisource-logo.svg.png" decoding="async" width="26" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/39px-Wikisource-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/51px-Wikisource-logo.svg.png 2x" data-file-width="410" data-file-height="430" /></span><span class="sister-link"><a href="https://en.wikisource.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="s:Special:Search/Prostate cancer">Texts</a> from Wikisource</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/27px-Wikibooks-logo.svg.png" decoding="async" width="27" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/41px-Wikibooks-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/54px-Wikibooks-logo.svg.png 2x" data-file-width="300" data-file-height="300" /></span><span class="sister-link"><a href="https://en.wikibooks.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="b:Special:Search/Prostate cancer">Textbooks</a> from Wikibooks</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0b/Wikiversity_logo_2017.svg/27px-Wikiversity_logo_2017.svg.png" decoding="async" width="27" height="22" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0b/Wikiversity_logo_2017.svg/41px-Wikiversity_logo_2017.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0b/Wikiversity_logo_2017.svg/54px-Wikiversity_logo_2017.svg.png 2x" data-file-width="626" data-file-height="512" /></span><span class="sister-link"><a href="https://en.wikiversity.org/wiki/Special:Search/Prostate_cancer" class="extiw" title="v:Special:Search/Prostate cancer">Resources</a> from Wikiversity</span></li></ul></div></div>
</div>
<ul><li><a rel="nofollow" class="external text" href="https://curlie.org/Health/Conditions_and_Diseases/Cancer/Genitourinary/Prostate">Prostate cancer</a> at <a href="/wiki/Curlie" class="mw-redirect" title="Curlie">Curlie</a></li>
<li><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160922192529/http://patients.uroweb.org/i-am-a-urology-patient/prostate-cancer/">Patient-centered information from the European Urological Association</a></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://connect.mayoclinic.org/page/podcasts/newsfeed-post/title/">"Diagnosing and treating prostate cancer (video)"</a>. <i>Mayo Clinic</i>. February 2020.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Mayo+Clinic&amp;rft.atitle=Diagnosing+and+treating+prostate+cancer+%28video%29&amp;rft.date=2020-02&amp;rft_id=https%3A%2F%2Fconnect.mayoclinic.org%2Fpage%2Fpodcasts%2Fnewsfeed-post%2Ftitle%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AProstate+cancer" class="Z3988"></span></li></ul>
<div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-label="Navbox" style="width:100%; margin:0.5em 0 0.5em 0;;padding:3px"><table class="nowraplinks navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">Classification</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><div style="position:relative; float:right; font-size:0.8em;"><a href="https://www.wikidata.org/wiki/Q181257" class="extiw" title="d:Q181257">D</a></div><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-11" title="ICD-11">11</a></b>: <a rel="nofollow" class="external text" href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1552457716">2C82</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></b>: <a rel="nofollow" class="external text" href="https://icd.who.int/browse10/2019/en#/C61">C61</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></b>: <a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=185">185</a></li><li><b><a href="/wiki/Online_Mendelian_Inheritance_in_Man" title="Online Mendelian Inheritance in Man">OMIM</a></b>: <a rel="nofollow" class="external text" href="https://omim.org/entry/176807">176807</a></li><li><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b>: <a rel="nofollow" class="external text" href="https://meshb.nlm.nih.gov/record/ui?ui=D011471">D011471</a></li><li><b><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></b>: <a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb10780.htm">10780</a></li></ul></div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">External resources</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></b>: <a rel="nofollow" class="external text" href="https://www.nlm.nih.gov/medlineplus/ency/article/000380.htm">000380</a></li><li><b><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></b>: <a rel="nofollow" class="external text" href="https://emedicine.medscape.com/radio/574-overview">radio/574</a></li><li><b><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></b>: <a rel="nofollow" class="external text" href="https://patient.info/doctor/prostate-cancer-pro">Prostate cancer</a></li></ul></div></div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"></div><div role="navigation" class="navbox" aria-labelledby="*_Tumors_of_the_male_urogenital_system" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Male_genital_neoplasia" title="Template:Male genital neoplasia"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Male_genital_neoplasia" title="Template talk:Male genital neoplasia"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Male_genital_neoplasia&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="*_Tumors_of_the_male_urogenital_system" style="font-size:114%;margin:0 4em">
<ul><li><a href="/wiki/Neoplasm" title="Neoplasm">Tumors</a> of the male <a href="/wiki/Urogenital_system" class="mw-redirect" title="Urogenital system">urogenital system</a></li></ul>
</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Testicular_cancer" title="Testicular cancer">Testicles</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sex_cord%E2%80%93gonadal_stromal_tumour" title="Sex cord–gonadal stromal tumour">Sex cord–<br />gonadal stromal</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Sertoli%E2%80%93Leydig_cell_tumour" title="Sertoli–Leydig cell tumour">Sertoli–Leydig cell tumour</a>
<ul><li><a href="/wiki/Sertoli_cell_tumour" title="Sertoli cell tumour">Sertoli cell tumour</a></li>
<li><a href="/wiki/Leydig_cell_tumour" title="Leydig cell tumour">Leydig cell tumour</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Germ_cell_tumor" title="Germ cell tumor">Germ cell</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Germ_cell_tumor#Germinomatous" title="Germ cell tumor">G</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Seminoma" title="Seminoma">Seminoma</a>
<ul><li><a href="/wiki/Spermatocytic_tumor" title="Spermatocytic tumor">Spermatocytic tumor</a></li>
<li><a href="/wiki/Germ_cell_neoplasia_in_situ" title="Germ cell neoplasia in situ">Germ cell neoplasia in situ</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Germ_cell_tumor#Nongerminomatous" title="Germ cell tumor">NG</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Embryonal_carcinoma" title="Embryonal carcinoma">Embryonal carcinoma</a></li>
<li><a href="/wiki/Endodermal_sinus_tumor" title="Endodermal sinus tumor">Endodermal sinus tumor</a></li>
<li><a href="/wiki/Gonadoblastoma" title="Gonadoblastoma">Gonadoblastoma</a></li>
<li><a href="/wiki/Teratoma" title="Teratoma">Teratoma</a></li>
<li><a href="/wiki/Choriocarcinoma" title="Choriocarcinoma">Choriocarcinoma</a></li>
<li><a href="/wiki/Embryoma" title="Embryoma">Embryoma</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a class="mw-selflink selflink">Prostate</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Adenocarcinoma" title="Adenocarcinoma">Adenocarcinoma</a></li>
<li><a href="/wiki/High-grade_prostatic_intraepithelial_neoplasia" title="High-grade prostatic intraepithelial neoplasia">High-grade prostatic intraepithelial neoplasia</a>
<ul><li><a href="/wiki/High-grade_prostatic_intraepithelial_neoplasia" title="High-grade prostatic intraepithelial neoplasia">HGPIN</a></li></ul></li>
<li><a href="/wiki/Small-cell_carcinoma#Prostate" title="Small-cell carcinoma">Small-cell carcinoma</a></li>
<li><a href="/wiki/Transitional_cell_carcinoma#Prostate" title="Transitional cell carcinoma">Transitional-cell carcinoma</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Penile_cancer" title="Penile cancer">Penis</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Penile_cancer" title="Penile cancer">Carcinoma</a>
<ul><li><a href="/wiki/Extramammary_Paget%27s_disease" title="Extramammary Paget&#39;s disease">Extramammary Paget's disease</a></li></ul></li>
<li><a href="/wiki/Bowen%27s_disease" class="mw-redirect" title="Bowen&#39;s disease">Bowen's disease</a></li>
<li><a href="/wiki/Bowenoid_papulosis" title="Bowenoid papulosis">Bowenoid papulosis</a></li>
<li><a href="/wiki/Erythroplasia_of_Queyrat" class="mw-redirect" title="Erythroplasia of Queyrat">Erythroplasia of Queyrat</a></li>
<li><a href="/wiki/Hirsuties_coronae_glandis" class="mw-redirect" title="Hirsuties coronae glandis">Hirsuties coronae glandis</a></li></ul>
</div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"><style data-mw-deduplicate="TemplateStyles:r1038841319">.mw-parser-output .tooltip-dotted{border-bottom:1px dotted;cursor:help}</style><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1038841319"></div><div role="navigation" class="navbox authority-control" aria-label="Navbox" style="padding:3px"><table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a>: National <a href="https://www.wikidata.org/wiki/Q181257#identifiers" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" class="noprint" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><span class="uid"><a rel="nofollow" class="external text" href="https://catalogue.bnf.fr/ark:/12148/cb12647583w">France</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://data.bnf.fr/ark:/12148/cb12647583w">BnF data</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://d-nb.info/gnd/4047511-6">Germany</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="http://uli.nli.org.il/F/?func=find-b&amp;local_base=NLX10&amp;find_code=UID&amp;request=987007541096505171">Israel</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://id.loc.gov/authorities/sh85107606">United States</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://id.ndl.go.jp/auth/ndlna/00575400">Japan</a></span></li>
<li><span class="uid"><span class="rt-commentedText tooltip tooltip-dotted" title="rakovina prostaty"><a rel="nofollow" class="external text" href="https://aleph.nkp.cz/F/?func=find-c&amp;local_base=aut&amp;ccl_term=ica=ph135009&amp;CON_LNG=ENG">Czech Republic</a></span></span>
<ul><li><span class="uid"><span class="rt-commentedText tooltip tooltip-dotted" title="nádory prostaty"><a rel="nofollow" class="external text" href="https://aleph.nkp.cz/F/?func=find-c&amp;local_base=aut&amp;ccl_term=ica=ph281339&amp;CON_LNG=ENG">2</a></span></span></li></ul></li></ul>
</div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw1383
Cached time: 20230627183522
Cache expiry: 1814400
Reduced expiry: false
Complications: [vary‐revision‐sha1, show‐toc]
CPU time usage: 2.101 seconds
Real time usage: 2.297 seconds
Preprocessor visited node count: 16707/1000000
Post‐expand include size: 354469/2097152 bytes
Template argument size: 18174/2097152 bytes
Highest expansion depth: 17/100
Expensive parser function count: 18/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 439545/5000000 bytes
Lua time usage: 1.385/10.000 seconds
Lua memory usage: 15498967/52428800 bytes
Lua Profile:
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::callParserFunction      260 ms       17.8%
    ?                                                                240 ms       16.4%
    recursiveClone <mwInit.lua:41>                                   160 ms       11.0%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::getAllExpandedArguments      140 ms        9.6%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::gsub      100 ms        6.8%
    dataWrapper <mw.lua:672>                                          80 ms        5.5%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::find       60 ms        4.1%
    (for generator)                                                   60 ms        4.1%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::getEntityStatements       40 ms        2.7%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::getSiteLinkPageName       40 ms        2.7%
    [others]                                                         280 ms       19.2%
Number of Wikibase entities loaded: 1/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 2044.451      1 -total
 35.21%  719.759      1 Template:Reflist
 23.81%  486.797    142 Template:Sfn
 17.23%  352.288     60 Template:Cite_journal
 11.37%  232.431     36 Template:Cite_web
  8.51%  173.928      4 Template:Navbox
  7.81%  159.641      1 Template:Medical_resources
  5.72%  116.918      2 Template:Hlist
  5.64%  115.382    158 Template:Main_other
  4.61%   94.224      1 Template:Sister_project_links
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:88078-0!canonical and timestamp 20230627183520 and revision id 1162216808. Rendering was triggered because: api-parse
 -->
</div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript>
<div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Prostate_cancer&amp;oldid=1162216808">https://en.wikipedia.org/w/index.php?title=Prostate_cancer&amp;oldid=1162216808</a>"</div></div>
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Prostate_cancer" title="Category:Prostate cancer">Prostate cancer</a></li><li><a href="/wiki/Category:Male_genital_neoplasia" title="Category:Male genital neoplasia">Male genital neoplasia</a></li><li><a href="/wiki/Category:Neoplastic_and_hyperplastic_prostate_disorders" title="Category:Neoplastic and hyperplastic prostate disorders">Neoplastic and hyperplastic prostate disorders</a></li><li><a href="/wiki/Category:Types_of_cancer" title="Category:Types of cancer">Types of cancer</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Wikipedia_articles_needing_clarification_from_September_2022" title="Category:Wikipedia articles needing clarification from September 2022">Wikipedia articles needing clarification from September 2022</a></li><li><a href="/wiki/Category:Articles_citing_retracted_publications" title="Category:Articles citing retracted publications">Articles citing retracted publications</a></li><li><a href="/wiki/Category:All_articles_with_dead_external_links" title="Category:All articles with dead external links">All articles with dead external links</a></li><li><a href="/wiki/Category:Articles_with_dead_external_links_from_October_2022" title="Category:Articles with dead external links from October 2022">Articles with dead external links from October 2022</a></li><li><a href="/wiki/Category:Articles_with_permanently_dead_external_links" title="Category:Articles with permanently dead external links">Articles with permanently dead external links</a></li><li><a href="/wiki/Category:CS1_maint:_unfit_URL" title="Category:CS1 maint: unfit URL">CS1 maint: unfit URL</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_matches_Wikidata" title="Category:Short description matches Wikidata">Short description matches Wikidata</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li><li><a href="/wiki/Category:Wikipedia_articles_in_need_of_updating_from_February_2023" title="Category:Wikipedia articles in need of updating from February 2023">Wikipedia articles in need of updating from February 2023</a></li><li><a href="/wiki/Category:All_Wikipedia_articles_in_need_of_updating" title="Category:All Wikipedia articles in need of updating">All Wikipedia articles in need of updating</a></li><li><a href="/wiki/Category:Articles_needing_additional_references_from_August_2020" title="Category:Articles needing additional references from August 2020">Articles needing additional references from August 2020</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:All_articles_lacking_reliable_references" title="Category:All articles lacking reliable references">All articles lacking reliable references</a></li><li><a href="/wiki/Category:Articles_lacking_reliable_references_from_November_2017" title="Category:Articles lacking reliable references from November 2017">Articles lacking reliable references from November 2017</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_December_2022" title="Category:Articles with unsourced statements from December 2022">Articles with unsourced statements from December 2022</a></li><li><a href="/wiki/Category:Pages_using_Sister_project_links_with_default_search" title="Category:Pages using Sister project links with default search">Pages using Sister project links with default search</a></li><li><a href="/wiki/Category:Articles_with_Curlie_links" title="Category:Articles with Curlie links">Articles with Curlie links</a></li><li><a href="/wiki/Category:Articles_with_BNF_identifiers" title="Category:Articles with BNF identifiers">Articles with BNF identifiers</a></li><li><a href="/wiki/Category:Articles_with_BNFdata_identifiers" title="Category:Articles with BNFdata identifiers">Articles with BNFdata identifiers</a></li><li><a href="/wiki/Category:Articles_with_GND_identifiers" title="Category:Articles with GND identifiers">Articles with GND identifiers</a></li><li><a href="/wiki/Category:Articles_with_J9U_identifiers" title="Category:Articles with J9U identifiers">Articles with J9U identifiers</a></li><li><a href="/wiki/Category:Articles_with_LCCN_identifiers" title="Category:Articles with LCCN identifiers">Articles with LCCN identifiers</a></li><li><a href="/wiki/Category:Articles_with_NDL_identifiers" title="Category:Articles with NDL identifiers">Articles with NDL identifiers</a></li><li><a href="/wiki/Category:Articles_with_NKC_identifiers" title="Category:Articles with NKC identifiers">Articles with NKC identifiers</a></li></ul></div></div>
				</div>
			</main>
			
		</div>
		<div class="mw-footer-container">
			
<footer id="footer" class="mw-footer" role="contentinfo" >
	<ul id="footer-info">
	<li id="footer-info-lastmod"> This page was last edited on 27 June 2023, at 18:35<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike License 4.0</a><a rel="license" href="//creativecommons.org/licenses/by-sa/4.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places">
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Universal_Code_of_Conduct">Code of Conduct</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Prostate_cancer&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
	<li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation" loading="lazy" /></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img src="/static/images/footer/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"></a></li>
</ul>

</footer>

		</div>
	</div> 
</div> 
<div class='vector-settings'>
	
<button
	id=""
	class="cdx-button cdx-button--icon-only vector-limited-width-toggle"
	><span class="vector-icon mw-ui-icon-fullScreen mw-ui-icon-wikimedia-fullScreen"></span>

<span>Toggle limited content width</span>

</button>

</div>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw1430","wgBackendResponseTime":135,"wgPageParseReport":{"limitreport":{"cputime":"2.101","walltime":"2.297","ppvisitednodes":{"value":16707,"limit":1000000},"postexpandincludesize":{"value":354469,"limit":2097152},"templateargumentsize":{"value":18174,"limit":2097152},"expansiondepth":{"value":17,"limit":100},"expensivefunctioncount":{"value":18,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":439545,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 2044.451      1 -total"," 35.21%  719.759      1 Template:Reflist"," 23.81%  486.797    142 Template:Sfn"," 17.23%  352.288     60 Template:Cite_journal"," 11.37%  232.431     36 Template:Cite_web","  8.51%  173.928      4 Template:Navbox","  7.81%  159.641      1 Template:Medical_resources","  5.72%  116.918      2 Template:Hlist","  5.64%  115.382    158 Template:Main_other","  4.61%   94.224      1 Template:Sister_project_links"]},"scribunto":{"limitreport-timeusage":{"value":"1.385","limit":"10.000"},"limitreport-memusage":{"value":15498967,"limit":52428800},"limitreport-logs":"anchor_id_list = table#1 {\n    [\"CITEREFAchardPutoraOmlinZilli2022\"] = 1,\n    [\"CITEREFAdams1853\"] = 1,\n    [\"CITEREFAlimirahChenBasrawalaXin2006\"] = 1,\n    [\"CITEREFArnst2007\"] = 1,\n    [\"CITEREFAzvolinsky2012\"] = 1,\n    [\"CITEREFBaadeYouldenKrnjacki2009\"] = 1,\n    [\"CITEREFBailey2000\"] = 1,\n    [\"CITEREFBergengrenPekalaMatsoukasFainberg2023\"] = 1,\n    [\"CITEREFBishayeeKhuda-Bukhsh2013\"] = 1,\n    [\"CITEREFBourdoumisPapatsorisChrisofosEfstathiou2010\"] = 1,\n    [\"CITEREFBrawleyMohanNein2018\"] = 1,\n    [\"CITEREFBrayFerlaySoerjomataramSiegel2018\"] = 1,\n    [\"CITEREFBrowne2001\"] = 1,\n    [\"CITEREFCabarkapaPereraMcGrathLawrentschuk2016\"] = 1,\n    [\"CITEREFCarlssonVickers2020\"] = 1,\n    [\"CITEREFCatalona2018\"] = 1,\n    [\"CITEREFClinical_Overview2022\"] = 1,\n    [\"CITEREFColemanCroucherPadhaniClézardin2020\"] = 1,\n    [\"CITEREFCompagnoGentiliniJaworskiPérez2014\"] = 1,\n    [\"CITEREFDenmeadeIsaacs2002\"] = 1,\n    [\"CITEREFDesaiMcManusSharifi2021\"] = 1,\n    [\"CITEREFDrakeJonesPowersNyalwidhe2015\"] = 1,\n    [\"CITEREFEllisHwangMorrowKimminau2021\"] = 1,\n    [\"CITEREFElshanRettigJung2019\"] = 1,\n    [\"CITEREFFagerlundCormioPalangiLewin2015\"] = 1,\n    [\"CITEREFFarrellSterba2008\"] = 1,\n    [\"CITEREFFerlaySteliarova-FoucherLortet-TieulentRosso2013\"] = 1,\n    [\"CITEREFFordGregoryKimSmitherman2003\"] = 1,\n    [\"CITEREFGeethakumariCooksonKelly2016\"] = 1,\n    [\"CITEREFGhabiliTosoianSchaefferPavlovich2016\"] = 1,\n    [\"CITEREFGhoshMyers1998\"] = 1,\n    [\"CITEREFGreeneHuangSerhanPanigrahy2011\"] = 1,\n    [\"CITEREFGrossmanCurryOwensBibbins-Domingo2018\"] = 1,\n    [\"CITEREFHerbertsAnnalaSipolaNg2022\"] = 1,\n    [\"CITEREFHugginsHodges1941\"] = 1,\n    [\"CITEREFKalishMcDougalMcKinlay2000\"] = 1,\n    [\"CITEREFKokontisHsuChuuDang2005\"] = 1,\n    [\"CITEREFKokontisTakakuraHayLiao1994\"] = 1,\n    [\"CITEREFLaderachGentiliniGiribaldiDelgado2013\"] = 1,\n    [\"CITEREFLeeKatabathinaBowersonMityul2016\"] = 1,\n    [\"CITEREFLinjaSavinainenSaramäkiTammela2001\"] = 1,\n    [\"CITEREFLoebEastham2021\"] = 1,\n    [\"CITEREFLuiningCysouwMeijerHendrikse2022\"] = 1,\n    [\"CITEREFLuszczakKumarSathyadevanSimpson2020\"] = 1,\n    [\"CITEREFLytton2001\"] = 1,\n    [\"CITEREFMartínez-BoschRodriguez-VidaJuanpereLloreta2019\"] = 1,\n    [\"CITEREFMerrielFunstonHamilton2018\"] = 1,\n    [\"CITEREFMinium2017\"] = 1,\n    [\"CITEREFMundleAfenyaAgarwal2021\"] = 1,\n    [\"CITEREFMunkleyMillsElliott2016\"] = 1,\n    [\"CITEREFNahonWaddingtonDoreyAdams2011\"] = 1,\n    [\"CITEREFOkoyeSaikali2022\"] = 1,\n    [\"CITEREFPDQ_Screening_and_Prevention_Editorial_Board2002\"] = 1,\n    [\"CITEREFPernarEbotWilsonMucci2018\"] = 1,\n    [\"CITEREFRebelloOingKnudsenLoeb2021\"] = 1,\n    [\"CITEREFRendonMasonMarzoukFinelli2017\"] = 1,\n    [\"CITEREFSamuel_David_Gross1851\"] = 1,\n    [\"CITEREFSandhuMooreChiongBeltran2021\"] = 1,\n    [\"CITEREFSchallyKastinArimura1971\"] = 1,\n    [\"CITEREFScherEastham2022\"] = 1,\n    [\"CITEREFScottJohnsonSchmidtGibbons1975\"] = 1,\n    [\"CITEREFStephensonAbouassalyKlein2021\"] = 1,\n    [\"CITEREFStrattonGodwin2011\"] = 1,\n    [\"CITEREFSuzukiUedaIchikawaIto2003\"] = 1,\n    [\"CITEREFTaitt2018\"] = 1,\n    [\"CITEREFTempleton2005\"] = 1,\n    [\"CITEREFTeoRathkopfKantoff2019\"] = 1,\n    [\"CITEREFThompsonWoodFeuer2007\"] = 1,\n    [\"CITEREFTolisAckmanStellosMehta1982\"] = 1,\n    [\"CITEREFUmekitaHiipakkaKokontisLiao1996\"] = 1,\n    [\"CITEREFUrismanMolinaroFischerPlummer2006\"] = 1,\n    [\"CITEREFWallisGlaserHuHuland2018\"] = 1,\n    [\"CITEREFWalshLeporEggleston1983\"] = 1,\n    [\"CITEREFYoung1905\"] = 1,\n}\ntemplate_list = table#1 {\n    [\"!\"] = 2,\n    [\"Authority control\"] = 1,\n    [\"Citation\"] = 1,\n    [\"Citation needed\"] = 1,\n    [\"Cite book\"] = 9,\n    [\"Cite encyclopedia\"] = 1,\n    [\"Cite journal\"] = 60,\n    [\"Cite news\"] = 2,\n    [\"Cite press release\"] = 3,\n    [\"Cite web\"] = 36,\n    [\"Curlie\"] = 1,\n    [\"DEFAULTSORT:Prostate Cancer\"] = 1,\n    [\"Dead link\"] = 1,\n    [\"Harvid\"] = 1,\n    [\"ICD10\"] = 1,\n    [\"ICD11\"] = 1,\n    [\"ICD9\"] = 1,\n    [\"Infobox medical condition (new)\"] = 1,\n    [\"Legend\"] = 13,\n    [\"Main\"] = 3,\n    [\"Male genital neoplasia\"] = 1,\n    [\"Medical resources\"] = 1,\n    [\"More citations needed section\"] = 1,\n    [\"Refbegin\"] = 2,\n    [\"Refend\"] = 2,\n    [\"Reflist\"] = 1,\n    [\"Retracted\"] = 1,\n    [\"Sfn\"] = 142,\n    [\"Short description\"] = 1,\n    [\"Sister project links\"] = 1,\n    [\"TOC limit\"] = 1,\n    [\"Ums\"] = 1,\n    [\"Update\"] = 1,\n    [\"Verify spelling\"] = 1,\n}\narticle_whitelist = table#1 {\n}\n","limitreport-profile":[["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::callParserFunction","260","17.8"],["?","240","16.4"],["recursiveClone \u003CmwInit.lua:41\u003E","160","11.0"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::getAllExpandedArguments","140","9.6"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::gsub","100","6.8"],["dataWrapper \u003Cmw.lua:672\u003E","80","5.5"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::find","60","4.1"],["(for generator)","60","4.1"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::getEntityStatements","40","2.7"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::getSiteLinkPageName","40","2.7"],["[others]","280","19.2"]]},"cachereport":{"origin":"mw1383","timestamp":"20230627183522","ttl":1814400,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Prostate cancer","url":"https:\/\/en.wikipedia.org\/wiki\/Prostate_cancer","sameAs":"http:\/\/www.wikidata.org\/entity\/Q181257","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q181257","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2002-09-20T07:03:46Z","dateModified":"2023-06-27T18:35:13Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/b\/b7\/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg","headline":"male reproductive organ cancer"}</script><script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Prostate cancer","url":"https:\/\/en.wikipedia.org\/wiki\/Prostate_cancer","sameAs":"http:\/\/www.wikidata.org\/entity\/Q181257","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q181257","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2002-09-20T07:03:46Z","dateModified":"2023-06-27T18:35:13Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/b\/b7\/Diagram_showing_the_position_of_the_prostate_and_rectum_CRUK_358.svg","headline":"male reproductive organ cancer"}</script>
</body>
</html>